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Abstract 
A one-pot, two step tandem process involving an Overman rearrangement and a ring 
closing metathesis reaction has been utilised for the efficient synthesis of various cyclic 
allylic trichloroacetamides from simple allylic alcohols. Various methods were then 
investigated for the allylic oxidation of a carbocyclic amide using TBHP along with 
different transition metals such as Pd, Se, Mn and Cr. This was required for the synthesis 
of the important building blocks for the construction of structurally diverse antiviral and 
anticancer carbocyclic nucleosides and natural products. 
The oxidation of (1S)-N-(cyclohexenyl)trichloroacetamide was then studied leading to the 
preparation of two diol analogues in excellent stereoselectivity. The cyclohexene 
derivative was also stereoselectively functionalised using Upjohn dihydroxylation 
conditions or by a directed epoxidation/hydrolysis sequence of reactions to generate two 
aminocyclitols, the enantiomer of dihydroconduramine C-1 and dihydroconduramine E-1 
in excellent stereoselectivity. 
 
In addition to this, a one-pot tandem process involving a substrate-directed Overman 
rearrangement and ring closing metathesis reaction was developed for the stereoselective 
synthesis of a functionalised carbocyclic allylic trichloroacetamide. The functionalised 
carbocyclic amide was employed in the successful synthesis of a syn-(4aS,10bS)-
phenanthridone framework using a Pd-catalysed cross-coupling reaction. Stereoselective 
epoxidation and dihydroxylation of the syn-(4aS,10bS)-phenanthridone was then 
investigated leading to the preparation of new analogues of 7-deoxypancratistatin. 
Attempts were also made to use the functionalised carbocyclic amide in the total synthesis 
of the Amaryllidaceae alkaloid (+)-γ-lycorane. 
Further studies were then investigated to expand the scope of the one-pot tandem process 
to include heterocyclic derived substrates. This led to a seven-membered carbocyclic 
amide, which has been modified to create a diastereomeric core of balanol. 
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1 Introduction 
1.1 Cascade/Domino and Tandem Reactions 
Organic chemistry utilises a number of methods for the preparation of an enormous range 
of chemicals e.g. pharmaceuticals, agrochemicals, petrochemicals, natural products and 
many other materials. These diverse synthetic methodologies along with their benefits have 
a substantial impact on the environment in terms of generating toxic waste. Modern 
synthetic organic chemistry demands atom economy, avoidance of hazardous reagents and 
reduction of waste along with excellent regio-, chemo-, diastereo-, and enantioselectivity.
1
 
Over the past decades several new strategies have been applied for the synthesis of 
complex molecules to address the above demands. Tandem reactions are one example of 
those methods and have been reported extensively for the preparation of structurally 
diverse compounds. A variety of different terms such as domino, cascade, concurrent, or 
sequential processes have been used interchangeably to describe such reactions by 
different authors. Some independent efforts have been made to synchronize the 
terminology in this field on the basis of lexis. For example, according to Tietze
2
 a “domino 
reaction is a process involving two or more bond-forming transformations (usually C-C 
bonds) which take place under the same reaction conditions without adding additional 
reagents and catalysts, and in which the subsequent reactions result as a consequence of the 
functionality formed in the previous step.” A similar description came from Nicolaou3 for 
the “cascade reaction” and it excludes all such processes in which the reaction conditions 
are altered during the process. Bazan
4
 employed the term “sequential” and Winkler5 used 
“tandem” in their reviews, for reactions which involve a combination of transformations 
that may operate independently and often require additional reagents or changes in reaction 
conditions but are carried out in a single reaction vessel without purification between steps. 
So cascade or domino should be used for the description of “uninterrupted simultaneous” 
reactions where as tandem is a more broad and frequent term for reactions which “follow 
one another”. 
The utility of tandem processes is continuously growing because of their distinguished 
intervening steps. These processes allow multiple transformations in one synthetic 
operation, minimising the need of handling and isolating intermediates and improving the 
practical efficiency. Thus, the number of laboratory operations in terms of waste and 
resource management is decreased.
6
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The first tandem reaction appeared in the literature with Robinson’s one-pot synthesis of 
tropinone in 1917 (Scheme 1).
7
 He made use of the Mannich reaction in which a mixture 
of succindialdehyde 1, methylamine, and calcium salt of acetonedicarboxylic acid 2 
combines to give the bridged bicyclic tropinone 4. However, the Mannich reaction itself 
can be quoted as a first tandem reaction, which involves the nucleophilic addition of an 
amine to a carbonyl group followed by dehydration to the Schiff base.  
 
Scheme 1 - Robinson’s total synthesis of tropinone 
There are several classic examples of tandem reactions by various research groups that 
illustrate undeniable benefits of such transformations. Hirsutene 8, which is a fungal 
metabolite and precursor of various antibiotic and antitumor compounds has been 
synthesised by a cascade radical approach.
8
 It demonstrates the viability of the process by 
the formation of two rings via radical cyclisation of readily available precursor 6 in a 
single step (Scheme 2).  
 
Scheme 2 - Cascade radical cyclisation in the total synthesis of (±)-hirsutene 
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Another elegant example of tandem conjugate addition-aldol cyclisation was reported by 
Krische and co-workers that established the role of tandem reactions in synthetic 
chemistry.
9
 It enables the synthesis of penta- and hexa-cyclic rings from aromatic and 
aliphatic mono-enone and mono-ketone precursors. It relies on a highly diastereo- and 
enantioselective catalytic carbometallative aldol cycloreduction. It remarkably generates 
three stereogenic centres in a single reaction and has distinctive advantages over other 
asymmetric addition reactions. This methodology allows the process to be carried out in 
aqueous solvent and at moderate temperature without reducing the enantioselectivity. The 
reaction proceeds via transmetalation of an aryl group from boron to rhodium and then 
enone insertion into an aryl rhodium bond makes a rhodium enolate. A Zimmerman-
Traxler transition state controls the stereoselectivity in the reaction, which on hydrolysis 
transforms the complex into the product 10 (Scheme 3).  
 
Scheme 3 - Diastereo- and enantioselective tandem conjugate addition-aldol cyclization 
1.1.1 The Classification of Tandem Reactions 
The classification of tandem reactions is difficult due to involvement of many distinctive 
steps. However, various authors have differentiated these processes on the basis of 
mechanism of each step.
2-4,10,11
 Nicolaou and co-workers grouped such reactions into five 
sections with the name of nucleophilic, electrophilic, radical mediated, pericyclic, and 
transition metal catalysed processes.
3
 However many others classified tandem reactions 
into cationic, anionic, radical, pericyclic and transition metal induced reactions. According 
to Tietze, combinations of reactions of the same mechanism are called homo-domino 
reactions; whereas sequences of reactions with different mechanisms are called hetero-
domino reactions.
2
 Various types of tandem reactions with their application in natural 
product synthesis have also been reviewed below.  
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1.1.2 Cationic Tandem Reactions 
Cationic tandem reactions are the oldest known tandem reactions. In this type of reaction, a 
carbocation is formed either by elimination or by addition of a proton. This carbocation 
further reacts with a nucleophile to produce a new carbocation. This transformation ends 
with the elimination of a proton or gets trapped with another nucleophile.
10
 Various 
cationic tandem reactions have been developed and have played a great role in the 
development of natural product chemistry. Synthesis of substituted pyrrolidines by 
Overman’s group can be placed under the heading of cationic tandem reactions (Scheme 
4).
12
 This involves the aza-Cope Mannich reaction and this approach solves formidable 
problems in natural product synthesis. In the first asymmetric total synthesis of (–)-
strychnine this approach worked well to construct the pentacyclic strychnan core.
13
  
 
Scheme 4 - Tandem aza-Cope Mannich Reaction 
Lewis acid promoted pinacol-terminated Prins cyclisation is another excellent example of 
the cationic tandem reactions. This reaction builds functionality and stereochemistry in an 
acyclic fragment and helps synthesise various oxacyclic natural products by constructing a 
tetrahydrofuran from a carbonyl carbon of an aldehyde or ketone and an allylic diol 
(Scheme 5).
14
 A large numbers of other cationic tandem reactions in different synthetic 
contexts have been reported with their undeniable benefits.
2,4,11
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Scheme 5 - Asymmetric tandem pinacol-terminated Prins cyclisation 
1.1.3 Anionic Tandem Reactions 
The anionic tandem reactions are the most common type of transformations in the 
literature. In this type of reaction, a carbanion is formed by deprotonation of a CH group. 
Thus, a newly formed carbanion attacks an electrophile to form anion functionality. This 
anion reacts with another electrophile in anionic-anionic fashion to complete the reaction.
11
 
Many anionic–anionic processes involve either a Michael-initiated or -terminated process 
to generate a cyclic structure. In the syntheses of many natural products it is very common 
to use Michael–Michael tandem reactions to generate cyclic systems. Several elegant 
examples of the anionic tandem reaction have been reported in the literature e.g. Robinson 
annulation, double Michael reaction, synthesis of oxygenated derivatives of the diterpene 
alkaloid atisine and the first total synthesis of the naturally occurring enantiomer of 
tylophorine.
15,16
 Synthesis of tricyclo[5.3.1.0]undecane 19 from E-isomer 18 is an efficient 
example of tandem double Michael reactions for the construction of polycyclic systems 
(Scheme 6). Tricyclo[5.3.1.0]undecane 19 is a component of various important 
biologically active compounds e.g. patchouli alcohol 20 and seychellene 21 which have 
been used for the synthesis of taxol and for the treatment of the influenza virus.
17
 The 
intramolecular double Michael reaction of the E-isomer 18 proceeds smoothly at –78 °C by 
the treatment with LHMDS and forms an intermediate, in which two oxygens complex to 
lithium. The resulting enolate reacts with gaseous CH2O to give desired cyclised product 
19 in 83% yield as a single stereoisomer (Scheme 6). 
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Scheme 6 - Anionic tandem reaction for the synthesis of tricycloundecane 19 
1.1.4 Pericyclic Tandem Reactions 
In this type of tandem reactions, cyclic geometry is formed during the transition state and 
the reaction proceeds in a concerted fashion. The processes normally involve 
rearrangement reactions and a combination of different pericyclic reactions (Diels–Alder, 
Claisen, Cope, or electrocyclic reactions) or a combination of pericyclic reactions along 
with cationic and anionic reactions. The enantioselective synthesis of (+)-sterpurene is an 
example of a pericyclic tandem reaction (Scheme 7).
18
 
 
Scheme 7- Asymmetric tandem [2,3]-sigmatropic shift/[4+2] cycloaddition reaction 
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Various anionic pericyclic reactions have been developed by the Tietze group and have 
been used for the synthesis of a range of biologically active natural products such as indole 
alkaloids, dihydrocorynantheine and heterosteroids, such as shown in Scheme 8.
19
 Its 
synthesis involves the combining of enantiomerically pure cyclopentane derivative 25 with 
cyclic 1,3-dioxo compounds 24 through a Knoevenagel condensation. It makes use of 
catalytic amounts of ethylenediammonium diacetate (EDDA) to construct the alkylidene 
compounds 26, which react in situ to make the heterosteroid 27.
20
 
 
Scheme 8 - Synthesis of heterosteroids by tandem Knoevenagel hetero-Diels–Alder reaction 
1.1.5 Radical Tandem Reactions 
The majority of these types of reactions are homo-domino reactions. These reactions take 
place under mild reaction conditions to afford a wide range of functionalities.
10
 Radical 
tandem reactions have been widely explored in organic chemistry for the synthesis of 
various bioactive targets.  
γ-Butyrolactones and β-amino acids have been synthesized using radical addition-
cyclisation reactions (Scheme 9).
21
 The process generates two C
_
C single bonds and two 
stereogenic centers via a free radical-mediated Mannich reaction and provides direct access 
to the target molecule.  
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Scheme 9 - Asymmetric Mannich-type tandem radical addition cyclisation reaction 
Synthesis of the taxane skeleton has been made using a tandem radical macrocyclisation-
radical transannulation strategy. The synthetic design makes use of two conjugated enone 
moieties in substrate 30, which facilitates the tandem cyclisation. It first undergoes a 
radical macrocyclisation with the aid of tributyltin hydride and AIBN to provide 31, and 
then cyclises to 32 and 33 as a 3:1 mixture of two diastereomers of 
tricyclo[9.3.1.0]pentadecanedione respectively (Scheme 10).
22
 
 
Scheme 10 - Tandem radical cyclisation for the synthesis of the taxane skeleton 
1.1.6 Transition Metal Catalysed Tandem Reactions 
Transition metal-catalysed tandem reactions are of great importance in synthetic organic 
chemistry. The discovery of the ability of transition metals to interact with organic 
moieties, to connect inter- or intra-molecularly to alkenes, alkynes, etc. in tandem 
processes was certainly a breakthrough in synthetic chemistry.
3
 A plethora of ingenious 
transformations have been designed to assemble the target molecules using a variety of 
transition metals, especially palladium, ruthenium and rhodium catalysed tandem 
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reactions.
2
 Almost 40 years ago, the first Pd(0)-catalysed vinylation of aryl halides 
appeared in the literature by Mizoroki and Heck but it could not find attention and 
remained unnoticed. In the last decade, this method has been turned into a powerful 
approach.
23
 Amongst the palladium-catalysed carbon-carbon bond forming tandem 
reactions, the utility of Heck reaction for generation of tertiary or quaternary stereocenters 
and multiple-ring systems, even in sterically crowded environments, has been well 
documented.
23,24
 Now the role of Pd catalysed cross-coupling transformations have been 
accepted as a reliable method and the Nobel prize for chemistry in 2010 was awarded to 
Heck along with Suzuki and Negishi.
25
 
Transition metal catalysed tandem processes for the efficient synthesis of desired 
compounds are continuously growing e.g. synthesis of seven membered rings, namely 
[5+2]-cycloaddition between vinylcyclopropenes (VCPs) and -systems using a Diels-
Alder reaction with rhodium complexes have been investigated by Wender and co-workers 
(Scheme 11).
26
 The scope of this reaction has been extended to alkenes, allenes, and even 
intermolecular processes.
27
 
 
Scheme 11 - Rhodium-catalyzed [5+2]-cycloadditions 
This methodology has begun to find application in the total synthesis of natural products. 
For example, Martin and Ashfeld made use of this approach for the enantioselective 
syntheses of tremulenolide A 38 and tremulenediol A 39.
28
 It involved the reaction of 
alkyne 36 and a dimeric rhodium species (10 mol%) under reflux which incited the series 
of events leading to the formation of two new rings and two new stereocenters in a 
complex diastereoselective fashion to yield bicyclic aldehyde 37 in 85% yield (Scheme 
12). Initially Rh(I) coordinates to the alkene–alkyne faces of 36 followed by oxidative 
cyclisation to yield a Rh(III) metallacyclopentene. Subsequent bond rotation about the C4–
C5 bond allows the strain driven cyclopropane cleavage to put together the carbon–
rhodium and carbon–carbon bonds required for concerted ring expansion. It finally 
undergoes reductive elimination to yield bicyclic product 37 (Scheme 12). Use of this 
rhodium(I)-catalysed [5+2]-intramolecular cycloaddition leads to first enantioselective 
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syntheses of the two representative tremulane sesquiterpenes tremulenolide A 38 and and 
tremulenediol A 39. 
 
Scheme 12 - Application to the total syntheses of tremulenolide A 38 and tremulenediol A 39 
Nakai and co-workers were among the first to report palladium-catalysed tandem 
reactions.
29 For the synthesis of a γ,δ-unsaturated ketone, they made use of a Pd(II)-
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catalysed step to generate the allyl vinyl backbone for the consecutive [3,3]-sigmatropic 
rearrangement (Scheme 13).
 
 
Scheme 13 - Asymmetric domino allylation-Claisen rearrangement reaction 
The Trost group developed an outstanding approach that involves the Pd-mediated 
enediyne 43 cyclisation to construct the fused tricyclic structure 46 (Scheme 14).
30,31
 High 
atom economy and excellent diasteteroselectivity are the signature characteristics of this 
transition metal catalysed tandem process. The reaction proceeds at room temperature and 
furnishes a single diastereoisomer in very good yield. To account for the high 
diastereoselectivity, a novel Diels-Alder cycloaddition of palladadiene 44 was proposed 
with cyclisation guided by minimization of steric interaction between the bulky silyl ether 
and the dienophilic side chain. The initial adduct 45 underwent 1,4-elimination of HPdX to 
afford the tricyclic product 46.  
 
Scheme 14 - Polycycle construction via transition metal catalyzed electrocyclic process 
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1.1.7 Conclusion to Classification of Tandem process 
After the development of the ring opening/ring closing metathesis, cycloaddition, 
photochemical, metal catalysed and sigmatropic rearrangement processes, a wide variety of 
tandem reactions have been recorded in organic synthesis by combination of above and 
other methodologies together.
2
 These synthetic designs construct rapid complexity in a 
molecule in a single flask starting from simple substrates. Its synthetic utility has 
blossomed remarkably into a powerful tool in terms of atom, waste and resource economy 
and shows synergistic interplay of reaction engineering to provide unique frameworks for 
target molecules.  
The increasing number of publications and several reviews on the subject of tandem 
reactions highlight the splendid future of this field.
2-4
 The development of new tandem 
processes by the combination of many distinctive processes such as the Overman 
rearrangement and metathesis steps for the synthesis of bioactive molecule is a vibrant area 
and research in this field continues apace in many research groups.
32
  
1.2 Overman Rearrangement 
The Overman rearrangement is a sub-type of the sigmatropic rearrangement of allylic 
imidates which involves the rearrangement of allylic trichloroacetimidates to allylic 
trichloroacetamides from the readily available allylic alcohol.
33
 The original idea for the 
rearrangement of allylic imidates can be traced back to Mumm and Möller who in 1937 
reported the rearrangement of allylic benzimidate 47 to corresponding benzamide 48 
during investigation of the mechanism of Claisen rearrangement (Scheme 15).
34
 Following 
this result, several research groups reported the rearrangement of allylic imidates. 
However, the reaction was plagued by low yields and harsh conditions and could not find 
widespread use until the Overman modification.
33
 
 
Scheme 15 - The rearrangement of an allylic benzimidate to an allylic benzamide  
The Overman rearrangement is an important variant of the Claisen rearrangement and 
carries enormous potential due to the relative ease with which a wide variety of allylic 
Introduction  22 
 
trichloroacetimidates can be prepared from corresponding alcohols. Transformation of the 
imidate to the amide is a unimolecular process and proceeds via a superafacial, concerted 
[3,3]-sigmatropic rearrangement. It involves the movement of a -bond from one place to 
another in a molecule to form a new -bond having a 3,3-relationship to the original bond 
(Scheme 16). The reaction is irreversible as the formation of the amide functionality is 
exothermic by 15 kcal mol
–1
.
35,36
 Regiospecificity and stereoselectivity are the 
characteristic features of the Overman rearrangement. Moreover, isolated yields for the 
rearrangement reaction are usually high. On hydrolysis, the allylic amines can be easily 
isolated allowing the synthesis of a variety of nitrogen containing compound like amino 
sugars, amino acids, nucleotides, N-heterocycles and natural products.
37
  
 
Scheme 16 - General overview of the Overman rearrangement  
The course of the Overman rearrangement reaction is facilitated either thermally or by 
using a metal catalyst at room temperature which significantly increases the rate of the 
transformation.
38
 The mechanism and scope of both methods have been studied thoroughly 
and are discussed below. 
1.2.1 Thermal Overman Rearrangement 
The thermal Overman rearrangement has broad scope and can be applied to a variety of 
primary, secondary and tertiary allylic alcohols. Mechanistically, the thermal Overman 
rearrangement is a pericyclic, concerted, suprafacial process. The reaction is irreversible, 
which is the result of the significant driving force associated with the formation of the 
amide functionality. It involves the formation of a highly ordered chair-like transition state 
53 which facilitates the transfer of stereochemical information from the substrate to the 
newly formed σ-bond (Scheme 17). Complete transfer of chirality was observed first by 
Yamamoto and co-workers during the rearrangement of allylic trichloroacetimidate 52 of 
(1E,3R)-4-phenyl-3-buten-2-ol to (1R,2E)-trichloroacetamide 54 and supports the chair 
model that forms during the course of the thermal process.
39
 This is the striking feature of 
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the Overman rearrangement and has been ingeniously utilised in a number of synthetic 
strategies,
40,41
 thus making the reaction extremely useful in organic synthesis. 
 
Scheme 17 - Thermal rearrangement of allylic trichloroacetimidates 
Typically, the rearrangement is carried out at elevated temperature in aprotic aromatic 
solvents like toluene or xylene. However in some cases more polar solvents are preferred 
e.g. the rearrangement of dissaccharide trichloroacetimidate 55 in xylene gives only 27% 
yield, whereas the yield increases to 80% when the rearrangement is carried out in DMF. 
DMF is a more polar and basic solvent which enhances the rate of reaction and slows down 
the acid catalysed decomposition of the substrate to improve the yield of the reaction 
(Scheme 18).
42
  
 
Scheme 18 - Effect of solvent over the yield of the Overman rearrangement  
Normally primary allylic trichloroacetimidates rearrange at 140 °C in the range of 4-24 
hours whereas secondary and tertiary allylic trichloroacetimidates proceed at 110 and 80 
°C respectively in comparatively shorter reaction times. Allylic trichloroacetimidates 
derived from double allylic alcohols rearrange at further higher rate and at room 
temperature. Higher reaction rates at lower temperature for increasingly substituted allylic 
trichloroacetimidates are primarily due to stabilisation of positive charge that evolves on 
the oxygen bearing carbon in the transition state. A few representative examples are shown 
in Scheme 19.
43-45
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Scheme 19 - Representative examples of the Overman rearrangement  
Steric and electronic factors play a major role in deciding the fate of the reaction towards 
the rate and yield of the Overman rearrangement, as it is totally substrate dependent e.g. E-
alkenes react more quickly and give higher yields than the Z-alkenes which end up with 
some by-products and lower yields. This is attributed to low stability and higher heat of 
enthalpy of Z-alkenes in comparison to E alkenes.
38
 
During the course of the Overman rearrangement some acid catalysed decomposition 
competes with the rearrangement, thus reducing the yield of the acid sensitive allylic 
trichloroacetamide. In 1998, Isobe and co-workers introduced an important modification in 
the thermal Overman rearrangement to avoid decomposition pathways.
46
 They made use of 
potassium carbonate which dramatically increases the yield of the rearrangement. The 
presence of potassium carbonate (2 mg/mL) in the reaction mixture acts as an acid 
scavenger and traps any acid that may be generated during the thermal rearrangement. 
However it has been noticed, addition of other bases like DBU and n-Bu3N could not 
inhibit acid catalysed decomposition. This simple modification has increased the scope of 
the reaction for previously nonviable rearrangements.  
1.2.2 Metal catalysed Overman Rearrangement  
The Overman rearrangement can also be carried out using metal catalysis. Various metals 
including palladium(0), palladium(II), rhodium(I), mercuric(II) and iridium(I) complexes 
catalyse the rearrangement of allyl imidates to allyl amides. The first report of a metal 
catalysed rearrangement of allylic trichloroacetimidates appeared in 1974 by Overman in 
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which he made use of mercuric trifluoroacetate. Use of mercury as a catalyst considerably 
increases the rate of the reaction to the order of 10
12
 in comparison to the thermal Overman 
rearrangement and allowed the reaction to proceed at room temperature. Later, different 
experiments demonstrated that soluble complexes of PdCl2 are more efficient than the 
mercury catalysed rearrangements in term of yield, low catalyst loading and high reaction 
rate.
38
 Very recently gold(I)-catalysed Overman rearrangement has been reported which 
can proceed in water under mild conditions.
47,48
 More work is required to determine the 
scope of the gold(I) catalysed rearrangement.  
Different research groups have worked extensively to determine the mechanism of the 
metal catalysed allylic rearrangement process.
49-52
 The first account regarding the 
mechanism of the metal catalysed acetate migration in allylic acetates appeared by 
Henry.
53
 Later, a similar explanation came from Overman to elucidate the mercury(II)- 
catalysed rearrangements of allylic carbamate and allylic imidates (Scheme 20). 
 
Scheme 20 - Mechanism of metal catalysed Overman rearrangement 
The mechanism involves a cyclisation induced transition state in which metal 63 activates 
the allylic double bond of imidate 64 and allows the intramolecular nucleophilic attack by 
the imidate nitrogen to the exo face of alkene 65. This leads to a six membered alkyl 
palladium intermediate 66 which readily rearranges to produce the product 67 and 
regenerates catalyst 63 (Scheme 20).
37,53-58
 
Some reports show that during the reaction, the metal bound six-membered cyclic 
carbocation intermediate 69 adopts a chair-like conformation which minimises allylic 
strain by having the bulky metal complex at an equatorial position (Scheme 21). This 
chair-like transition state explains the formation of the new C-N bond towards the same 
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face of alkene where C-O bond breaks. Thus, chirality is transferred from reactant to 
product.
57
 
 
Scheme 21 - Chair-like transition state during metal catalysed Overman rearrangement  
Metal catalysts for the rearrangement of allyl imidates can be classified into two types. 
Type I includes bi-valent complexes e.g. Hg(CF3CO2)2, PdCl2(PhCN)2 and H2[PtCl6]. Such 
complexes give the same product as the thermal process i.e the [3,3]-sigmatropic product. 
Type II involves zero-valent complexes like Pd(PPh3)4 and Pt(PPh3)4 and give mixtures of 
[3,3] and [1,3]-sigmatropic rearrangements (Scheme 22).
59
 
 
Scheme 22 - Rearrangements of allyl imidates by the thermal, type I and type II catalysts  
Palladium(II) appeared as the most effective catalyst for the Overman rearrangement and 
exclusively generates the [3,3]-sigmatropic rearrangement product regioselectivity and 
with excellent stereoselectivity. As in the case of thermal Overman rearrangement, the 
metal catalysed process also proceeds more efficiently for E-alkenes. Pd(II) complexes 
have been used widely for the Overman rearrangement at room temperature with 4-8 mol% 
catalyst loading in aprotic solvents like THF and toluene.
55,60
 Usually Pd(II)-catalysed 
Overman rearrangements work well for primary allylic trichloroacetimidates in 
comparison to secondary allylic trichloroacetimidate rearrangements and the process is 
completed in a few hours at or below room temperature.  
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1.2.3 Enantioselective Overman Rearrangement 
Recently methods have been developed that allow the Overman rearrangement to be 
applied in asymmetric synthesis. Different types of catalyst have been synthesised by 
various research groups and have been reported with variable yields. Overman and co-
workers were pioneers in developing the enantioselective Pd(II) catalyst for the 
rearrangement of allylic imidates.
61
 Initially achiral diamine complexes of [PdCl2(bpy)] 
and [PdCl2(TMEDA)] were tried but these dichlorides could not catalyse any 
rearrangements.  
 
Figure 1 - First enantioselective Overman rearrangement catalysts 
Extensive research by the Overman and Hayashi groups resulted in the form of a series of 
cationic oxazoline and cationic Pd(diamine) chiral catalysts (selected examples are shown 
in Figure 1).
61,62
 These catalysts showed moderate to good yields and poor to moderate 
enatioselectivity (Table 1). However, in most cases Pd-diamine complexes proved 
incompatible. This was mainly due to coordination between the imidate nitrogen and the 
cationic palladium which caused undesired ionisation and elimination products in 
significant amounts.
56
 While these results revealed that an asymmetric Pd complexes could 
effect an Overman rearrangement, further efforts were required.  
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Table 1 - Rearrangement of allylic imidiates catalysed by various catalysts shown in Figure 1 
 
To circumvent ionisation and elimination pathways during the enantioselective allylic 
imidate rearrangements, a neutral catalyst was required to escape from any competing 
elimination reactions due to imidate nitrogen coordination with the cationic Pd. Subsequent 
studies by Overman and others revealed a series of neutral chiral palladacycles catalysts 
(Figure 2).
63,64
 
 
Figure 2 - Neutral chiral and ferrocenyl oxazoline palladacycle catalysts 
Many of them proved efficient catalysts for the [3,3]-sigmatropic rearrangement of allylic 
imidates to allylic amides in terms of yield and enantioselectivity, e.g. rearrangement of 
benzimidates was carried out using ferrocenyl palladacycles 76 without undergoing side 
reaction pathways in excellent yield and moderate enantioselectivity (Table 2). 
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Table 2 - Evaluation of ferrocenyl oxazoline catalysts for the Overman rearrangement 
 
In an attempt to improve the enantioselectivity, Overman and co-workers synthesised 
various ferrocenyl oxazoline (FOP) catalysts. Many of those demonstrated promising 
yields and enantioselectivities, especially 77 which catalysed the rearrangement in 
moderate to excellent yields and enantioselectivities (Table 2). However the catalyst was 
limited in scope to benzimidate substrates and gave higher enantioselectivity for Z-alkenes. 
Further study elucidated much better catalysts e.g. 78 and 79, having broad substrate scope 
along with good yields and enantioselectivity (Scheme 23). However, catalyst 78 still 
showed some drawbacks e.g. limited tolerance for cleavable protecting groups and 
required activation of the catalyst prior to use, employing 4 equivalent of AgOCOCF3. 
Thus, this could not be adopted as a practical route to enantioenriched chiral allylic 
amines.
65,66
 
 
Scheme 23- Rearrangement using ferrocenyl oxazoline catalysts  
Later cobalt oxazoline palladacycles 82 appeared as the catalyst of choice (Figure 3).
67
 
Kang and co-workers used COP for the rearrangement of Z-benzimidates 84 and reported 
excellent yields and enantioselectivities (Scheme 24).
68
 At the same time, Overman and co-
workers used COP for the rearrangement of E-allylic acetimidates 86 and showed 
rearranged products in 80–85% yield and in 92–96% ee. These reactions required 5 mol% 
of catalyst loading, which was further reduced to 2 mol% in certain cases and furnished the 
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product generally around room temperature, whilst maintaining excellent yield and 
enantioselectivity.
69,70
 
 
Scheme 24- COP-Cl catalysed rearrangement of allylic trichloroacetimidates 
Now COP-Cl has emerged as a powerful catalyst for the synthesis of of chiral allylic 
amines from achiral allylic alcohols and has found widespread application in organic 
synthesis. The COP-Cl catalysts 82 and 83, have become popular catalysts and are 
commonly referred to as (S)-(+)-COP-Cl and (R)-(–)COP-Cl respectively (Figure 3).  
 
Figure 3- Commercially available asymmetric COP-Cl catalysts 
1.2.4 Substrate directed Overman Rearrangement  
The substrate directed Overman rearrangement is an important approach to introduce new 
stereogenic centres into a compound without employing a chiral catalyst. It is based upon 
the pre-association of the reacting partners in the proximity of the reaction centre to 
influence the stereochemical outcome of the rearrangement. Such interaction of the 
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reacting partners proceeds through a highly ordered transition state during the course of the 
transformation and elicits the stereoselectivity in the process. In the Overman 
rearrangement, use of an asymmetric centre having a polar functional group in the close 
vicinity of the reaction point directs the metal catalyst towards one face of the double bond 
in preference to other. This leads to a certain level of diastereoselectivity during the 
rearrangement process and excludes any need of chiral reagents to achieve this. The degree 
of diastereoselectivity can be variable as it depends upon the nature of directing group and 
reaction conditions. 
Work by the groups of Bellûs
71
 and Sutherland
72
 have demonstrated the substrate directing 
effect in the Overman rearrangement and showed various aspects of the process. The first 
example appeared in 1993, when Bellûs noticed the significant diastereoselectivity for the 
anti-diastereomer 90 during the palladium(II)-catalysed rearrangement of 89 (Scheme 25).  
 
Scheme 25- The first substrate directed rearrangement 
Excellent anti-diastereoselectivity of this process was attributed to coordination of the 
palladium with the nitrogen atom and alkene during the rearrangement. This then adopts a 
chair-like conformation 91 and directs the catalyst towards the back face of the alkene and 
forcing the nitrogen atom of the trichloroacetimidate to attack from the other face leading 
to the major diastereomer (Scheme 26). 
 
Scheme 26- Coordination of nitrogen atom to Pd(II) directs the rearrangement 
To evaluate the substrate directing effect of different ether functional groups in the 
Overman rearrangement process, a series of the experiments were designed by Sutherland 
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and co-workers.
72
 Initially, the aim was to reveal the utility of the ether functional group as 
a directing group. A number of allylic trichloroacetimidates were prepared carrying 
different ether groups and subjected to the Overman rearrangement using 
bis(acetonitrile)palladium(II) chloride as the rearrangement catalyst. The methoxymethyl 
group appeared as the most efficient ether and allowed effective coordination with the 
metal catalyst and gave the anti-diasteromer as a major product with the ratio of 10:1. 
Bulky and encumbered ether groups plagued the coordination and as a consequence 
showed low diastereoselectivity (Table 3).
73,74
 
Table 3 - Rearrangement of allylic trichloroacetimidate having different ethers 
 
Further work by Sutherland and co-workers demonstrated the role of the oxygen atoms 
during the substrate directed rearrangement and established that presence of the oxygen 
atoms adjacent to alkene as vital for high levels of diasteroselectivity (Table 4).
72
 Results 
from the carefully designed strategy clearly demonstrate that presence of two oxygen 
atoms increases the diastereoselectivity. It is mainly due to enhanced coordination between 
the Pd(II)-metal catalyst and the oxygen atoms of the MOM group. 
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Table 4 - Pd(II)-catalysed rearrangement of the MOM-analogues 
 
It was postulated that the significant anti-diastereoselectivity of this process is due to 
coordination of Pd(II)-catalyst with the oxygen atoms of the MOM group and these direct 
the catalyst selectively to the back face of the alkene and in this way the compound adopts 
a chair-like conformation.
72
 This conformation not only minimises the allylic strain but 
also allows intramolecular attack of the imidate nitrogen from the front face of the alkene, 
thus giving major diastereomer 93a (Scheme 27). Minor diastereomer 93b is likely formed 
via 94b in which the ether group is unable to coordinate to the catalyst and is further away 
from the reaction centre. Thus, the catalyst coordinates directly to the least hindered face of 
the double bond and furnishes the minor diastereomer.  
 
Scheme 27 - Reacting conformation that leads to the major and minor diastereomer 
The scope and limitations of the substrate directed rearrangement was also investigated by 
the Sutherland group.
75
 Initially several MOM protected allylic trichloroacetimidates with 
a variety of side chains were prepared and subjected to a substrate directed Overman 
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rearrangement (Table 5). In most cases the reaction proceeded to the anti-diastereomer as 
the major product. It was noticed that rearrangements of sterically hindered allylic 
trichloroacetimidates proceeded slowly and gave significant amounts of the [1,3]-
rearrangement product while showing good diastereoselectivity (except entry 2 in Table 5, 
which showed no directing effect and give the [1,3]-product). It was attributed to extra 
steric impediments and due to Pd(0) that was formed in the reaction due to a competing β-
elimination process during the slow Pd(II)-catalysed rearrangement of the allylic imidate. 
It has already been established by the work of Ikariya and Bosnich that Pd(II) gives only 
the [3,3]-product whereas Pd(0) furnishes the [1,3]-product.
56,57
 This was further 
confirmed by addition of p-benzoquinone into the reaction mixture which forced the 
formation of the [1,3]-product (Table 5).
76
  
Table 5 - Rearrangement of allylic trichloroacetimidates having different side chains 
 
The Sutherland group have also investigated different metal catalysts for the substrate 
directed Overman rearrangement. A range of metal complexes were employed to catalyse 
the rearrangement. Best results observed were with the use of Pd(II), Pt(II) and Au(I), 
whereas NiCl2 and Cl2Ru(PPh3)3 did not show any catalytic activity. Further work was 
employed to investigate any role of solvent on the origin of directing effect in the 
rearrangement of allylic trichloroacetimidates.
73
 Several solvents were screened and results 
are listed in Table 6. Enhancement of selectivity was observed in the case of non-
coordinating solvents e.g. toluene gave significant diastereoselectivity in the ratio of 15:1, 
whereas coordinating solvents such as the ionic liquid, 1-butyl-3-methylimidazolium 
tetrafluoroborate decreased the diastereoselectivity. These results clearly demonstrate that 
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use of a coordinating solvent disrupts the binding of the catalyst to the MOM ether group 
and diminishes the directing effect while non-coordinating solvents such as toluene 
minimise competition for the coordination leading to a selective process.
75
  
Table 6 - Rearrangement of allylic trichloroacetimidates using various solvents 
 
On the basis of the above discussed results, the substrate directed Overman rearrangement 
can be regarded as an excellent substitute for chiral catalysts for a diastereoselective 
rearrangement. Generally MOM-ether groups switch on the selectivity while non- 
coordinating solvents further enhance the directing effect. Recently, substrate directed 
rearrangements have been reported as excellent methodology to generate 
diastereoselectivity in the synthesis of various natural products.
40,77,78
  
1.3 Applications of Overman rearrangement 
The Overman rearrangement has been central to the synthesis of a broad range of 
biologically active precursors including various amino acids, selective enzyme inhibitors 
and a variety of natural products. Ready access to allylic amines with complete transfer of 
chirality is the signature characteristic of this process. Several dozen applications of the 
Overman rearrangement have been reported and this number is continuously growing.
77,78
  
The first application appeared in the literature by Overman for the synthesis of 1-
azaspiro[5.5]undec-7-en-2-one 98.
79
 Such structures show their presence in a wide range of 
naturally occurring molecules and exhibit a broad range of important pharmacological 
activities.
80
 Overman designed a short and general route for the unsaturated spirolactam 98 
by utilising his developed thermal rearrangement process (Scheme 28). The substrate for 
the Overman rearrangement was synthesised by converting readily available ketone 95 into 
Introduction  36 
 
an alcohol. This alcohol was reacted with sodium hydride followed by trichloroacetonitrile 
to afford allylic trichloroacetimidate 96 and directly rearranged to allylic 
trichloroacetamide 97. The rearranged product was hydrolysed to remove the acetal 
protecting group, which was directly followed by oxidation to afford carboxylic acid. 
Hydrolysis of the trichloroacetyl group with base, followed by removal of water and 
esterification gave the corresponding ester which underwent concomitant cyclisation to 
afford the spirolactam 98. The yield of the amide was low in this synthesis but it illustrated 
the potential of the Overman rearrangement.  
 
Scheme 28 - Overman synthesis of 1-azaspiro[5.5]undec-7-en-2-one 98 
Recently the Sutherland group used the MOM ether directed Overman rearrangement for 
the stereocontrolled synthesis of several biologically active molecules and precursors of 
unnatural amino acids. For example, it has been employed for the synthesis of alkaloid 
natural product (+)--conhydrine 104 and its analogue 105 (Scheme 29).78 These are 
biologically active alkaloids and are famous for their antitumor and antiviral properties.
81
 
In this synthesis, the key substrate was prepared from allylic alcohol 99 using DBU and 
trichloroacetonitrile. It was followed by a Pd(II)-catalysed Overman rearrangement to 
generate erythro- and threo- trichloroacetamide in a ratio of 16:1 respectively. In the next 
stage the major diastereomer was further functionalised to give diene 102. Ring closing 
metathesis of 102 followed by hydrogenation, reduction and acid-mediated removal of the 
protecting group yielded target molecule 104 and its pyrrolidine analogue 105. 
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Scheme 29 - Synthesis of (+)--conhydrine using a substrate directed rearrangement 
Similar methodology was utilised for a stereoselective synthesis of (+)-monanchorin 111.
40
 
In this approach the allylic trichloroacetimidate 107 was converted to allylic 
trichloroacetamide 108 using a bis(acetonitrile)palladium(II) chloride catalysed Overman 
rearrangement in 84% yield over two steps (Scheme 30). MOM-ether directed Overman 
rearrangement gave two diastereomers in ratio of 12:1. Trace amount of the 1,3-
rearrangement product was also isolated in the reaction mixture. It was avoided by the use 
of p-benzoquinone, which reoxidised Pd(0) to Pd(II) that forms in situ due to competing β-
elimination in the reaction mixture of bulky substituents. The trichloroacetyl group of the 
major diastereomer was replaced with the Cbz-protecting group and cross metathesis was 
employed to couple 2-vinyl-1,3-dioxolane to construct the backbone of (+)-monanchorin. 
Amine 109 was coupled with the readily available guanidine unit to give 110 in 87% yield. 
Here TFA was employed for deprotection of the aldehyde, guanidine and hydroxyl groups 
to generate the natural product 111 in 75% yield.  
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Scheme 30- Synthesis of (+)-monanchorin using a substrate directed rearrangement 
Chida and co-workers reported the use of the suprafacial nature of the Overman 
rearrangement to transfer chirality for the synthesis of enantiomerically pure (–)-agelastatin 
A 120 (Scheme 31).
82
 It is recognised as an antimetastatic agent and also acts as an 
inhibitor of a number of human tumor cell lines.
83,84
 In designing the route for the synthesis 
of this target, the two nitrogen substituted stereocenters were achieved by the Overman 
rearrangement of 112 in a single operation. It was followed by a Mislow-Evans 
rearrangement of an allylic sulfide to create a hydroxyl group on the main core. Ring 
closing metathesis followed by treatment with methanesulfonic anhydride of 117, 
generated the oxazoline 118 in good yield. Further functionalisation of oxazoline 118 
produced the ,β-unsaturated ketone 119. It was then exposed to TEA to induce the aza-
Michael addition followed by cleavage of 2,4-dimethoxybenzyl group with CAN to afford 
(–)-agelastatin A 120. This very elegant synthetic approach by Chida made use of the 
concerted nature of the Overman rearrangement as a powerful tool for the transfer of 
chirality from an allylic alcohol to a newly formed diamino moiety in a complex natural 
product.  
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Scheme 31 - Synthetic strategy toward (–)-Agelastatin A 
Very recently Wang and co-workers disclosed the stereoselective synthesis of a [5.6.7]-
tricyclic ring system 127.
85
 This structure is commonly found in a range of the 
Daphniphyllum subclass Calyciphylline A-type alkaloids, especially those in calyciphylline 
A, daphnihlaucins, daphnilongeranins, and daphniyunnines.
86
 The daphniphyllum class of 
alkaloids are very recently reported natural products and their biological and 
pharmacological properties still need to be clarified. To achieve the synthesis of this 
fascinating target, the Overman rearrangement was devised as a key step in the proposed 
strategy. The substrate for the Overman rearrangement was prepared from commercially 
available (S)-(+)-carvone (Scheme 32). It was easily converted to allylic alcohol 122 and 
then subjected to a standard Overman rearrangement to yield allylic trichloroacetamide 
123. After methanolysis of the resulting allylic trichloroacetamide, the amide nitrogen was 
functionalised with the MOM group. This set the stage for the Mannich condensation with 
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cyclopentanedione to give enone 124. It was further followed by acylation and a [2+2]-
photochemical cycloaddition, which resulted in the Mayo-type diketone structure 125. The 
[5.6.7]-tricyclic core skeleton 127 was completed through Grob-type fragmentation after 
reduction and mesylation of carbonyl ketone 125, to give the target molecule. The chirality 
in 123 developed through Overman rearrangement played a vital role to control the four 
contiguous stereogenic centres on cyclobutane ring 125 during the photochemical 
cycloaddition step. 
 
Scheme 32 - Synthesis of [5.6.7]-tricyclic Core  
1.3.1 Conclusions 
The Overman rearrangement has been established as an effective approach in the total 
synthesis of natural products and in many other interesting molecules. The recent advances 
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in the substrate directed rearrangement and chiral Pd(II)-catalysis to effect asymmetric 
allylic trichloroacetimidate rearrangements has played an enormous role in enhancing the 
scope of the Overman rearrangement. Moreover, a combination of the Overman 
rearrangement with other developed methodologies e.g. ring closing metathesis can be a 
substantial development to assist in the synthesis of even more complex molecules.  
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2 Aims and Objectives 
The prime objective of this PhD research programme is to develop new methodology by 
utilising a one-pot, two-step tandem process involving an Overman rearrangement and a 
ring closing metathesis reaction for the quick and efficient synthesis of various simple and 
substituted cyclic allylic trichloroacetamides from the corresponding allylic alcohols. The 
next stage is to study the oxidations of the resulting carbocyclic amides for the 
stereoselective synthesis of valuable precursors for the construction of structurally diverse 
antiviral and anticancer carbocyclic nucleosides, aminocyclitols and Amaryllidaceae 
alkaloids.  
In all of the studied projects, the basic strategy involves the synthesis of various allylic 
alcohols from commercially available alcohols using a one pot Swern oxidation and 
Horner-Wadsworth-Emmons reaction followed by DIBAL-H reduction. These were then 
to be subjected to a one-pot, two-step tandem process involving an Overman 
rearrangement and a ring closing metathesis reaction for the quick synthesis of cyclic 
allylic trichloroacetamides. Finally, different oxidation techniques such as allylic 
oxidation, epoxidation and dihydroxylation were then to be studied to efficiently provide 
the valuable desired targets. 
In the first part of the research project, allylic alcohol 128 was to be synthesised and be 
subjected to a one-pot, two-step tandem process to synthesise carbocyclic amide 129. 
Resulting carbocyclic amide 129 would then be subjected to allylic oxidation to yield the 
amino substituted carbocyclic ketone 130 (Scheme 33 ).
87
 If this reaction proved to be 
successful, it would provide a highly efficient synthetic route to variable ring sizes of 
valuable carbocyclic ketones.  
 
Scheme 33 - Proposed synthesis of amino substituted cycloketone 130 
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Following the development of an expeditious route to carbocyclic ketones, our aim was to 
undertake the highly stereoselective synthesis of aminocyclitols such as 
dihydroconduramine E-1 132 and the enantiomer of dihydroconduramine C-1 133. It was 
proposed to make use of a stereoselective variant of the one-pot tandem Overman 
rearrangement and ring closing metathesis step for the asymmetric synthesis of an (S)-N-
(cyclohexenyl)trichloroacetamide 131, and then to explore the stereoselective epoxidation 
and dihydroxylation of this synthetic intermediate for the preparation of 
dihydroconduramines 132 and 133 (Scheme 34). As such, a new method for the synthesis 
of polyhydroxylated aminocyclohexane derivatives would be of significant benefit to 
synthetic chemistry. It would also broaden the scope of the tandem process, allowing it to 
be employed for the synthesis of a wider variety of natural products. 
  
Scheme 34 - Proposed route to polyhydroxylated aminocyclohexanes 
In the second part of this PhD programme, a one-pot tandem process involving a substrate-
directed Overman rearrangement and ring closing metathesis reaction was to developed for 
the stereoselective synthesis of a functionalised carbocyclic allylic trichloroacetamide. The 
plan was to make use of a MOM-ether directed Overman rearrangement and combine it 
with a ring closing metathesis step to construct key synthetic intermediate 135 and utilise it 
in order to synthesise Amaryllidaceae alkaloids such as (+)-γ-lycorane 136 and syn-
(4aS,10bS)-phenanthridone carbon skeleton 137 (Scheme 35). The synthesis of syn-
(4aS,10bS)-phenanthridone carbon skeleton is significant as its stereoselective epoxidation 
and directed dihydroxylation would provide the polyoxygenated phenanthridone 
framework and would lead to the preparation of novel analogues of 7-deoxypancratistatin. 
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They can serve as significant synthetic scaffolds in organic synthesis as similar (+)-7-
deoxypancratistatin exhibited strong activity against human cancerous cell lines.
88
  
 
Scheme 35 - Proposed synthesis of (+)--lycorane and 7-deoxypancratistatin analogues 
In the final part of this research project, further studies were to be carried out to expand the 
scope of the one-pot tandem process to include heterocyclic derived substrates. This would 
provide an attractive route to synthesise a seven-membered carbocyclic amide, which 
would be subjected to epoxidation to access the hexahydroazepine core of balanol (Scheme 
36). Balanol is a PKC-inhibitor of cellular signal transduction pathways.
89-91
 
 
Scheme 36 - Proposed synthesis of the balanol core structure
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3 Results and Discussions 
3.1 Synthesis of Carbocyclic Ketones 
3.1.1 Introduction 
Amino substituted cyclopentenone is the well-known building block of a vast majority of 
important naturally occurring carbocyclic nucleosides.
92
 Various natural carbocyclic 
nucleosides and their analogues occupy a prominent position in famous marketed drugs by 
virtue of their useful antibiotic and antitumor activities. These include AZT (zidovudin), 
known for its antiviral activity against HIV, and acyclovir (zovirax), most commonly used 
as an antiviral drug against Herpex simplex.
93
 Aristeromycin
94
 148 and neplanocin
95
 150 
are naturally occurring carbocyclic nucleosides and are recognised for their broad-
spectrum antiviral and antitumor activities. However, they exert a profound toxic effect on 
the cells and have limited clinical applications. Some well known carbocyclic nucleosides 
are shown in Figure 4. 
 
Figure 4 - Structures of some pharmacologically important carbocyclic nucleosides 
Many synthetic carbocyclic nucleosides have been reported to show similar biological 
activities to the above results. For example carbovir 146 and abacavir 147 have been 
shown to hold considerable activity as an inhibitor of HIV reverse transcriptase.
96
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Significant improvements in HIV-infected patients have been observed when using 
abacavir without significant side effects and thus, it is as an FDA approved drug for HIV 
treatment. However, carbovir had limitations due to its cytotoxicity. Later, several 
synthetic carbocyclic nucleosides were reported including 5′-noraristeromycin97,98 149 
which is a desmethylene analogue of aristeromycin 148, which has shown antiviral activity 
without significant cytotoxicity.  
Due to their pharmaceutical importance, a variety of routes have been adopted to 
synthesise carbocyclic nucleosides. Many of these utilise either a retro Diels-Alder reaction 
of a norbornadiene derivative,
99,100
 stereospecific synthesis from sugars,
101
 functional 
group manipulation of natural building blocks or intramolecular Pauson-Khand
102
 reactions 
as the key step. Recently Miller and co-workers
100
 have made use of the Diels-Alder 
reaction of acylnitroso compounds with N-Cbz-protected spirocyclic dienes to afford the 
corresponding spirocyclo adducts. These are useful scaffolds in the synthesis of spiro-
noraristeromycin. More recently, Chattopadhyay and Tripath have reported the synthesis of 
(1S,4S)-4-(benzyloxymethyl)-cyclopenten-2-enol 156a and (1S,4R)-4-(benzyloxymethyl)-
cyclopenten-2-enol 156b starting from (R)-2,3-cyclohexylideneglyceraldehyde 151, which 
are the key precursors for the synthesis of L-(+)- and D-(–)-carbovirs, respectively (Scheme 
37). The key steps of the approach involve Luche allylation of formaldehyde with allylic 
bromide and a RCM reaction to generate the basic precursor of carbovir in good yield.
103
  
 
Scheme 37 - Chattopadhyay approach towards carbocyclic nucleosides 
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3.1.2 Synthesis of an amidocyclohexenone 
During previous years, attention has been focused on the synthesis of carbocyclic 
nucleosides with a pentacyclic ring. However, the development of compounds with 
different ring sizes, particularly with six-membered rings needed to be explored. The 
proposed methodology for the synthesis of carbocyclic ketones as precursors for the 
carbocyclic nucleosides is outlined in Scheme 38. It makes use of a one-pot tandem 
process previously developed in our group, which utilises an Overman rearrangement and 
a ring closing metathesis (RCM) reaction, for a quick and highly efficient synthesis of 5-, 
6-, 7- and 8-membered carbocyclic amides.
104
 The resulting carbocyclic amide would then 
be subjected to allylic oxidation to yield the amino substituted carbocyclic ketone 130. The 
allylic oxidation of carbocyclic amide 129 (Scheme 38) relies on chemistry published by 
Corey and co-workers.
87
 If this reaction proved to be successful, it would provide a highly 
efficient synthetic route to variable ring sizes of carbocyclic ketones. The resulting 
carbocyclic ketones could be reduced to give cyclic amino alcohols or subjected to an 
asymmetric one-pot tandem process using chiral palladium(II)-catalysts for the Overman 
rearrangement to get di-amino substituted chiral building blocks. These could be further 
functionalised for the asymmetric synthesis of structurally diverse antiviral and anticancer 
carbocyclic nucleosides such as aristeromycin 148 and noraristeromycin 150. 
 
Scheme 38- Proposed synthesis of amino substituted cycloketone 130 
The first stage of this project required the synthesis of N-(cyclohexenyl)-
trichloroacetamide 129 which is readily available from the corresponding allylic alcohol 
128. Allylic alcohol 128 was prepared in 2 steps from the commercially available 5-hexene 
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1-ol 157, via a one-pot Swern oxidation and Horner-Wadsworth-Emmons reaction using 
Masamune-Roush conditions.
105
 This was followed by reduction of the ester 158 with 
DIBAL-H to give allylic alcohol 128 in excellent yield (Scheme 39). 
 
Scheme 39 - Synthesis of allylic alcohol 128 
Allylic alcohol 128 was then reacted with trichloroacetonitrile and a catalytic amount of 
1,8-diazabicyclo[5,4,0]undec-7-ene (DBU) to convert it into allylic trichloroacetimidate 
160. It was further subjected to the standard conditions of the one-pot tandem process 
using bis(acetonitrile)palladium(II) chloride to effect the Overman rearrangement. This 
was followed by the addition of Grubbs first generation catalyst to promote the RCM 
reaction which gave cyclic allylic trichloroacetamide 129 in an excellent 90% yield over 
three steps (Scheme 40). 
 
Scheme 40 - Synthesis of carbocyclic amide 129 
3.1.3 Efforts towards allylic oxidation 
After synthesis of hexacyclic allylic trichloroacetamide 129 in multigram quantities, allylic 
oxidation of this substrate to yield the amino substituted carbocyclic ketone 130 was 
attempted. This substrate is the key precursor for the synthesis of a number of natural 
products such as epibatidine.
106
  
Allylic oxidation is a very important reaction in many areas of synthetic chemistry.
87
 A 
large number of procedures have been reported for allylic oxidations, which make use of a 
variety of reagents such as pyridinium dichromate (PDC),
107
 selenium dioxide,
108
 Cr(IV) 
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compounds and various other transition metal complexes.
109
 In the last decade, use of tert-
butyl hydroperoxide (TBHP) along with various transition metal complexes for allylic 
oxidation appeared as an attractive choice. However, there are only a few examples of 
allylic oxidation with compounds of increasing complexity. 
In recent literature, it has been determined that a radical pathway is involved in the allylic 
oxidation by TBHP (Scheme 41).
87
 Various transition metals including Pd(II)-complexes 
are capable of generating the tert-butylperoxy radicals (
t
BuOO·) from tert-butyl 
hydroperoxide either by radical transfer or by homolysis.  
 
Scheme 41 - Radical base activation of cycloalkene using TBHP 
The resulting tert-butylperoxy radical undergoes hydrogen atom abstraction from the 
allylic position of the alkene (hydrocarbon substrate) 161. This position having the lowest 
carbon-hydrogen bond dissociation energy, which allows the formation of the alkylperoxy 
radical 162.
110
 The alkylperoxy radical goes on to form either the the allylic tert-butyl 
peroxyether 163 or hydroperoxide 164. This is followed by either hydrogen atom 
abstraction from another hydrocarbon or undergoes oxidation of Pd(II) to form the enone 
165 products (Scheme 42).
87
 
 
Scheme 42 - Palladium catalysed allylic oxidation using TBHP 
Results and Discussions  50 
 
Initially, allylic oxidation of carbocyclic amide 129 was carried out according to a 
literature procedure published by Yu and Corey, using 5 equivalents of TBHP as an 
oxidant along with a catalytic amount of 10% Pd on carbon and potassium carbonate at 20 
°C in dichloromethane.
111
 Under these conditions, the desired product was not formed even 
after 5 days of stirring, with mainly starting material found in the reaction mixture. The 
reaction was attempted again under reflux conditions, but the same result was obtained. It 
was thought that the failure of this reaction could be attributed to the presence of the 
trichloroacetamide group that can also form radicals. To combat this, the nitrogen was re-
protected with the Boc-protecting group in quantitative yield (Scheme 43). The oxidation 
of the Boc-protected carbocyclic amide was performed again under the same reaction 
conditions as reported above. Although some of the starting material was consumed, the 
rate of the reaction was very poor and could not be improved despite the elevated 
temperatures and extended reaction times tried. This resulted in only a 10% yield of the 
ketone 167 along with unreacted starting material and side products (Scheme 43). To 
increase the rate and yield of the reaction, pre-treatment of Pd on-carbon with tert-butyl 
hydroperoxide in dichloromethane at 24 °C with stirring for 1 h was employed. This was 
followed by addition of Boc protected carbocyclic amide 166 and the reaction was stirred 
for 12 h. It was found that the initial rate of the reaction increased but the reaction did not 
proceed to completion even after an extended reaction time at elevated temperature and 
gave only 6% yield. In the next attempt, the reagents were added in batches, after periods 
of 12 h, for three days keeping the reaction under reflux in dichloromethane. However, the 
yield of the reaction could not be improved (Table 7). Despite investigating various 
conditions and increasing amounts of oxidant, all conditions gave starting material back 
along with only a small amount of ketone and side products. Chromatographic and 
spectroscopic studies revealed the possible structures of the side products in the reaction 
mixture. However, due to the short life span and transitory nature of those undesired 
compounds, they could not be characterised in confidence. 
 
Scheme 43 - Boc protection and allylic oxidation of 129 
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Table 7 - Results for allylic oxidation with various methods 
 
To achieve a better yield and selectivity for the allylic oxidation of Boc protected 
carbocyclic amide 166, oxidation with manganese(III) acetate was also attempted. 
Recently manganese(III) acetate along with tert-butyl hydroperoxide as a co-oxidant, has 
been reported for mild, efficient, regioselective and chemoselective allylic oxidation of 
simple and complex alkenes.
112
 This method works on a similar principle as proposed for 
the palladium catalysed process in the reported literature.
87
 A detailed mechanistic pathway 
for the Mn3O(OAc)9 mediated allylic oxidation is shown below (Scheme 44). 
 
Scheme 44 - The mechanistic pathway for the allylic oxidation using Mn(III) and TBHP 
Mn(III) acetate has a stabilised trinuclear structure and its use along with TBHP gives 
t
BuOOMn3O(OAc)8 as an active species by displacing one acetate ligand by a TBHP 
molecule.
112
 To improve the reaction conditions, use of molecular sieves is recommended 
to remove any traces of moisture, which is known to cause disintegration of 
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manganese(III) acetate. However, in our case, using 10 mol% of Mn3O(OAc)9, 5 
equivalents of TBHP, 4 Å molecular sieves and ethyl acetate as the solvent gave similar 
results to the palladium mediated reactions (Table 7).  
Other classical methods of oxidations were also attempted. In this regard pyridinium 
dichromate and selenium dioxide are important.
108,109
 Selenium dioxide has long been used 
as a favoured reagent for the conversion of allylic methylene to the corresponding ketone. 
Initially, a literature procedure was used as described by Camps, using selenium dioxide in 
ethanol with a catalytic amount of pyridine.
113
 However, these conditions did not give any 
desired oxidised product, instead alcohol derivative 155 was isolated in 2% yield along 
with 48% of unreacted starting material (Scheme 45).  
 
Scheme 45 - Selenium dioxide oxidation using dry Pyridine 
The reaction was again tried using TBHP as a co-oxidant along with selenium dioxide but 
no significant improvement could be noticed. In another attempt, substrate 166 was 
dissolved in dichloromethane and subjected to sonication (as a source of energy instead of 
usual heating) using 5 equivalents of TBHP. Again no difference to the yield of desired 
product was observed. In all cases, only traces of the desired product along with unreacted 
substrate was isolated by flash column chromatography. Allylic oxidation of 166 was also 
attempted with copper(I)-iodide along with TBHP in dichloromethane. Initially, the 
reaction was performed at 25 °C for 48 h, however, only starting material was present. 
Elevation of the temperature to 45 °C for a further 24 h showed that the starting material 
had begun to decompose. The results are summarised in the Table 8. 
Significant difficulties were encountered in the allylic oxidation, however we continued 
our efforts for allylic oxidation. To accomplish the allylic oxidation of substrates 129 and 
166, it was decided to attempt metal free oxidation using TBHP as an oxidant and 
microwave heating as an energy source. This technique is renowned for reducing reaction 
times and increasing yields.
114
 It provides opportunities for some reactions to precede 
which under standard conditions are not feasible. Initially a reaction using 5 equivalents of 
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TBHP in toluene in a microwave reactor was attempted. Unfortunately, only starting 
material was recovered. To increase the heating efficiency of the microwave reaction, solid 
silicon carbide bars were employed which act as passive heating elements (PHE) in the 
reaction tube. Solid silicon carbide is chemically inert and is a microwave absorbing 
material which can transfer thermal energy to the reaction mixture via conduction 
phenomena. However, microwave heating did not have any positive effect on the fate of 
the reaction and gave the same disappointing yield (Table 8, entry 7).  
Table 8 - Results for allylic oxidation with various methods 
 
In all of these approaches towards allylic oxidation from carbocycles 129 or 166 with or 
without metal complexes, problems were faced in terms of both yield and selectivity due to 
the unusual reactivity of the substrates. From the results obtained, it can be concluded that 
above the methods are intolerant for allylic oxidation of a cyclic alkene bearing a 
substituted amide.  
3.1.4 New approach towards the synthesis of an amidocyclohexenone 
To achieve the synthesis of amino substituted carbocyclic ketone 130, another strategy was 
devised that negated the need of allylic oxidation and would install the allylic oxy-
substituent before the introduction of the amide group in the system. 2,3-Dihydrofuran 171 
was the starting point of the new planned route. Compound 171 was hydrolysed with 0.2 
M hydrochloric acid to give cyclic hemiacetal 172 in 92% yield. The resulting cyclic 
hemiacetal 172 exists in equilibrium with the 4-hydroxybutanal 173. This was further 
reacted with vinylmagnesium bromide to give 1-hexene-3,6-diol 174 in 86% yield. Both 
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the primary and secondary alcohols of the resulting diol 174 required protection at this 
stage to avoid interference in subsequent steps. Protection of the primary alcohol was 
carried out using tert-butyldimethylsilyl chloride with the aid of imidazole. Subsequently, 
the MOM ether was successfully introduced using Hünig’s base and bromomethyl methyl 
ether to afford 175 in quantitative yield. Removal of the silyl protecting group was 
accomplished using tetra-n-butylammonium fluoride in quantitative yield. The resulting 
primary alcohol 176 was further subjected to a one-pot Swern oxidation and Horner-
Wadsworth-Emmons reaction under conditions reported by Masamune and Roush,
105
 
which uses triethyl phosphonoacetate, lithium chloride and DBU, to give E-α,β-unsaturated 
ester 177 in 94% yield. The geometry of the resulting alkene could be easily determined 
from the 
1
H NMR spectrum of the product. The 
1
H NMR spectrum showed a 15.7 Hz 
coupling constant for the alkene protons proving that the geometry is trans. Finally 
DIBAL-H reduction of the ester 177 furnished allylic alcohol 178 in 93% yield (Scheme 
46). 
 
Scheme 46 - Synthesis of allylic alcohol 178 
With allylic alcohol 178 in hand, this compound was subjected to the tandem Overman 
rearrangement/RCM process. Initially, the reaction of the allylic alcohol 178 with 
trichloroacetonitrile was performed using DBU at 0 °C. The reaction ran smoothly and 
gave the allylic trichloroacetimidate in 100% yield. Without purification, 
trichloroacetimidate was subjected to an Overman rearrangement with the aid of 
bis(acetonitrile)palladium(II) chloride (10 mol%) to give allylic trichloroacetamide 180 
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(Scheme 47). The rearranged product 180 was then subjected to a RCM reaction using 
Grubb’s 1st generation catalyst. The MOM protected carbocyclic amide 181 was achieved 
in a rather modest yield of 59% in 24 h. This might be due to the greater complexity of 
substrate 178, which leads to a slower process in comparison to the previous rearrangement 
substrate 159, which completes in 12 h and furnished the carbocyclic amide 129 in 
excellent 90% yield (Scheme 40). This tandem process results in the formation of both the 
syn and anti-product showing that at the 6-position the MOM-ether is too far to exert a 
directing effect. 
To make this approach more efficient, an improved process was required. Previously, the 
Sutherland group have shown that toluene can enhance the yield and diastereoselectivity of 
MOM ether-directed Overman rearrangements due to its non-coordinating nature.
75
 The 
reaction was attempted again using toluene as a solvent and to our surprise, the yield of the 
reaction dropped further to 30%. It was found that deprotection of the MOM-group 
competes during the ring closing metathesis and allows competing side reactions to take 
place. In an attempt to increase the overall yield, the tandem process was repeated using 
Grubb’s 2nd generation catalyst and pleasingly, the desired product was obtained in an 
excellent 93% yield over three steps. The Grubb’s 2nd generation catalyst proved a better 
RCM catalyst for the substrate in terms of catalyst loading, reaction time and yield in 
comparison to Grubb’s 1st. generation catalyst (Scheme 47). 
 
Scheme 47 - Overman rearrangement and ring closing metathesis 
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In the next stage, the deprotection of the MOM group of 181 was attempted using 6M 
hydrochloric acid. However, this reaction was found to be low yielding and gave a 
complex mixture of products. To optimise the deprotection of product 181, different 
concentrations of HCl were investigated. Optimal results showed that dilute hydrochloric 
acid (0.5M)f in methanol at 40 °C accomplished the deprotection of the MOM group to 
give alcohol 182 in 72% yield. Treatment of the resulting alcohol 182 with the Dess-
Martin periodinane reagent gave the desired amidocyclohexenone 130 in 83% yield 
(Scheme 48). 
 
Scheme 48 - Synthesis of amidocyclohexenone 130 
3.1.5 Synthesis of an amidocyclopentenone 
As previously mentioned, due to the significant difficulties in allylic oxidation of amino 
carbocyclic amides, the short, quick and high yielding one-pot tandem approach towards 
the synthesis of carbocylic amides of variable ring sizes could not be utilised. To exclude 
the need of an allylic oxidation at the end of the synthesis, an alternative approach was 
adopted. The synthesis of the amino substituted pentacarbocyclic amide 193 commenced 
with the protection of penta-4-ene-1-ol 183 with a silyl ether using tert-butyldimethylsilyl 
chloride in 99% yield. To install the hydroxyl group, the resulting silyl protected pentene 
184 was treated with selenium dioxide in the presence of TBHP. The reaction worked 
smoothly to give a 70% yield of 185. The remaining steps are similar to that mentioned 
before for the synthesis of aminocyclohexenone 130. The synthesis involved the treatment 
of 185 with bromomethyl methyl ether in the presence of Hünig’s base to protect the 
secondary alcohol followed by treatment with TBAF to remove the silyl protecting group 
in an excellent 96% yield. A one-pot Swern oxidation and Horner-Wadsworth-Emmons 
reaction gave E--unsaturated ester 187. Once again the E-geometry of the alkene was 
established through the 
1
H NMR spectrum of the product, which showed a coupling 
constant of 15.7 Hz for the 2-H and 3-H hydrogen atoms. The resulting ester was reduced 
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with DIBAL-H to give the corresponding allylic alcohol 188 in quantitative yield (Scheme 
49). 
 
Scheme 49 - Synthesis of allylic alcohol 188  
The allylic alcohol 188 was then transformed into the allylic trichloroacetimidate 189 by 
reacting with trichloroacetonitrile in the presence of a catalytic amount of DBU. It was 
rearranged using bis(acetonitrile)palladium(II) chloride (10 mol%) to the allylic 
trichloroacetamide 190 and this was followed by ring closing metathesis step with Grubbs 
first generation catalyst. Surprisingly, this process gave only a 25% yield of RCM product 
191 over three steps (Scheme 50).  
 
Scheme 50 - Overman rearrangement and ring closing metathesis 
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To determine the optimal reaction conditions for the development of a tandem process, all 
three steps of the tandem process were investigated carefully and it was found that the 
rearrangement was not going to completion, even after 72 h. During this time, it was 
observed that the allylic trichloroacetimidate 189 had begun to decompose. To improve the 
yield of the reaction, the rearrangement was also carried out under thermal conditions. This 
involves heating of 189 at 135 °C in toluene in the presence of a small amount of 
potassium carbonate (2 mg/mL) in a sealed tube. The use of thermal rearrangement 
conditions led to an appreciably cleaner product in 12 h with a much better yield. The 
rearranged product 175 was then subjected to RCM using Grubbs 2
nd
 generation catalyst 
(12 h under reflux), to provide the desired cyclic allylic trichloroacetamide 191 in 83% 
yield over three steps. This tandem process gave both the syn and anti-product showing 
that at the 5-position the MOM-ether is too far to exert a directing effect. 
Finally, the MOM group was easily deprotected by heating the solution of 191 in methanol 
with 0.5M HCl. Without purification this reaction was followed by a Dess-Martin 
oxidation in dichloromethane to yield amidocyclopentenone 193 in 73% yield over two 
steps (Scheme 51). 
  
Scheme 51 - Synthesis of 4-amidocyclopentenone 193 
3.1.6 Conclusions 
In summary, new methodology was devised for the successful synthesis of 5- and 6- 
membered amido substituted carbocyclic ketones compounds which are important building 
blocks for the synthesis of structurally diverse antiviral and anticancer carbocyclic 
nucleosides and natural products. Initially, various methods were investigated for the 
allylic oxidation of carbocyclic amides formed from a one-pot tandem process. It appeared 
that these carbocylic amides are resistant to allylic oxidation when TBHP along with 
different transition metals such as Pd, Se, Mn and Cr. In addition to this, the employment 
of sonication and microwave techniques also found no success. A new approach was 
devised involving installation of the hydroxyl group before the tandem process. The 
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intermediate from this new route were then subjected to high yielding one-pot tandem 
Overman rearrangements and ring closing metathesis steps to eventually furnish amido 
substituted five and six membered carbocyclic ketones. The resulting carbocyclic amides 
are relatively more complex than have been synthesised previously using this approach and 
in this way, highlights the potential of this methodology for the synthesis of more complex 
target compounds. 
Results and Discussions  60 
 
3.2 Synthesis of Polyhydroxy Aminocyclohexanes 
3.2.1 Aminocyclitols 
Aminocyclitols are cycloalkanes having at least one hydroxyl group on each of three or 
more ring atoms and one free or substituted amino group.
115
 Because of their close 
structural association with sugars, aminocyclitols are also considered as aminocarbasugars. 
Validamine 194 and other structurally related compounds such as conduramines 195 and 
196 constitute a class of significant compounds which display a diverse range of behaviour 
and possess unique characteristics that make them important for various types of synthetic 
applications (Figure 5).
116
 
 
Figure 5 
Various aminocyclitols, natural 194 as well as synthetic 195 and 196 belong to an 
important class of glycosidase inhibitors.
117-119
 Glycosidase inhibitors have been 
established as potential therapeutic agents for the treatment of diabetes,
120
 obesity,
121
 
viruses,
122
 cancer,
123
 and genetic disorders.
124
 The inhibition of glycosidases by a diverse 
range of chemical compounds has been extensively studied and this has led to a new class 
of antibiotics known as aminoglycoside antibiotics. Several aminocyclitols and 
conduramines are aminoglycoside antibiotics which have been revealed to bind with a 
number of RNA sequences as well as with important HIV regulatory domains to disclose 
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the interplay between the hydroxyl substituents and their neighbouring ammonium 
groups.
125
 Acarbose
126
 197 and voglibose
127
 198 are aminocyclitols and are active -
glucosidase inhibitors utilised clinically to lessen postprandial blood glucose levels in 
patients with type II diabetes mellitus. 
Some natural aminocyclitols are secondary metabolites, such as validamycins 202 that 
have been isolated from the fermentation culture of streptomyces hygroscopicus 
limoneus.
128
 Validamycins 202 are composed of one valienamine unit 199, together with 
an additional unit of either validamine 200, valiolamine 201, or hydroxyvalidamine 203 
(Figure 6). Apart from aminocyclitols glycosidase inhibiting and antibiotic activity their 
use as molecular probes for quorum sensing modulation has also been reported.
129
  
 
Figure 6 
In addition, aminocyclitols are not only aspirant for drug discovery but also have paved the 
way for the development of the new potential therapeutic agents. Aminocyclitol 
frameworks have been found to be incorporated into a wide variety of organic compounds. 
These serve as key intermediates in the preparation of azasugars,
130
 aminosugars,
131
 
sphingosines,
132
 lactams, and narcissus alkaloids.
133
  
As a result of their utility and versatility, many fascinating and elegant synthesis of 
racemic and optically pure aminocyclitols and conduramines have been reported. Many 
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approaches make use of natural building blocks as a starting material. For example Shing 
and Wan synthesised valiolamine 201 in 14 steps strating from (–)-quinic acid in an overall 
8.4% yield.
134
 Ogawa and co-workers employed vibo-quercitol for the convenient 
syntheses of valiolamine 201.
135
 Several other synthetic strategies include cycloaddition 
reactions,
136
 radical cyclisations
137
 and rearrangement reactions such as the classical 
Ferrier rearrangement
138
 or the Claisen rearrangement.
139
 
3.2.2 Synthesis of aminocyclitols 
In this project, our aim was to undertake the highly stereoselective synthesis of 
aminocyclitols such as dihydroconduramine E-1 132 and the enantiomer of 
dihydroconduramine C-1 133. It was proposed to make use of a stereoselective variant of 
the recently developed one-pot tandem process Overman rearrangement and ring closing 
metathesis step for the asymmetric synthesis of an (S)-N-(cyclohexenyl)trichloroacetamide 
131, and then to study the stereoselective oxidation of this synthetic intermediate for the 
preparation of polyhydroxylated aminocyclohexane derivatives (Scheme 34). The first 
stage of the project involved the synthesis of the allylic alcohol starting from commercially 
available 5-hexen-1-ol 157 in two steps using a one-pot Swern oxidation and Horner-
Wadsworth-Emmons reaction using Masamune-Roush conditions.
105
 This gave E-,β-
unsaturated ester 158 which was then followed by reduction of the ester functional group 
by two equivalents of DIBAL-H to give allylic alcohol 128 in excellent yield (Scheme 52). 
 
Scheme 52- Synthesis of allylic alcohol 128 
Allylic alcohol 157 was then reacted with trichloroacetonitrile and a catalytic amount of 
DBU to convert it into allylic trichloroacetimidate 160. It was further subjected to the 
standard conditions of the one-pot tandem process using commercially available (S)-COP-
Cl 82 (see Figure 3) to effect the Overman rearrangement. This was followed by the 
addition of Grubbs first generation catalyst to promote ring closing metathesis which 
resulted in allylic trichloroacetamide 131 in an excellent 90% yield over three steps and 
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with 88% enantiomeric excess. The enantiomeric excess of 131 was improved to >99% on 
recrystallisation from a mixture of ethyl acetate and petroleum ether (Scheme 53). 
 
Scheme 53 - Stereoselective one-pot tandem Overman rearrangement and RCM reaction 
After the synthesis of (1S)-1-(2′,2′,2′-trichloromethylcarbonylamino)cyclohexa-2-ene (131) 
in multigram quantities, our subsequent objective was to investigate the stereoselective 
dihydroxylation and epoxidation of 131. Initially, dihydroxylation of the cyclic allylic 
amide was pursued. Transition-metal-catalysed oxidations of alkenes represent a 
distinctive approach for dihydroxylation with defined relative configuration. Several 
reagents are now used as an oxidant such as KMnO4, RuO4 or OsO4. Among these 
reagents, the osmium-catalysed dihydroxylation has gained wide acceptance and has 
emerged as a benchmark in terms of its generality and selectivity. We made use of 
Donohoe’s procedure which is an efficient method for the directed syn-selective 
dihydroxylation of cyclic allylic trichloroacetamides.
140
 It involves the in situ formation of 
a bidentate complex which is prepared by mixing stoichiometric amounts of osmium 
tetroxide and N,N,N′,N′-tetramethylethylenediamine (TMEDA) at –78 °C. Use of TMEDA 
along with OsO4 not only makes the oxidant more electron rich but also more reactive. 
This newly formed bidentate complex then reacts with the substrate to form the osmate 
ester 205 towards the face of the alkene which is influenced by hydrogen bonding between 
the amide and the electron rich oxo-ligands. On hydrolysis, it liberates mainly the syn-
dihydroxylated product. Following this procedure, 131 was subjected to standard 
conditions of the directed dihydroxylation. The reaction proved successful to yield the 1,2-
syn-2,3-syn-isomer 206 in 94% diastereomeric excess. Diastereomeric excess could be 
determined from the 
1
H NMR spectrum of the crude reaction mixture. The desired product 
was then easily isolated from the crude mixture using flash column chromatography to 
give a single stereoisomer in 93% yield (Scheme 54).  
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Scheme 54 - Steroselective dihydroxylation showing formation of osmate ester 
In order to synthesise the 1,2-syn-2,3-anti-isomer 208, a simple two-step strategy was 
adopted. The first step involved the epoxidation of 131 utilising meta-chloroperbenzoic 
acid (m-CPBA) which provided cis-epoxide 207 via a substrate directed intermediate.
141
 
The diastereomeric excess was determined from the 
1
H NMR spectrum of the crude 
reaction mixture and found to be 90%. Separation of the major diastereomers was carried 
out by flash column chromatography giving 207 as a single stereoisomer in 95% yield. 
This was followed by acid mediated hydrolysis to furnish 207 in 75% yield as a single 
stereoisomer. It was fully characterised by detailed COSY and NOE experiments which 
clearly demonstrated the 1,2-syn-2,3-anti relationships of the trichloroacetamide and 
hydroxyl groups (Scheme 55). 
 
Scheme 55 - Stereoselective epoxidation and its cleavage 
In the next step, it was proposed to install three hydroxyl groups to 131. This would allow 
access to aminocyclitols 132 and 133. We intended an approach that entailed 
stereoselective functionalisation of the alkene of 131 to furnish a hydroxyl group at C-2 
and a leaving group at C-3 of the cyclohexane ring. Elimination of the leaving group will 
then yield an alkene which on subsequent stereoselective oxidation should produce the 
conduramine derivatives. 
The synthesis of this fragment commenced with the reaction of 131 with N-
iodosuccinimide in chloroform to afford iodoxazole 210 (Scheme 56). The resulting 
oxazole 210 is sensitive to acid so was purified using an alumina column in 85% yield as a 
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single stereoisomer. As 210 was found to be relatively unstable, it was subsequently 
hydrolysed under acidic conditions which yielded 1,2-syn-2,3-anti-iodoalcohol 211 in 76% 
yield.  
 
Scheme 56 - Stereoselective functionalisation of carbocyclic amide 211 
The relative stereochemistry of 211 was confirmed by X-ray crystallography. The X-ray 
image of the 1,2-syn-2,3-anti-iodoalcohol 211 is shown below (Figure 7). It clearly 
illustrates the 1,2-syn-2,3-anti-relationship of the trichloroacetamide, hydroxyl and iodide 
substitutents, respectively. 
 
Figure 7 - ORTEP representation of X-ray crystal structure of compound 211 
The stereochemistry of 211 suggested that iodination takes place anti to the trichloroamide 
to form iodonium ion 209 (Scheme 56). It is followed by syn-formation of 4,5-dihydro-1,3-
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oxazole ring yielding 210. In suitable acidic medium, hydrolysis takes place at C-2 to 
cleave the 4,5-dihydro-1,3-oxazole ring to furnish 211.  
When investigating the elimination of the iodide to generate the allylic alcohol, 1,2-syn-
2,3-anti-iodoalcohol was treated with sodium hydrogencarbonate and heated under reflux 
overnight. However, none of the desired allylic alcohol 213 was isolated. Changing the 
base to DBU also failed to lead to the formation of any of the product, returning only 
starting material. In another attempt, 131 was again reacted with N-iodosuccinimide to give 
4,5-dihydro-1,3-oxazole 210 (Scheme 57). Without purification, 210 was treated with 
DBU in toluene at 110 °C for 12 h. It resulted in the intermediate 212 which was further 
hydrolysed under acidic conditions to afford the desired allylic alcohol 213 in 60% yield 
over the three steps. 
 
Scheme 57 - Formation of amidocyclohexanol 213  
When this advanced stage of the synthesis was reached, the introduction of the other two 
hydroxyl groups via directed dihydroxylation was investigated. To synthesise the 
stereoisomer of trihydroxy carbocylic amine 133, amidohexanol 213 was subjected to 
dihydroxylation using osmium tetroxide in the presence of TMEDA (Scheme 58). High 
diasteroselectivity was expected due to the enhanced directing effect of amide and 
hydroxyl at adjacent positions. These functional groups are in a position to direct the 
dihydroxylation to form triol 215 as the major diastereomer. However, under these 
conditions, a 3:1 mixture of two diastereomeric triols in 87% yield was isolated.  
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Scheme 58 - Dihydroxylation of 213 
The ratio of the stereosiomers was determined by 
1
H NMR spectroscopy using the crude 
reaction mixture. The major isomer was easily separated by flash column chromatography 
in 53% yield. The exact stereochemisty of this major isomer could not be assigned using 
NMR techniques due to overlapping signals of adjacent hydrogen atoms. However, 
recrystallisation of the major product allowed X-ray structure determination and it 
appeared that that the major diastereomer was 1,2-syn-2,3-anti-3,4-syn isomer 214 (Figure 
8).  
 
Figure 8 - ORTEP representation of X-ray crystal structure of compound 214 
The results illustrate that the reaction takes place from the least hindered site of the 
cyclohexene 213 to generate trichloroacetamide derivative 214. However, a certain level of 
directed dihydroxylation also occurs to afford triol 215, as a minor diastereoisomer. To 
investigate the stereochemical outcome of the Donohoe reaction, the Upjohn reaction was 
employed. The Upjohn reaction is a method for dihydroxylation through a non-directed 
mechanism.
142
 It makes use of a OsO4 in catalytic amounts along with N-
methylmorpholine N-oxide (NMO) as a stoichiometric re-oxidant. As such, the allylic 
alcohol was subjected to standard Upjohn conditions to give triol 214 as a single 
stereoisomer in 56% yield. The outcome from the Upjohn dihydroxylation of 213 provides 
evidence that formation of triol 215 using Donohoe conditions, must take place by a 
directing effect and it is not due to a face selective, non-directed dihydroxylation. In the 
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next step, removal of the trichloroacetyl protecting group of 214 was attempted using 
sodium hydroxide in methanol to access aminocyclitol 133. Purification was carried out by 
ion exchange chromatography to yield dihydroconduramine E-1 133 in 68% yield (Scheme 
59).  
 
Scheme 59 - Synthesis of dihydroconduramine E-1 133 
To access the enantiomer of dihydroconduramine C-1 132, a directed epoxidation of cyclic 
allylic alcohol using m-CPBA was proposed. It works presumably via Henbest’s rule 
which states that an alcohol group directs the epoxidation reaction to generate the cis-
epoxide stereochemistry.
143
 The epoxide would then be subjected to hydrolysis to give the 
dihydroxy product upon treatment with an acidic solution of dioxane. As such, allylic 
alcohol 213 was treated with m-CPBA to yield cis-epoxide in 90% diastereomeric excess 
(Scheme 60). Purification by flash column chromatography gave the major product, the 
syn-diastereomer 216 in 69% yield.  
 
Scheme 60 - Epoxidation of 213 and formation of dihydroconduramine derivative 217 
The stereochemistry of compound 216 was confirmed by NOE studies, which showed a 
positive NOE between hydrogen atoms Hb and Hc (0.8%). This shows that Hc of epoxide 
and Hb of hydroxyl group are on the same face of the ring. Hydrogen Ha of position 1 was 
then irradiated and an enhancement was observed (0.7%) with Hb indicating the syn 
relationship of the adjacent hydrogens, thus confirming that the major diastereomer is 1,2-
syn-2,3-syn-3,4-syn-isomer 216 (Figure 9).  
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In the next step, 216 was subjected to 0.2N H2SO4, to cleave the epoxide which resulted in 
the formation of dihydroconduramine derivative 217 in 87% yield (Scheme 60). The 
stereochemistry of the dihydroconduramine derivative 217 was again confirmed by 
difference NOE experiments. Dihydroconduramine derivative 217 was irradiated at 
stereogenic center Hb to determine the orientation in relation to Hc. It showed a positive 
NOE between hydrogen atoms Hb and Hc (1.3%) which implies they have syn relation to 
each other. In addition, there was no positive enhancement for the proton Hd upon 
irradiation of proton Hc, confirming that the compound 217 is the 1,2-syn-2,3-syn-3,4-anti-
isomer (Figure 9).  
 
Figure 9 - NOE enhancement studies for the polyhydroxylated aminocyclohexane derivatives 
Finally, treatment of 1,2-syn-2,3-syn-3,4-anti-isomer 217 with sodium hydroxide in 
methanol accomplished the hydrolysis of the trichloroacetamide group (Scheme 61). 
Purification was carried out using an ion exchange column which gave the enantiomer of 
dihydroconduramine C-1 132 in 98% yield. 
 
Scheme 61 - Synthesis of the enantiomer of dihydroconduramine C-1 132 
3.2.3 Conclusions 
In conclusion, the stereoselective synthesis of dihydroconduramine E-1 and the enantiomer 
of dihydroconduramine C-1 was achieved using a stereoselective variant of the one-pot 
tandem Overman rearrangement and ring closing metathesis process in excellent yield and 
diastereomeric excess. During the course of the synthesis (1S)-N-(cyclohexenyl) 
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trichloroacetamide was efficiently prepared starting from the commercially available 
alcohol in 75% overall yield in six steps and in excellent enantiomeric excess. Initially 
Donohoe conditions and Henbest’s principle were investigated for the synthesis of syn and 
anti diol derivatives of 131 respectively, in excellent diastereoselectivity. The noteworthy 
successes of a relevant model study provided the foundation for the synthesis of two 
dihydroconduramines. In the first approach, the allylic alcohol 213 was synthesised from 
131 via 4,5-dihydro-1,3-oxazole 210 as a single stereoisomer. Non-directed 
dihydroxylation and directed epoxidation were then employed which resulted in the 
production of the two dihydroconduramines. This operationally simple route is very 
efficient and granted further insight into the stereoselective functionalisation of substituted 
cyclohexenes for the production of related natural products such as pancratistatins and 
other Amaryllidaceae alkaloids (see Section 3.3). 
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3.3 New Routes towards the Synthesis of Amaryllidaceae Alkaloids 
3.3.1 Introduction 
After the development of a one-pot tandem Overman rearrangement/ring closing 
metathesis process for the direct synthesis of cyclic allylic amides, the Sutherland group 
reported various interesting synthetic strategies to exploit its role in natural product 
synthesis.
40,41,77 
Cyclic allylic amides are excellent synthetic intermediates that can be 
easily functionalised using a number of different reactions e.g. dihydroxylation,
140
 
stereoselective epoxidation,
141
 Kharasch addition 
 
and conversion to bicyclic structures.
144
 
Such reactions can build up complexity on the ring framework to generate structures of 
interest. In this project, the aim was to expand the scope of this tandem process and use it 
in combination with a MOM-ether directed Pd(II)-catalysed Overman rearrangement for 
the diastereoselctive synthesis of cyclic allylic amide 135 (Scheme 62).  
 
Scheme 62 - MOM-ether directed tandem Overman rearrangement and RCM reaction 
This reaction pathway involves directed coordination of the Pd(II)-catalyst by the MOM 
ether to the allylic trichloroacetimidate resulting in a diastereoselective rearrangement. The 
product of this tandem process can then be used for the synthesis of various nitrogen 
containing natural products, antibiotics and unnatural amino acids or sugars.
 
Initially, it 
was planned to use the directed rearrangement for the synthesis of some derivatives of the 
Amaryllidaceae alkaloids and screen them for biological activity.  
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The Amaryllidaceae family, consists of around 1100 species each belonging to eighty-five 
different genera and has produced a large number of structurally diverse alkaloids.
145
 The 
galanthane ring system is a common characteristic of most of these compounds and is 
known for wide range of interesting physiological effects including antitumor, antiviral, 
acetylcholinesterase inhibitory, immunostimulatory and antimalarial activities.
146
 Some of 
these alkaloids are of particular interest because of their potential use in clinical therapy. 
Some well-known alkaloids from this family include (+)--lycorane 136, (+)-2-
deoxylycoricidine 221, (+)-7-deoxypancratistatin 222, and (+)-lycoricidine 223 (Figure 
10). 
 
Figure 10 - Amaryllidaceae alkaloids 
3.3.2 Previous syntheses of (+)-γ-lycorane 
The unprecedented structure and potent pharmacological properties of the Amaryllidaceae 
alkaloids has motivated the development of many interesting synthetic strategies.
 
In 
particular, subsequent to the first synthesis of γ-lycorane 136 in 1966, several different 
racemic and enantioselective approaches have been reported.
147-151
 Many of these employ 
Pictet–Spengler,152 Bischler–Napieralski cyclisations153 or metal catalysed 
alkylation/cyclisations
149
 as a key step for the construction of key parts of the 
Amaryllidaceae alkaloids. Some of the advances employed in the total synthesis of γ-
lycorane 136 are discussed below. 
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The first asymmetric synthesis of (+)-γ-lycorane 136 was disclosed by Mori and co-
workers.
149
 They made use of an asymmetric Pd(0)-catalyst as the key enantioselective 
step for the allylic alkylation coupling of the A and C rings to give benzoate 226. A 
subsequent amination and Pd(0)-catalysed intramolecular Heck reaction was used to finish 
the synthesis of γ-lycorane in 23% yield and 46% ee. Several years later, Ojima and co-
workers
147
 used the same strategy but made use of chiral monodentate phosphoramidite 
ligands and improved the overall yield from 23% to 41% and enantioselectivity further to 
>99% (Scheme 63). 
 
Scheme 63 - Ojima synthesis of (+)--lycorane 
In another approach, Gong and co-workers
154
 described an enantioselective synthesis of γ-
lycorane in 38% overall yield and 98% ee (Scheme 64). They used an asymmetric 
rhodium(II)-catalysed nitroallylation employing an aryl boronic acid 228 and a nitroallyl 
acetate 229 to construct the AC ring fragment 230. This was followed by a conjugate 
addition of the enolate of methyl acetate to give 231. The resulting compound 231 was 
then hydrogenated before performing a modified Pictet-Spengler ring closure reaction to 
construct the BD ring. This furnished (+)-γ-lycorane in an excellent yield after reduction 
with lithium aluminum hydride. 
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Scheme 64 - Gong synthesis of (+)--lycorane 
More recently, Funk and co-workers
155
 reported a concise total synthesis of (±)-γ-lycorane 
136 (Scheme 65). This synthesis involves the pre-functionalisation of commercially 
available Boc-2-pyrrolidinone 232. It was then subjected to a Stille coupling using an 
appropriate vinyl halide to give the trienecarbamate 234 (AD ring) of γ-lycorane. Reflux in 
toluene performed the 6-π-electrocyclic ring closure which provided tetrahydroindole 235. 
The resulting tetrahydroindole was ultimately hydrogenated with the aid of PtO2 in acetic 
acid followed by deprotection of the carbamate. It was then converted to γ-lycorane by 
employing a Pictet–Spengler cyclisation using formalin in a solution of methanol. Once 
again it is an elegant synthesis giving the target molecule in 24% overall yield. 
 
Scheme 65 - Funk synthesis of (±)-γ-lycorane 
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3.3.3 Proposed synthesis of (+)-γ-lycorane  
It is important to mention that in all previous asymmetric syntheses of (+)-γ-lycorane 136, 
chiral catalysis were employed to achieve the key enantioselective steps. In contrast to this, 
our plan was to make use of a MOM-ether directed Overman rearrangement and combine 
it with a ring closing metathesis step to construct key synthetic intermediate 135 (C ring) 
and utilise it in order to synthesise (+)-γ-lycorane 136 and other structurally related 
compounds (Scheme 66). The main advantage of the one-pot tandem MOM-ether directed 
Overman rearrangement/RCM process, is that it will quickly generate a second stereogenic 
center on the resulting cyclic allylic trichloroacetamide from the corresponding allylic 
alcohol 134. The new stereogenic centre in the resulting cyclic allylic trichloroacetamide 
would provide an additional reaction site for further functionalisation. Following this, the 
cyclic allylic amide will be subjected to a Kharasch cyclisation
144,156
 to introduce the D 
ring, which would be subsequently dechlorinated using Raney
®
-Nickel. An alkylation 
reaction would then introduce the piperonyl moiety to put in the left hand aromatic 
fragment (ring A) to give compound 238. It would be followed by a functional group 
interconversion to yield 239. The palladium-mediated cyclisation of 239 is similar to that 
described by Mori and co-workers
147,149
 during their synthesis of (+)-γ-lycorane and would 
allow the synthesis of the all cis-ring system. Finally, hydrogenation of the alkene and 
reduction of the amide would give Amaryllidaceae alkaloid, (+)-γ-lycorane 136.  
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Scheme 66 - Proposed synthesis of (+)--lycorane 
3.3.4 Development of an ether-directed tandem reaction 
The first stage of this synthesis requires the formation of allylic alcohol 134 which would 
act as a substrate for the MOM-ether directed Overman rearrangement and RCM step. The 
synthesis of the corresponding allylic alcohol 134 began with the protection of the 
hydroxyl group of the commercially available glycidol 236 with a tert-butyldimethyl silyl 
group (Scheme 67). The resulting compound 240 was regioselectively ring-opened with 
allyl magnesium bromide in the presence of copper bromide dimethyl sulfide at –78 °C to 
give 241 in 90% yield. In the next step, the secondary alcohol of the resulting (2R)-1-(tert-
butyldimethylsilyloxy)hex-5-en-2-ol (241) was protected with a MOM-group using N,N-
diisopropylethylamine and bromomethyl methyl ether in quantitative yield. It was 
subsequently treated with TBAF to give the primary alcohol 243 again in quantitative 
yield. Primary alcohol 243 was then subjected to a one-pot Swern oxidation and Horner-
Wadsworth-Emmons reaction to give the E-,β-unsaturated ester 244. The E-α,β-
unsaturated ester was further reduced with DIBAL-H to provide allylic alcohol in an 
excellent 86% yield over the 6 steps.  
Results and Discussions  77 
 
 
Scheme 67 - Synthesis of an allylic alcohol for directed rearrangement 
With the allylic alcohol 134 in hand, it was further subjected to a one-pot tandem Overman 
rearrangement and RCM reaction to give the corresponding cyclic allylic 
trichloroacetamides 135 (Scheme 68). Initially the reaction of the allylic alcohol with 
trichloroacetonitrile was performed using DBU at 0 °C in two hours to form allylic 
trichloroacetimidate 218. The Overman rearrangement was then performed using 
bis(acetonitrile)palladium(II) chloride (10 mol%) followed by the RCM reaction using 
Grubb’s 1st generation catalyst. This resulted in the formation of 135a and 135b, as a 5:1 
ratio of diastereomers in a 45% yield over 3 steps from the allylic alcohol 134 (Scheme 
68).  
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Scheme 68 - Ether-directed tandem Overman rearrangement and RCM reaction 
The diastereomeric ratio of the resulting MOM-protected carbocyclic amides could be 
easily determined from the 
1
H NMR spectrum. The hydrogen atoms for the anti-product 
135b are observed at 3.75 ppm (1-H) and 4.42 ppm (2-H). The desired cyclic product 135a 
showed its stereogenic hydrogen atoms at 4.05 ppm (1-H) and 4.63 ppm (2-H). The 
stereochemistry of the 135a was further established by NOE studies, which showed an 
enhancement of hydrogen Ha (0.68% NOE) upon irradiation of hydrogen Hb, confirming 
the cis-geometry between these adjacent hydrogen atoms (Figure 11).  
 
Figure 11 - NOE enhancement studies for the carbocyclic amide 
Results and Discussions  79 
 
To generate an efficient total synthesis of (+)-γ-lycorane 136 the yield and selectivity of 
the tandem process required improvement. Previously, it has been observed in our research 
group that toluene can enhance the yield and diastereoselectivity of MOM ether-directed 
Overman rearrangements due to its non-coordinating nature.
75
 The reaction was repeated in 
toluene and pleasingly, this modification improved the yield from 45% to 60% and 
increased the diastereoselectivity from 5:1 to 10:1. However, the reaction takes more time 
to complete in comparison to a non-substituted six membered allylic trichloroacetamide 
(Section 3.1.2). The slow rate of the reaction can be attributed to the greater complexity of 
the substrate, which leads to a slower Overman rearrangement and ring closing metathesis 
steps. The more significant anti-diastereoselectivity of this process is due to the 
coordination of the Pd(II) catalyst with the oxygen atoms of the MOM group without 
having to compete with the THF solvent. This directs the catalyst selectively to the back 
face of the alkene and resulting in a diastereoselective rearrangement. This chair-like 
conformation not only minimises the allylic strain but also allows intramolecular attack of 
imidate nitrogen from the front face of the alkene, thus giving the major diastereomer 135a 
(Scheme 68). To improve the yield of RCM step, the reaction was also carried out with 
Grubb’s 2nd generation catalyst but no further improvement was observed and gave 49% of 
the major diastereomer 135a. 
3.3.5 Attempted Synthesis of (+)--lycorane 
Having synthesised the MOM protected carbocyclic amide 135a, it was proposed to 
perform a Kharasch cyclisation on the carbocyclic amide 135a to provide the D-ring of γ-
lycorane. The groups of Snapper and Itoh have reported the development of a ruthenium 
catalysed Kharasch cyclisation of allylic trichloroamides to give the corresponding bicyclic  
ring systems in high yields.
144,156
 In addition, both groups have shown that all the 
substrates used in this process furnished exclusively the cis-ring junction between the 5- 
and 6-membered rings, confirming that our use of the Kharasch cyclisation will yield the 
correct stereochemistry required for the synthesis of (+)-γ-lycorane 136. A Kharasch 
cyclisation is a Ru(II)-catalysed reaction that proceeds via a radical mechanism (Scheme 
69).
156
 During the course of the reaction, ruthenium(II) triggers the sequence of the 
reaction leading to the formation of the bicyclic product. Initially, ruthenium(II) attacks the 
trichloroacetyl group of 131 and abstracts a chlorine atom to form Ru(III)-Cl and supplies 
the radical 245. The carbon radical 245 then attacks the alkene to form the new C-C bond 
of the 5-membered ring and generates the new carbon radical 246. This reaction is then 
terminated by re-introduction of Ru(III)-Cl which introduces a chloride to the face opposite 
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to the new 5-membered ring 246, thus providing the Kharasch product 247 as a single 
diastereomer.
 
 
 
Scheme 69 - Radical mechanism of Kharasch cyclisation 
Previously, in the Sutherland group efforts have been made to do the Kharasch cyclisation 
of 135a employing the Grubbs I catalyst in toluene at 155 °C but this resulted in the 
formation of the tricyclic product 248 and in a poor yield (Scheme 70). 
 
Scheme 70 - Kharasch cyclisation using Grubbs catalyst 
In this project, the MOM protected carbocylic amide 135a was treated with RuCl2(PPh3)3 
catalyst under the conditions reported by Itoh however, this gave a mixture of the Kharasch 
product 237 and tricyclic product 248 in low yields.
138,150
 To improve the yield and 
selectivity of the reaction, when 135a was subjected to higher temperature (155 °C) in 0.1 
M p-xylene in a Schlenk tube, the reaction was completed after 2 h and the desired product 
237 was isolated in 42% yield. However, the formation of a small amount (10%) of 
tricyclic compound 248 could not be avoided. During the course of the reaction, unwanted 
side reactions were deemed likely due to the HCl that is formed due to the decomposition 
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of the staring material or product during the high temperatures of the Kharasch cyclisation. 
To overcome this issue, any acid that was produced during the reaction had to be trapped. 
It was therefore envisioned that adding an acid scavenger would be appropriate to keep the 
reaction selective. Three different additives were tried including DBU, potassium 
carbonate and molecular sieves (4Å). The reaction did not work by utilising DBU and 
returned only starting material 135a, whilst addition of potassium carbonate also did not 
improve the reaction and again yielded a mixture of the two products (135a and 248). 
However the use of 4Å molecular sieves gave only the desired product 237 in a 56% yield. 
The use of powdered 4Å molecular sieves further improved the reaction and increased the 
yield to 75%. Powdered molecular sieves increased the surface area of the sieve and 
therefore trap the acid more efficiently. This inhibits the side reaction and in turn improves 
the yield of the reaction (Scheme 71).  
 
Scheme 71 - Optimised reaction conditions for the Kharasch cyclisation 
The stereochemistry of the resulting compound 237 was established by NOE studies. 
Irradiation of hydrogen Hb showed a positive enhancement to the adjacent hydrogen atoms 
(Ha and Hc) thus, confirming the all cis-geometry between Ha, Hb and Hc (Figure 12). The 
stereochemistry at C-4 was confirmed by irradiation of hydrogen Ha and as expected there 
was no enhancement of hydrogen Hd proving that the chlorine was on the top face of the 
molecule. 
 
Figure 12 - NOE studies confirming cis-ring junction 
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In the next step, the reductive dechlorination of the Kharasch cyclised product 228 was 
accomplished by using procedure described by Barrero and co-workers.
157
 It involved the 
heating of 237 with Raney
®
-Nikel to afford 249. The reaction worked well and gave an 
85% yield for the desired dechlorinated product (Scheme 72). 
 
Scheme 72 - Dechlorination using Raney
®
-Nickel 
The next stage of the synthesis involved incorporation of the piperonyl moiety. This would 
give substrate 238 which would be subsequently oxidised to get ketone 252 (Scheme 66). 
The resulting ketone 252 would be converted into an enol triflate by means of a protocol 
described by Hagiwara.
158
 There is significant literature precedent that enol triflates are 
amenable to palladium catalysed cross coupling reactions under mild conditions and with 
high chemo- and stereoselectivity. It was proposed that as the methylene hydrogens of the 
C ring are more acidic in comparison to that of the D ring then the use of base such as 
LDA would allow the selective enolisation of 252 followed by triflation with triflic 
anhydride to generate 239. Moving towards the desired enol triflate, the dechlorinated 
MOM protected compound 249 was alkylated with the piperonyl bromide 250 to provide 
the A ring of the γ-lycorane. This was conducted under the reaction conditions previously 
reported by Fujioka and co-workers involving reaction of 249 (Scheme 73).
159,160
 The 
reaction worked smoothly and gave the desired compound 238 in an excellent 97% yield. 
Cleavage of the MOM protecting group was performed with 1.5M HCl in methanol at 40 
°C to give the alcohol 251 in 100% yield. This was subsequently oxidised to give 252 with 
the Dess-Martin reagent again in an excellent 95% yield.  
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Scheme 73 - Synthesis of cyclohexanone 252 
Having successfully synthesised the ketone 252, the substrate was treated with LHMDS in 
THF at –78 °C followed by reaction with triflic anhydride. However, neither the desired 
product nor the starting material was identified upon work-up. In another effort, Commins 
reagent was employed instead of triflic anhydride. This resulted in only traces of the 
desired product 239 with mainly recovery of the starting material. This was taken as a good 
sign after the initial failure and so the reaction was repeated with additional equivalents of 
LHMDS and stirred for an extended period of time. The reaction gave a complex mixture 
of products. Moreover 8% of the desired product along with 39% of the starting material 
was also isolated. To deal with the problem, the reaction was also attempted using freshly 
prepared LDA along with DMPU. However, this could not improve the results, giving only 
traces of the desired product along with a considerable amount of unidentifiable by-
products (Table 9).  
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Table 9 - Attempted synthesis of enol triflate 239  
 
To limit the formation of undesired by-product and to achieve high yields of the desired 
triflate 239, it was proposed to re-order the synthetic steps and reduce the amide prior to 
deprotection of the MOM group. This would allow triflate formation selectively and would 
limit the possibility of a second triflate formation. Compound 238 was heated under reflux 
in THF with LiAlH4 to afford 244 in an 85% yield (Scheme 74). Next the MOM group was 
cleaved and the resulting alcohol 254 was subjected to oxidation. Initially, the Dess-Martin 
reagent was employed for the oxidation of the secondary alcohol 254 and the reaction was 
stirred for 4 h. However, only starting material was present in the reaction mixture. The 
reaction was stirred for a further 12 h and it was observed that the starting material had 
begun to decompose. As such, it was decided to try another oxidising agent in order to 
proceed further. In a second attempt, 254 was treated with PDC at room temperature. 
However, this reagent also led to decomposition of the starting material and no desired 
product was formed. The reaction was tried again at 0 °C using only an half equivalent of 
PDC. These conditions also proved unrewarding, failing to give any identifiable oxidised 
product, giving the same result as before even after 10 minutes of stirring. As a final 
option, a Swern oxidation was attempted. Although, the starting material was consumed 
leading to the formation of a number of spots on the TLC plate, none of them could be 
identified as the desired compound.  
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Scheme 74 - New strategy for the synthesis of substrate for triflate formation 
Unfortunately none of these procedures were successful in generating the desired 
compound in high yield for the eventual synthesis of (+)-γ-lycorane. Work in this area was 
discontinued and we turned our intensions to the synthesis of pancratistatin analogues. 
3.3.6 Synthesis of pancratistatin analogues 
Among the numerous members of the Amaryllidaceae family, phenanthridone alkaloids 
such as (+)-2-deoxylycoricidine 221, (+)-7-deoxypancratistatin 222, and (+)-lycoricidine 
213 are the most well known due to their interesting structures and potent biological 
activities (Figure 10, page 71).
88
 Over the years, a number of creative approaches have 
appeared in the literature to synthesise these fascinating targets by several research 
groups.
161-165
 Our interest in 221 and 222 is heightened by its promising activity in several 
anticancer tests against the NCI human tumour cell line panel.
88,166
 These compounds have 
also shown antitumor activities and have appeared as potent therapeutic agents against a 
set of diverse viruses. The mode of action for these compounds is still not known in detail. 
However, various investigations have shown that the activities of such compounds can be 
attributed to the oxygenated cycle and to their tricyclic structure.
167
  
In continuation of our ongoing research program, our aim was to use the mono-substituted 
cyclic allylic amide 135a to undertake a highly stereoselective synthesis of various novel 
pancratistatin analogues and screen them for their biological activities. As such, a new 
strategy for the synthesis of pancratistatin analogues and their related derivatives was 
devised and is outlined below (Scheme 75). 
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Scheme 75 - Proposed route for the synthesis of Pancratistatin analogues 
The synthetic route involved the removal of the trichloroacetyl group under base mediated 
conditions followed by a coupling with a piperonyl moiety 256. The resulting compound 
257 would set the stage for the synthesis of the basic core of the pancratistatin (B ring) 
through the action of the Pd-catalysed cross coupling reaction. At this point, the synthesis 
of many different pancratistain analogues should be straightforward. Removal of the MOM 
protecting group followed by hydrogenation would give the first target 259. In order to 
achieve the synthesis of the other poly-hydroxylated analogues, 137 will be subjected to 
allylic oxidation, directed dihydroxylation and epoxidation to provide various 
pancratistatin analogues. If the allylic oxidation reaction proved to be successful, then 
resulting ketone would be reduced and directed dihydroxylation would furnish the fully 
oxygenated C ring. 
The pancratistatin analogue synthesis commenced with the hydrolysis of the cyclic allylic 
trichloroacetamide 135a. The reaction was carried out by stirring a solution of 135a in a 
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1:1 mixture of methanol and 2.0 N sodium hydroxide to provide the amine in quantitative 
yield (Scheme 77). The A-ring building block of the phenathridone was prepared via the 
bromination of the commercialy available piperanal 262 in glacial acetic acid to give 6-
bromopiperonal 263 as a crystalline solid in 96% yield. The resulting 6-bromopiperonal 
263 was oxidised through the action of potassium permanganate to furnish 6-
bromopiperonylic acid 264 in overall 85% yield (Scheme 76).
168
 
 
Scheme 76 - Synthesis of 6-bromopiperonylic acid 256 
Having the carbocyclic amine and 6-bromopiperonylic acid in hand, we turned our 
attention to coupling them together with the aid of 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDCI). A synthetically useful virtue of EDCI is that it can be employed as a 
carboxyl activating agent for the coupling of primary amines to yield amide bonds. In a 
typical procedure, the solution of amine in acetonitrile was treated with EDCI along with a 
catalytic amount of DMAP followed by acidic work up to give the desired compound 257 
in 79% yield. To make the basic core of pancratistatin 137 and lycoricidine analogues 258, 
two different approaches both involving palladium acetate were investigated (Scheme 77 
and 78). Initially, Ogawa’s169 protocol of an intramolecular Heck reaction was attempted to 
give 258. This approach requires the protection of the carbamate nitrogen of 257 with a 
suitable protecting group such as Boc or PMB. The Boc protection of 257 was attempted 
using Boc anhydride, TEA and DMAP in acetonitrile and was stirred at room temperature 
for 24 h. These conditions did not show any sign of reaction. The reaction temperature was 
then increased to 80 °C and stirred overnight but again this reaction failed to lead to the 
generation of the desired Boc protected compound 264 (Scheme 77). After this failure, a p-
methoxybenzyl protecting group was employed. The reaction was attempted in DMF using 
p-methoxybenzyl chloride in the presence of sodium hydride. Again no product was 
formed despite long reaction times at elevated temperatures (80 °C) and returned only 
starting material. Our attempts to protect the carbamate nitrogen of 257 did not prove 
successful. Therefore, compound 257 was subjected to the Ogawa protocol where 
compound 257 is exposed to Pd(OAc)2, Tl(OAc), and 1,2-bis(diphenylphosphino)ethane 
(DIPHOS) in DMF at 140 °C. These conditions again failed to promote the reaction 
towards the desired compound and gave only starting material back.  
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Scheme 77 - Alkylation and cross coupling of carbocyclic amide 135a 
It was decided instead to perform the reaction using conditions previously reported by 
Mori.
149
 Thus, the reaction was attempted using Hünig’s base and triphenylphosphine 
along with Pd(OAc)2 in a solution of DMF and was heated to 100 °C (Scheme 78). 
However, only starting material was present after 24 h of stirring. Some further 
experimentation revealed that the B ring of the phenanthridone forms smoothly in 78% 
yield when the reaction was carried out in a Schlenk tube at 150 °C (Scheme 78). To 
accomplish the synthesis of 137, a combination of Hünig’s base, triphenylphosphine and 
Pd(OAc)2 at 150 °C in a sealed tube was essential. During the course of the reaction, 
triphenylphosphine reduces the Pd(II) to Pd(0). Once formed, Pd(0) activates the sequence 
of events by taking part in an oxidative addition with 257 to give the 16-electron complex 
266 (Scheme 78). In the following step, insertion of alkene into the C-Pd bond generated a 
four-centred transition state 267 in a syn-fashion. Subsequently, a simple bond rotation 
occurs to relieve the torsional strain and allows the syn-relationship between a β-hydrogen 
and the palladium atom. Having a β-hydrogen and the transition metal in a common plane, 
β-hydride elimination takes place to give the phenanthridone skeleton 137. In the final 
step, the palladium(0) is regenerated by a base assisted reductive elimination. It is worth 
mentioning that the use of other phosphine ligands such as DIPHOS and additives such as 
Tl(OAc) in the presence of Pd(OAc)2 did not give the desired cyclisation even in Schlenk 
tube at 150 °C. Moreover, the cross coupling of 247 works only when the reaction is 
carried out in a sealed tube. During the cyclisation, the alkene moves out of conjugation 
and furnishes only the single stereoisomer 137.  
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Scheme 78 - Heck type reaction for the synthesis of Phenanthredone core 137 
The sterochemistry of the 137 was confirmed by difference NOE experiments. The 
compound 137 was irradiated at Hb to determine the orientation in relation to Ha and Hc. It 
showed a positive enhancement between Hb, Ha and Hc which implies they all have a syn-
relationship to each other (Figure 13). 
 
Figure 13 - NOE enhancement studies for the compound 137 
There are some reports which show that using Ogawa’s modified Heck reaction protocol, 
258 can be furnished via anti-elimination instead of the generally observed syn reductive 
elimination of palladium.
170
 In our case no anti-elimination was observed. However 
formation of 137 implies that the β-hydride elimination takes place formally via syn- 
elimination.  
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Having synthesised the phenanthridone skeleton 137, an investigation into further 
functionalisation was proposed. Initially, allylic oxidation was attempted using the Cory 
procedure.
111
 In the first attempt, substrate 137 was exposed to 5 equivalents of TBHP as 
an oxidant along with a catalytic amount of 10% Pd on carbon and potassium carbonate at 
20 °C for 12 h. Under these conditions, the desired product was not detected in the reaction 
mixture. The temperature of the reaction mixture was raised to 45 °C and was stirred for a 
further five days. Once again this proved unrewarding. Previously, we have faced 
considerable difficulties for the allylic oxidation for the much simpler substrate 129. Many 
of the more commonly known oxidation protocols were examined and proved to be futile 
(Section 3.1.3). It was proposed that allylic oxidation might work in this instance as there 
was literature precedent for similar substrates.
171
 Moreover in this substrate, the amide 
functionality is far away from the reaction activation site. However, all attempts were 
again unsuccessful.  
To progress, the synthesis of 268 was achieved by removal of the MOM group of 137 
under acidic conditions. This was followed by treatment with palladium on carbon under 
an atmosphere of hydrogen to achieve hydrogenation in an excellent 88% yield to supply 
target compound 259 (Scheme 79).  
 
Scheme 79 - Attempted allylic oxidation and formation of pancratistatin analogue 259 
In order to achieve the synthesis of pancratistatin analogues 138 and 261, compound 268 
was dihydroxylated using conditions previously employed for the synthesis of 
dihydroconduramines C-1 132 and E-1 133. At first, the phenanthridone skeleton 268 was 
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reacted with osmium tetroxide in the presence of TMEDA at –78 °C, followed by 
treatment with conc. HCl to cleave the osmate ester (Scheme 80). The hydroxylation 
reaction occurred smoothly, producing 139 as a single stereoisomer in 90% yield (Scheme 
81). 
 
Scheme 80 - Dihydroxylation of 268 
The result from this transformation showed that formation of triol 139 occured exclusively 
from the less hindered convex face of the ring, without any directed dihydroxylation of the 
alkene. This can be explained due to the extraordinary steric congestion of the C ring, in 
the phenanthridone skeleton 268. Initially, the stereochemistry of 139 was assigned 
through coupling constants of the cyclohexane ring hydrogens from the 
1
H NMR spectrum 
as well as the acquisition of COSY and NOE spectra. It was further established by X-ray 
crystallography of the resulting compound 139 (Figure 14). 
 
Figure 14 - ORTEP representation of X-ray crystal structure of the compound 139 
To access the pancratistatin analogue 138, the directed epoxidation of cyclic allylic alcohol 
using m-CPBA was employed. The pioneering work of Henbest and Wilson, established 
that cyclic allylic alcohols can be diasteroselectively epoxidised with m-CPBA to furnish 
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the corresponding cis-epoxy alcohol diastereomer. On the basis of this, as well as our own 
results during the synthesis of aminocyclitols (Section 3.2.2), it was proposed that the m-
CPBA is small enough to coordinate to either the C4-hydroxy or C4a amide from the more 
hindered concave face of phenanthridone ring 268 for the directed epoxidation to give 
corresponding cis-epoxy alcohol stereosiomer. The allylic alcohol 268 was subjected to 
standard conditions and stirred overnight. A rather sluggish reaction was observed, 
although the starting material was consumed after 48 h. Gratifyingly, this reaction gave 
cis-epoxy alcohol 138 as a single diastereomer (by 
1
H NMR spectroscopy of the crude 
reaction material). Purification by flash column chromatography afforded the epoxide 138, 
in 75% yield (Scheme 81).  
 
Scheme 81 - Epoxidation of 268 
The stereochemistry of the resulting epoxide was confirmed by NOE studies. The 
stereochemistry of Hb had already been established. On irradiation of Hb, a positive NOE 
between the of position Hb and Hc (0.58%), indicated the syn-relationship, thus confirming 
the preparation of the (1R,2S,4R,4aS,10bS)-stereoisomer 138 (Figure 15). 
 
Figure 15 - NOE enhancement studies for the epoxy alcohol 138 
Finally, 138 was subjected to 0.2N H2SO4 in 1,4-dioxane, to cleave the epoxide (Scheme 
82). Surprisingly, this resulted in a 1:1 mixture of 261a and 261b in only 34% yield even 
after 4 days of stirring at 100 °C. Compound 138 was also treated with sodium benzoate in 
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an attempt to perform a more selective ring opening but again a 1:1 mixture of 261a and 
261b was isolated in only 18% yield. 
 
Scheme 82 - Epoxide ring opening of 138 
3.3.7 Conclusions 
In conclusion a one-pot diastereoselective tandem Overman rearrangement and RCM 
reaction was developed by combining the ether-directed Overman rearrangement and 
RCM. This reaction provides quick access to a diastereoselective synthesis of a 
functionalised chiral cyclic allylic trichloroacetamide in good yield and in high 
diastereoselectivity starting from the corresponding allylic alcohol. The allylic alcohol was 
easily prepared from commercially available starting material, (S)-glycidol in an excellent 
86% yield over 6 steps. Having the cyclic allylic trichloroacetamide in hand, two parallel 
synthetic strategies were devised to furnish the synthesis of (+)-γ-lycorane and various 
novel pancratistatin analogues. The cyclic allylic amide was employed to give the C ring of 
the target compounds. Kharasch cyclisation and alkylation with a piperanoyl moiety 
furnished the A and D ring for the synthesis of (+)--lycorane 136. Significant problems 
were encountered with the final steps of the route and prevented the successful ring closure 
towards the synthesis of (+)-γ-lycorane. However the basic core of pancratistatin was 
successfully prepared using a Pd-catalysed cross coupling reaction. Its further 
functionalisation using allylic oxidation, dihydroxylation and directed epoxidation were 
then explored. Allylic oxidation of 137 was unrewarding, however a directed epoxidation 
and dihydroxylation gave novel pancratistain analogues in excellent yield and 
diastereomeric excess. These results have revealed that the syn-(4aS,10bS)-phenantridone 
skeleton 268 has significant influence on the functionalisation of the alkene where size of 
the reagent and its ability to undergo a directed reaction dictates the face of the attack. 
Results and Discussions  94 
 
3.3.8 Future Work 
After the successful synthesis of the pancratistatin analogues, the ether-directed tandem 
reaction could then be applied for the synthesis of other alkaloids in the Amaryllidaceae 
family. One such compound is (+)-2-deoxylycoricidine 221, which has only previously 
been synthesised in racemic form. Its asymmetric synthesis could also be achieved from 
allylic trichloroacetamide 135a (Scheme 83). Conversion of 135a to the ketone 263, 
followed by dihydroxylation would introduce the syn-diol require for the target compound. 
After protection of the diol, the trichloroacetyl group could be hydrolysed to provide the 
amino ketone 271. This will set the stage to introduce the aromatic component to give 272, 
which will then be converted to the enol triflate using Commins reagent 273 to provide 
274. The resulting compound 274 would then undergo a Heck-type cyclisation which after 
deprotection would provide the first asymmetric synthesis of (+)-2-deoxylycoricidine 221. 
 
Scheme 83 - Proposed synthesis of (+)-2-deoxylycoricidine 221  
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3.4 New Synthesis of Balanol Analogues 
3.4.1 Introduction 
(–)-Balanol 275 is a metabolite of the fungi Verticillium balanoides172 and Fusarium 
merismoides
173
 and is a structural isomer of the known antifungal ophiocordin 276 (Figure 
16). Balanol has been shown to be an effective inhibitor of human protein kinase C. The 
protein kinase C (PKC) family is a series of serine/threonine-specific protein kinase 
enzymes that are recognised as controling the function of a variety of cellular signal 
transduction pathways.
89-91
 They are involved in the gene expression, cell proliferation and 
cell growth. The activated PKC has been implicated in the progression of several disease 
processes including, cancer, asthma, inflammation, cardiovascular dysfunctions, diabetic 
complications, HIV infection and central nervous system disorders. 
 
Figure 16 - Balanol 275 and Ophiocordin 276 
As PKC is important for a number of cellular processes, the use of PKC inhibitors has been 
recommended for clinical applications ranging from the treatment of diabetic 
complications to the treatment of cancer.
174
 The isolation and structural revelation of the 
PKC-inhibitory fungal metabolite balanol endowed a new structural motif to the PKC 
inhibitor area. Therefore, it is a critical biological target for the development of 
chemotherapeutic agents. The structure of balanol is comprised of two primary fragments, 
a benzophenone part 277 and a chiral hexahydroazepine core 145 (Scheme 84). In this 
project, our aim was to utilise the one-pot rearrangement and ring closing metathesis 
process combined with subsequent hydroxylation chemistry to facilitate easy access to the 
chiral hexahydroazepine core of balanol 145. We intended to use this chemistry to 
synthesise a number of stereoisomers and various hydroxylated analogues. 
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Scheme 84 - A chiral hexahydroazepine core and a benzophenone fragment 
3.4.2 Proposed synthesis 
As mentioned above, the aim of this research project was to develop a new flexible 
approach for the stereoselective synthesis of the balanol core and its analogues in an 
efficient manner. The strategy under investigation can be considered in three distinct 
stages. The first stage of this programme would be the synthesis of the key substrate 140 as 
a precursor for the tandem process (Scheme 85). The synthesis of 140 would start with 
glycine 278 which would be subjected to a one-pot protection strategy generating both a 
methyl ester and the Boc-protected amine 279. The amine will be alkylated with 4-bromo-
1-butene 280 and the resulting compound 281 would be reduced with DIBAL-H. A one-
pot Swern-HWE reaction would give the ,β-unsaturated ester 283 and this would again be 
reduced with DIBAL-H to supply the key substrate 140 for the tandem process. 
 
Scheme 85 - Synthesis of the the allylic alcohol 140 from glycine 
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In the next stage of the synthesis, the allylic alcohol 140 would then be transformed into 
the corresponding allylic trichloroacetimidate 284 under standard conditions (Scheme 86). 
Initially, to optimise the rearrangement conditions, the allylic trichloroacetimidate would 
be rearranged using bis(acetonitrile)palladium(II) chloride. Later, (R)-COP-Cl 83 would be 
employed to undergo a stereoselective rearrangement and its further treatment with Grubbs 
first generation catalyst would yield the seven-membered carbocyclic amide 141. 
 
Scheme 86 - One-pot tandem Overman rearrangement and RCM 
To generate the (–)-balanol core 145, the allylic trichloroacetamide 141 would be further 
protected with a benzyl moiety (Scheme 87). The doubly protected amide then should 
undergo epoxidation from the least hindered face of the ring according to work carried out 
by O’Brien and co-workers.141 Reduction of the epoxide 143 with LiAlH4 would then give 
the desired amino alcohol core 286. In a similar fashion, direct epoxidation should yield 
the syn-epoxide 142 which could be regioselectively ring-opened with LiAlH4 to generate 
the syn-amino alcohol 289. To complete the (–)-balanol core, the trichloroacetamide 286 
will be hydrolysed and the resulting amine 287 will be re-acylated with 4-
benzyloxybenzoyl chloride. Hydrogenation will then remove both benzyl protecting groups 
and finally treatment with TFA will give the (–)-balanol core 145. The syn-stereoisomer 
144 can also easily be accessed by similarly hydrolysing the amide and re-acylating with 4-
benzyloxybenzoyl chloride (Scheme 87). Hydrogenation of the benzyl protecting group 
followed by Boc-deprotection of the amine will yield the other desired stereoisomer 144. 
As well as generating these two targets, there is the potential to prepare a whole range of 
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hydroxylated analogues by epoxidation, dihydroxylation and iodolactamisation of the 
alkene from the tandem process. 
 
Scheme 87 - Proposed synthesis of the balanol core structures 
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3.4.3 Synthesis of allylic alcohols  
The first step in the production of the allylic alcohol 140 involved the synthesis of the Boc-
protected amine 279. This was easily synthesised in quantitative yield by esterification of 
the commercially available glycine 278 with trimethylsilyl chloride followed by treatment 
with Boc anhydride in the presence of TEA.
175
 Attempted alkylation of compound 279 was 
then investigated with 4-bromo-1-butene 280. This reaction was carried out according to a 
literature procedure published by Andino and co-workers,
176
 using sodium hydride in DMF 
at 0 °C. However, application of the literature reaction conditions failed to deliver any of 
the desired alkylated product 281, but led to the decomposition of the starting material. In 
order to avoid decomposition, the reaction was tried again using the milder potassium 
carbonate with acetone as solvent and the reaction heated under reflux. In this case, the 
reaction did not decompose but failed to react returning a significant amount of starting 
material. In another attempt, potassium tert-butoxide was employed to effect the alkylation 
of 279. Once again, the reaction did not prove successful and starting material was found 
to be present in the crude reaction mixture (Scheme 88). 
 
Scheme 88 - Esterification, Boc protection and attempted alkylation 
The failure of the alkylation led to the design of a new strategy for the synthesis of the 
alkylated amine. In this synthesis, the amino alcohol 292 was chosen as a starting point 
instead of glycine and was reacted directly with 4-bromo-1-butene 280. The reaction was 
carried out in the presence of sodium iodide and was stirred at 80 °C to furnish the desired 
compound in an excellent yield. The resulting product 293 was subjected to Boc protection 
and it resulted in the formation of three products giving only a trace amount of the desired 
compound 282 (Scheme 89). 
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Scheme 89 - Boc protection of 292 
In order to prevent the protection of the hydroxyl group of 293 with the Boc anhydride, 
silylation of the hydroxyl group was carried out using TBDPS prior to Boc protection. This 
was followed by treatment with Boc anhydride and then with TBAF to supply 282 in 86% 
yield over three steps. At this juncture, compound 282 was subjected to a one-pot Swern 
oxidation and HWE reaction to give the ,β-unsaturated ester 283 in 94% yield. To 
complete the synthesis of the desired allylic alcohol, reduction of the resulting ester was 
attempted using DIBAL-H (Scheme 90). 
 
Scheme 90 - Synthesis of the allylic alcohol 140 
Previously, DIBAL-H has been shown as a successful reagent for the reduction of ,β-
unsaturated esters to allylic alcohols using 2.2 equivalents. However, this time it did not 
prove to be as efficient and gave only 37% of the desired allylic alcohol along with a 
complex mixture of unidentifiable compounds. A similar problem has been discussed 
previously in the literature and has been successfully avoided by the Moriwake 
modification.
177
 Moriwake and co-workers have shown that trimeric DIBAL-H might 
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coordinate with the amino moiety and alkene leading to 1,4-addition and the formation of 
complex mixture of products via transition state 298 (Figure 17). This can be avoided with 
the application of appropriate Lewis acids such as boron trifluoride diethyl etherate in the 
reaction before the start of reduction. The use of boron trifluoride diethyl etherate 
coordinates with the Boc-protected nitrogen causing the reaction to proceed via the 
hypothetical transition state 299 to promote the desired reduction. As such, this reaction 
was attempted again using these conditions, but no improvement was observed and the 
reaction led to an inseparable mixture of several products, along with the desired 
compound 140 in 41% yield. 
 
Figure 17 - Hypothetical transition states during DIBAL-H reduction of 283 
In order to obtain a high yield of the allylic alcohol 140, it was envisioned that a Wittig 
reaction could be employed subsequent to the Swern oxidation of alcohol 282 instead of 
the HWE reaction. The resulting aldehyde 301 would then be reduced using sodium 
borohydride to provide the allylic alcohol 140. As such the primary alcohol was subjected 
to a Swern oxidation followed by the Wittig reaction to afford 301 (Scheme 91). The NMR 
spectra of the crude reaction mixture showed a mixture of E and Z alkenes in a ratio of 5:1, 
which could not be separated until they were reduced. Reduction of the mixture of E and Z 
alkenes was carried out smoothly using sodium borohydride in a solution of methanol and 
the desired allylic alcohol 140 was separated in 88% yield. This new sequence of reactions 
proved successful and provided the allylic alcohol without adding extra steps to the 
strategy. 
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Scheme 91 - Synthesis of the allylic alcohol using sodium borohydride 
With the allylic alcohol 140 in hand, the Overman rearrangement and RCM steps were 
then investigated. The allylic alcohol 140 was subjected to a standard one-pot tandem 
process as previously described initially using trichloroacetonitrile and DBU (Scheme 92). 
The formation of allylic trichloroacetimidate 284 was accomplished after 3 h. During the 
optimisation of the reaction conditions, it was observed that the allylic trichloroacetimidate 
284 is unstable and decomposed back to the starting material 140 at room temperature. 
Thus, the resulting allylic trichloroacetimidate 284 was quickly rearranged using 
bis(acetonitrile)palladium(II) chloride at 0 °C. The reaction was gradually warmed to room 
temperature and stirred for 24 h to afford the allylic trichloroacetamide 302. Compound 
302 was then subjected to RCM using Grubb’s 1st generation catalyst to furnish the seven 
membered carbocyclic amide 303 in 49% yield over three steps starting from the allylic 
alcohol 140.  
 
Scheme 92 - One-pot tandem Overman rearrangement and RCM 
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In the next stage, compound 303 was subjected to epoxidation utilising the conditions 
employed previously which provided epoxide 304 in modest 51% yield (Scheme 93). As 
per purposed route, compound 304 was then treated with lithium aluminum hydride to 
cleave the epoxide ring. This resulted in 56% yield of the oxo-diaza-azulen 305 along with 
16% unreacted starting material. 
 
Scheme 93 - Formation of epoxide 304 and its treatement with LiAlH4 
3.4.4 Conclusions and Future work 
At this stage, time restrictions unfortunately dictated that further development of this 
synthetic route is not currently possible. However, significant progress towards the 
synthesis of the (–)-balanol core 145 has been made, although problems were encountered 
in the preparation of the allylic alcohol 140 which prevented the successful synthesis of the 
target compound within the timeframe of this PhD project. The advanced stage key 
intermediate 303, a seven membered carbocyclic amide has been synthesised. Further 
investigation into the optimisation of the Overman rearrangement using (R)-COP-Cl, will 
hopefully allow the development of a stereoselective rearrangement and the subsequent 
treatment with Grubbs first generation catalyst will supply seven membered carbocyclic 
amide 141. Following this, relatively straight forward chemistry can be applied to 
synthesise the two desired core structures of balanol 144 and 145 as described in Scheme 
87.
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4 Conclusions 
In the first part of the project, it was planned to develop a fast and efficient method for the 
synthesis of the carbocyclic ketone 130. During the course of the research, new 
methodology was devised for the successful synthesis of 5- and 6-membered amido 
substituted carbocyclic ketones which are important building blocks for the synthesis of 
structurally diverse antiviral and anticancer carbocyclic nucleosides and natural products.  
Initially, various methods were investigated for the allylic oxidation of carbocyclic amides 
formed from a one-pot tandem process. It appeared that these carbocylic amides are 
resistant to allylic oxidation using TBHP along with different transition metals such as Pd, 
Se, Mn and Cr. In addition to this, the employment of sonication and microwave 
techniques also found no success. In order to achieve the target compounds, a new 
approach was devised involving installation of a hydroxyl group in the substrate before the 
tandem process. The intermediates from this new route were then subjected to a high 
yielding one-pot tandem Overman rearrangement and ring closing metathesis step to 
eventually furnish amido substituted five and six membered carbocyclic ketones in overall 
61% and 56% yield from corresponding allylic alcohols respectively. The resulting 
carbocyclic amides are relatively more complex than have been synthesised previously in 
the group using this approach and in this way, highlights the potential of this methodology 
for the synthesis of more complex target compounds. 
Stereoselective synthesis of the enantiomer of dihydroconduramine C-1 132 and 
dihydroconduramine E-1 133 was achieved using a stereoselective variant of the one-pot 
tandem Overman rearrangement and ring closing metathesis process in excellent yield and 
diastereomeric excess. During the course of the synthesis (1S)-N-(cyclohexenyl) 
trichloroacetamide 131 was efficiently prepared starting from the commercially available 
alcohol in 75% overall yield in six steps and in excellent enantiomeric excess. Initially 
Donohoe conditions for dihydroxylation and a two stage epoxidation and hydrolysis 
sequence were investigated for the synthesis of syn and anti diol derivatives of 131 
respectively, in excellent diastereoselectivity. The noteworthy successes of a relevant 
model study provided the foundation for the synthesis of two dihydroconduramines. In the 
first approach, allylic alcohol 213 was synthesised from 131 via 4,5-dihydro-1,3-oxazole 
210 as a single stereoisomer. Non-directed dihydroxylation and directed epoxidation were 
then employed which resulted in the production of the two dihydroconduramines. This 
operationally simple route is very efficient and granted further insight into the 
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stereoselective functionalisation of substituted cyclohexenes for the production of related 
natural products such as pancratistatins and other Amaryllidaceae alkaloids.  
In next part of this PhD programme, the aim was to develop a one-pot diastereoselective 
tandem Overman rearrangement and RCM reaction by combining the MOM-ether-directed 
Overman rearrangement and RCM step. This process provided quick access to a 
functionalised chiral cyclic allylic trichloroacetamide in good yield and in high 
diastereoselectivity starting from the corresponding allylic alcohol 134. The allylic alcohol 
was easily prepared from commercially available starting material, (S)-glycidol in an 
excellent 86% yield over 6 steps. Having the cyclic allylic trichloroacetamide in hand, two 
parallel synthetic strategies were devised to furnish the synthesis of (+)-γ-lycorane and 
various novel pancratistatin analogues. The cyclic allylic amide was employed to give the 
C ring of the target compounds. Kharasch cyclisation and alkylation with a piperanoyl 
moiety furnished the A and D ring for the synthesis of (+)--lycorane 136. Significant 
problems were encountered with the final steps of the route and prevented the successful 
ring closure towards the synthesis of (+)-γ-lycorane. However the basic core of 
pancratistatin was successfully prepared using a Pd-catalysed cross coupling reaction. Its 
further functionalisation using allylic oxidation, stereoselective dihydroxylation and 
directed epoxidation were then explored. Allylic oxidation of 137 was unrewarding, 
however a directed epoxidation and dihydroxylation gave novel pancratistain analogues in 
excellent yield and diastereomeric excess. These results have revealed that the syn-
(4aS,10bS)-phenantridone skeleton 268 has significant influence on the functionalisation of 
the alkene where the size of the reagent and its ability to undergo a directed reaction 
dictates the face of the attack. In summary, use of the one-pot tandem MOM-ether directed 
Overman rearrangement/RCM process quickly generated a second stereogenic center 
within the resulting cyclic allylic trichloroacetamide and excluded the need of a chiral 
catalyst to generate the stereogenic center on the resulting cyclic allylic trichloroacetamide. 
The new stereogenic centre in the resulting cyclic allylic trichloroacetamide would provide 
an additional reaction site for further functionalisation and is the advantage of this 
methodology in comparison to other available approaches. This feature can be further 
exploited by synthesising other related natural products. 
In the final part of this PhD programme, studies were carried out to expand the scope of the 
one-pot tandem process to include heterocyclic derived substrates. This provided an 
attractive route to synthesise a seven-membered aza-carbocyclic amide. At this stage, time 
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restrictions unfortunately dictated that further development of this synthetic route is not 
currently possible. However, significant progress towards the synthesis of the (–)-balanol 
core 145 has been made, although problems were encountered in the preparation of the 
allylic alcohol 140 which prevented the successful synthesis of the target compound within 
the timeframe of this PhD project. The advanced stage key intermediate 141, a seven 
membered aza-carbocyclic amide has been synthesised. Further investigation into the 
optimisation of the Overman rearrangement using (R)-COP-Cl, will hopefully allow the 
development of a stereoselective rearrangement and the subsequent treatment with Grubbs 
catalyst will supply seven membered aza-carbocyclic amide 141. Following this, relatively 
straightforward chemistry can be applied to synthesise the two desired core structures of 
balanol 144 and 145 as described in Scheme 87. 
In summary, this PhD programme provided facile, general and efficient methods for the 
synthesis of various valuable novel building blocks such as carbocyclic ketone (193), 
aminocyclitols (132 and 133) and pancratistatin analogues (137, 138, 139 and 259). These 
novel compounds can be further utilised as important scaffolds within organic and 
medicinal research and can be further explored to determine their full therapeutic potential. 
Experimental  107 
 
5 Experimental 
5.1 General Experimental 
Reactions were carried out in the flame-dried glassware under a positive atmosphere of 
argon. All reagents and starting materials were obtained from commercial sources and used 
as received. Dry solvents were purified using a PureSolv 500 MD solvent purification 
system or tetrahydrofuran and diethyl ether were distilled from sodium and benzophenone, 
whilst dichloromethane was distilled from calcium hydride. All reactions were performed 
under an atmosphere of argon unless otherwise mentioned. Flash column chromatography 
was carried out using Fisher matrix silica 60. Macherey–Nagel aluminium-backed plates 
pre-coated with silica gel 60 (UV254) were used for thin layer chromatography and were 
visualised by staining with KMnO4. 
1
H NMR and 
13
C NMR spectra were recorded on a 
Bruker DPX 400 spectrometer with chemical shift values in ppm relative to TMS (H 0.00 
and C 0.0) or residual chloroform (H 7.28 and C 77.2) as standard. Mass spectra were 
obtained using a JEOL JMS-700 spectrometer. Infrared spectra were recorded using 
Golden Gate apparatus on a JASCO FTIR 410. Melting points were determined on a 
Reichert platform melting point apparatus. Optical rotations were determined as solutions 
irradiating with the sodium D line ( = 589 nm) using an Auto pol V polarimeter. D 
values are given in units 10
–1
 deg cm
2
 g
–1
. Chiral HPLC was performed on a Hewlett 
Packard Agilent 1100 series instrument and were calibrated with the appropriate racemic 
mixture. 
5.2 General Procedures 
General Procedure 1: One pot Swern oxidation-Horner/Wadsworth/Emmons 
reaction. 
Dimethyl sulfoxide (2.5 equiv.) was added to a stirred solution of oxalyl chloride (1.4 
equiv.) in dichloromethane (100 mL) at –78 C. The reaction mixture was stirred for 0.3 h 
before the alcohol (1.0 equiv.) in dichloromethane (50 mL) was slowly added. The mixture 
was stirred for a further 0.3 h before triethylamine (5 equiv.) was added. This reaction 
mixture was stirred for 0.5 h at –78 C and then allowed to warm to room temperature and 
stirred for a further 2 h. Meanwhile, a solution of lithium chloride (1.8 equiv.), triethyl 
phosphonoacetate (1.8 equiv.) and 1,8-diazabicyclo[5,4,0]undec-7-ene (1.8 equiv.) in 
acetonitrile (100 mL) was prepared and stirred for 1.0 h. The Swern solution was 
concentrated in vacuo, then the Horner Wadsworth Emmons solution was added and the 
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reaction mixture was stirred at room temperature overnight. The reaction was quenched by 
the addition of a saturated solution of ammonium chloride (50 mL) and concentrated to 
give an orange residue, which was then extracted with diethyl ether (4 × 75 mL). The 
organic layers were combined, dried (MgSO4) and concentrated to give an orange oil. 
Purification by flash column chromatography using diethyl ether/petroleum ether as eluent 
gave the pure product. 
General Procedure 2: DIBAL-H reduction to allylic alcohol. 
The -unsaturated ester (1.0 equiv.) was dissolved in diethyl ether (100 mL) and cooled 
to –78 C. DIBAL-H (1.0 M in hexane) (2.2 equiv.) was added dropwise and the reaction 
mixture was stirred at –78 C for 3 h, before warming to room temperature. The solution 
was cooled to 0 C and quenched by the addition of a saturated solution of ammonium 
chloride (10 mL) and warmed to room temperature with vigorous stirring over 1 h 
producing a white precipitate. The precipitate was filtered through a pad of Celite

 and 
washed with diethyl ether (400 mL). The filtrate was then dried (MgSO4) and concentrated 
in vacuo. Purification was carried out by flash column chromatography eluting with diethyl 
ether/petroleum ether.  
General procedure 3: MOM protection of secondary alcohol. 
N,N′-Diisopropylethylamine (1.5 equiv.) and bromomethyl methyl ether (1.5 equiv.) were 
added to a solution of the alcohol (1.5 equiv.) in dichloromethane (20 mL). The reaction 
mixture was then heated under reflux for 12 h before being diluted with dichloromethane 
(50 mL) and washed with 2.0 M hydrochloric acid solution (25 mL). The organic layer was 
dried (MgSO4) and concentrated in vacuo. Purification was carried out by flash column 
chromatography using diethyl ether/petroleum ether to give the desired compounds as 
colourless oils. 
General Procedure 4: Synthesis of allylic trichloroacetimidate and subsequent 
tandem Overman rearrangement - ring closing metathesis reaction.  
Allylic alcohol (1 equiv.) was dissolved in dichloromethane (20 mL) and cooled to 0 C. 
1,8-Diazabicyclo[5.4.0]undec-7-ene (0.25 equiv.) was added to the solution followed by 
trichloroacetonitrile (1.5 equiv.). The solution was then warmed to room temperature and 
stirred for 2 h. The reaction mixture was filtered through a short pad of silica gel and 
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washed with diethyl ether (100 mL). The resulting filtrate was then concentrated to give 
the allylic trichloroacetimidate, which was used without further purification. The allylic 
trichloroacetimidate (1 equiv.) was then dissolved in dichloromethane (10 mL). The 
rearrangement catalyst (0.1 equiv., 10 mol%) was added to the solution and the reaction 
mixture was stirred at room temperature for 3 h. Grubb’s catalyst (1st Generation) (0.1 
equiv., 10 mol%) was then added and the reaction mixture was heated under reflux 
overnight. The mixture was cooled to room temperature and then filtered through a short 
pad of Celite

 and washed with diethyl ether (100 mL). Concentration of the filtrate 
followed by flash column chromatography gave the pure cyclic allylic amides as white 
solids. 
5.3 Experimental Procedures 
5.3.1 Synthesis of Carbocyclic Ketones 
Ethyl (2E)-2,7-octadienoate (158).
178
 
 
Reaction was carried out according to general procedure 1, using 5-hexen-1-ol (157) (4.00 
g, 0.04 mol). Flash column chromatography (elution with petroleum ether/diethyl ether, 
10:1) yielded ethyl (2E)-2,7-octadienoate (158) (5.78 g, 86%) as a colourless oil. 
Spectroscopic data is entirely consistent with the literature.
178
 max/cm
–1
 (NaCl) 2933 (CH), 
1721 (CO), 1655 (C=C), 1367, 1267, 1198, 1044; H (400 MHz, CDCl3) 1.28 (3H, t, J 7.1 
Hz, OCH2CH3), 1.52–1.58 (2H, m, 5-H2), 2.06–2.12 (2H, m, 6-H2), 2.18–2.25 (2H, m, 4-
H2), 4.17 (2H, q, J 7.1 Hz, OCH2CH3), 4.96–5.06 (2H, m, 8-H2), 5.73–5.96 (2H, m, 2-H 
and 7-H), 6.95 (1H, dt, J 15.5, 6.9 Hz, 3-H); C (100 MHz, CDCl3) 14.3 (CH3), 27.1 (CH2), 
31.5 (CH2), 33.1 (CH2), 60.2 (CH2), 115.1 (CH2), 121.5 (CH), 138.0 (CH), 149.0 (CH), 
166.7 (C); m/z (CI) 169.1232 (MH
+
. C10H17O2 requires 169.1229), 141 (90%), 123 (75), 95 
(100), 81 (53), 55 (32). 
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(2E)-Oct-2,7-dien-1-ol (128).
178
 
 
Reaction was carried out according to general procedure 2, using ethyl (2E)-2,7-
octadienoate (158) (2.00 g, 11.00 mmol). Flash column chromatography (elution with 
petroleum ether/diethyl ether, 1:4) yielded (2E)-oct-2,7-dien-1-ol (128) (0.68 g, 91%) as a 
colourless oil. Spectroscopic data is entirely consistent with the literature.
178
 max/cm
–1
 
(NaCl) 3346 (OH), 2928 (CH), 1640 (C=C), 1439, 1090, 997, 970; H (400 MHz, CDCl3) 
1.34 (1H, br s, OH), 1.46–1.51 (2H, m, 5-H2), 2.02–2.10 (4H, m, 4-H2 and 6-H2), 4.07 (2H, 
d, J 4.6 Hz, 1-H2), 4.94–4.97 (1H, m, 8-HH), 5.01 (1H, dq, J 17.0, 1.7 Hz, 8-HH), 5.60–
5.73 (2H, m, 2-H and 3-H), 5.80 (1H, ddt, J 17.0, 10.2, 6.7 Hz, 7-H); C (100 MHz, 
CDCl3) 28.3 (CH2), 31.6 (CH2), 33.2 (CH2), 63.7 (CH2), 114.6 (CH2), 129.2 (CH), 133.0 
(CH), 138.6 (CH); m/z (CI) 109.1009 (MH
+–H2O. C8H13 requires 109.1017), 95 (16%), 81 
(12), 67 (47). 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohex-2-ene (129).38 
 
Reaction was carried out according general procedure 4 using (2E)-oct-2,7-dien-1-ol (128) 
(0.50 g, 3.97 mmol) by using bis(acetonitrile)palladium(II) chloride (0.10 g, 0.39 mmol) as 
a catalyst for the Overman rearrangement. Purification by flash column chromatography 
(elution with petroleum ether/diethyl ether, 97:3) gave 1-(2′,2′,2′-
trichloromethylcarbonylamino)cyclohex-2-ene (129) (0.83 g, 90% yield over 3 steps) as a 
white solid. Spectroscopic data is entirely consistent with the literature. Mp 85–86 C, lit.38 
86–87 C; max/cm
–1
 (NaCl) 3421 (NH), 2941 (CH), 1676 (CO), 1519, 1073, 822; H (400 
MHz, CDCl3) 1.62–1.79 (3H, m, 5-H2 and 6-HH), 1.94–2.03 (1H, m, 6-HH), 2.03–2.16 
(2H, m, 4-H2), 4.42–4.54 (1H, m, 1-H), 5.65 (1H, ddt, J 10.0, 4.0, 2.2 Hz, 2-H), 5.98 (1H, 
dtd, J 10.0, 4.0, 1.9 Hz, 3-H), 6.60 (1H, br s, NH); C (100 MHz, CDCl3) 19.4 (CH2), 24.7 
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(CH2), 28.6 (CH2), 46.9 (CH), 92.7 (C), 125.7 (CH), 132.7 (CH), 161.1 (C); m/z (CI) 
261.0144 (MNH4
+
. C8H14
35
Cl2
37
ClN2O requires 261.0143), 259 (100%), 242 (23), 225 (9), 
206 (21), 81 (10). 
1-(tert-Butoxycarbonylamino)cyclohex-2-ene (166).
179
 
 
1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclohept-2-ene (129) (1.0 g, 4.12 mmol) was 
dissolved in 2 M sodium hydroxide (40 mL) and stirred vigorously for 12 h at room 
temperature. Di-tert-butyl dicarbonate (2.34 g, 10.31 mmol) was added and the solution 
was stirred for 6 h before a further portion of di-tert-butyl dicarbonate (2.34 g, 10.31 
mmol) was added and the reaction mixture stirred for a further 12 h. The reaction mixture 
was then extracted with ethyl acetate (4  30 mL) and the combined organic layers dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography (diethyl 
ether/petroleum ether, 1:9) gave 1-(tert-butoxycarbonylamino)cyclohex-2-ene (166) (0.81 
g, 100% yield) as a white solid. Spectroscopic data is entirely consistent with the literature. 
Mp 38–40 C, lit.179 mp 33–35 C; max/cm
–1
 (NaCl) 3334 (NH), 2929 (CH), 1693 (CO), 
1494, 1366, 1216, 1118, 1065; H (400 MHz, CDCl3) 1.45 (9H, s, O
t
Bu), 1.48–1.57 (1H, 
m, 6-HH), 1.58–1.68 (2H, m, 5-H2), 1.82–1.93 (1H, m, 6-HH), 1.94–2.02 (2H, m, 4-H2), 
4.15 (1H, br s, NH), 4.46–4.61 (1H, m, 1-H), 5.57–5.64 (1H, m, 1-H), 5.77–5.84 (1H, m, 
1-H); C (100 MHz, CDCl3) 19.7 (CH2), 24.8 (CH2), 28.5 (3 × CH3), 29.9 (CH2), 45.7 
(CH), 79.2 (C), 128.2 (CH), 130.5 (CH), 155.2 (C); m/z (CI) 198 (MH
+
, 10%), 180 (5), 142 
(100), 107 (3), 81 (10).  
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1-(tert-Butoxycarbonylamino)cyclohex-2-en-4-one (167).
180
 
 
A mixture of 1-(tert-butoxycarbonylamino)cyclohex-2-ene (166) (0.10 g, 0.50 mmol), 10% 
palladium on carbon (0.005 g), dichloromethane (15 mL), tert-butyl hydroperoxide (0.46 
mL, 2.5 mmol, 5.0–6.0 M in decane) and anhydrous potassium carbonate (0.02 g, 0.13 
mmol) was heated under reflux for 5 days. The reaction mixture was filtered through a pad 
of silica which was subsequently washed with dichloromethane 10 mL. After removal of 
solvent under reduced pressure, the crude material was purified by flash column 
chromatography using (diethyl ether/petroleum ether, 1:1) to give 1-(tert-
butoxycarbonylamino)cyclohex-2-en-4-one (167) (0.01 g, 10% yield) as a white solid. 
Spectroscopic data is entirely consistent with the literature. Mp 110–112 C, lit.180 mp 
112–113 C; max/cm–1 (NaCl) 3351 (NH), 2924 (CH), 1680 (CO), 1519, 1455, 1367, 
1165, 1016; H (400 MHz, CDCl3) 1.47 (9H, s, O
t
Bu), 1.82–1.94 (1H, m, 6-HH), 2.28–
2.37 (1H, m, 6HH), 2.44 (1H, ddd, J 17.0, 12.6, 4.7 Hz, 5-HH), 2.55 (1H, dt, J 17.0, 4.7 
Hz, 5-HH), 4.53 (1H, br s, NH), 4.62–4.71 (1H, m, 1-H), 5.98–6.02 (1H, m, 3-H); 6.83 
(1H, ddd, J 10.0, 2.2, 1.5 Hz, 2H); C (100 MHz, CDCl3) 27.2 (3 × CH3), 29.8 (CH2), 35.7 
(CH2), 46.6 (CH), 79.7 (C), 129.5 (CH), 150.7 (CH), 153.3 (C), 197.5 (C); m/z (CI) 
212.1290 (MH
+
. C11H18NO3 requires 212.1287), 198 (10%), 156 (100), 118 (20), 71 (12). 
(1R*,4S* and 1S*,4S*)-1-(tert-Butoxycarbonylamino)cyclohex-2-en-4-ol (170). 
 
A mixture of 1-(tert-butoxycarbonylamino)cyclohex-2-ene (166) (0.05 g, 0.27 mmol), 
selenium dioxide (0.04 g, 0.39 mmol) and pyridine (0.03 mL, 0.41 mmol) was heated 
under reflux for 4 days. The reaction mixture was filtered through a pad of celite
®
 which 
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was subsequently washed with dichloromethane 15 mL. After removal of solvent under 
reduced pressure, the crude material was purified by flash column chromatography using 
(ethyl acetate/petroleum ether, 1:1) to give (1R*,4S* and 1S*,4S*)-1-(tert-
butoxycarbonylamino)cyclohex-2-en-4-ol (170) (1.1 mg, 2% yield) as a a colourless oil. 
max/cm–1 (NaCl) 3330 (NH/OH), 2977 (CH), 1688 (CO), 1491, 1247, 1045; H (400 
MHz, CDCl3) 1.45 (9H, s, O
t
Bu), 1.62–1.73 (1H, m, 6-H), 2.01–2.18 (3H, m, 5-H2 and 6-
HH), 4.04–4.31 (2H, m, 1-H and 4-H), 4.46 (1H, br s, NH), 5.67–5.90 (2H, m, 2-H and 3-
H); C (100 MHz, CDCl3) 28.1 (CH2), 28.4 (3 × CH3), 30.9 (CH2), 64.7 (CH), 66.1 (CH), 
79.6 (C), 131.1 (CH), 132.8 (CH), 155.1 (C); m/z (CI) 214.1444 (MH
+
. C11H20NO3 
requires 214.1443), 196 (10%), 158 (100), 90 (94), 69 (32). 
4-Hydroxytetrahydrofuran (172).
181
 
 
2,3-Dihydrofuran (171) (4.00 g, 0.06 mmol) was added to 0.2 N hydrochloric acid (20 mL) 
with stirring and cooling on an ice bath. After 0.15 h, a homogeneous solution was 
obtained. Stirring was continued at room temperature for 0.45 h. The aqueous phase was 
extracted with dichloromethane (8 × 50 mL). The combined organic phases were washed 
with a saturated solution of sodium hydrogencarbonate and dried (MgSO4). After removal 
of the solvent, a colourless liquid, 4-hydroxytetrahydrofuran (172) (5.25 g, 92%) was 
obtained. Spectroscopic data is entirely consistent with the literature.
181
 max/cm
–1
 (NaCl) 
3462 (OH), 2957 (CH), 1733 (CO), 1458, 1179, 1036; H (400 MHz, CDCl3) 1.81–1.99 
(3H, m, 2-H2 and 3-HH), 2.00–2.12 (1H, m, 3-HH), 3.39 (1H, s, OH), 3.82–4.09 (2H, m, 1-
H2), 5.54 (1H, s, 4-H); C (100 MHz, CDCl3) 23.5 (CH2), 33.2 (CH2), 67.3 (CH2), 98.4 
(CH); m/z (CI) 89 (MH
+
, 36%), 71 (100), 68 (14). 
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5-Hexen-1,4-diol (174).
182
 
 
To a solution of vinylmagnesium bromide (1.0 M in tetrahydrofuran) (22.7 mL, 0.02 
mmol) at –15 C was added a solution of 4-hydroxybutanal (173) (1.00 g, 0.01 mol) in 
tetrahydrofuran (60 mL). After being stirred for 8 h, the reaction was quenched slowly with 
a saturated solution of ammounium chloride (50 mL). The organic layer was separated, and 
the aqueous layer was extracted with diethyl ether (6 × 50 mL). The combined organic 
layer was dried (MgSO4) and the resulting crude oil was purified by flash column 
chromatography (elution with petroleum ether/diethyl ether, 1:9) which gave 5-hexen-1,4-
diol (174) (1.12 g, 86% yield) as colourless oil. Spectroscopic data is entirely consistent 
with the literature.
182
 max/cm
–1
 (NaCl) 3347 (OH), 2943 (CH), 1644 (CH), 1427, 1179, 
1036; H (400 MHz, CDCl3) 1.58–1.74 (4H, m, 2-H2 and 3-H2), 3.01 (1H, br s, OH), 3.13 
(1H, br s, OH), 3.59–3.71 (2H, m, 1-H2), 4.10–4.20 (1H, m, 4-H), 5.10 (1H, d, J 10.4 Hz, 
6-HH), 5.23 (1H, d, J 17.2 Hz, 6-HH), 5.87 (1H, ddd, J 17.2, 10.4, 6.2 Hz, 5-H); C (100 
MHz, CDCl3) 26.3 (CH2), 31.7 (CH2), 60.2 (CH2), 70.3 (CH), 112.1 (CH2) 138.6 (CH); 
m/z (CI) 117 (MH
+
, 75%), 99 (100), 81 (54), 71 (6). 
1-(tert-Butyldimethylsilyloxy)-5-hexen-4-ol.
182 
 
To 5-hexene-1,4-diol (174) (1.22 g, 0.01 mol) in N,N′-dimethylformamide (20 mL) at –15 
C was added imidazole (0.88 g, 0.01 mol) and tert-butyldimethylsilyl chloride (1.66 g, 
0.01 mol). After being stirred for 0.15 h at –15 C, the mixture was gradually warmed to 
room temperature. The reaction mixture was diluted with diethyl ether (50 mL) and water 
(50 mL). The organic layer was separated, and the aqueous layer was extracted with 
diethyl ether (3 × 50 mL). The combined organic layer was dried (MgSO4) and resulting 
crude oil was purified by flash column chromatography on silica gel (elution with 
petroleum ether/ethyl acetate, 1:9) gave 1-(tert-butyldimethylsilyloxy)-5-hexen-4-ol (1.96 
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g, 78% yield) as a colourless oil. Spectroscopic data is entirely consistent with the 
literature.
182 max/cm
–1
 (NaCl) 3373 (OH), 2954 (CH), 1472, 1255, 835; H (400 MHz, 
CDCl3) 0.01 (6H, s, Si(CH3)2), 0.83 (9H, s, SiC(CH3)3), 1.46–1.66 (4H, m, 2-H2 and 3-H2), 
2.64 (1H, d, J 4.5 Hz, 4-OH), 3.59 (2H, t, J 5.3 Hz, 1-H2), 4.02–4.10 (1H, m, 4-H), 5.02 
(1H, d, J 10.2 Hz, 6-HH), 5.17 (1H, d, J 17.2 Hz, 6-HH), 5.80 (1H, ddd, J 17.2, 10.2, 5.7 
Hz, 5-H); C (100 MHz, CDCl3) –5.3 (2 × CH3), 18.3 (C), 25.9 (3 × CH3), 28.8 (CH2), 34.5 
(CH2), 63.4 (CH2), 72.7 (CH), 114.3 (CH2), 141.2 (CH); m/z (CI) 231 (MH
+
, 100%), 213 
(48), 173 (6), 81 (28). 
1-(tert-Butyldimethylsilyloxy)-4-(methoxymethoxy)hex-5-ene (175). 
 
Reaction was carried out according to general procedure 3, using 1-(tert-
butyldimethylsilyloxy)-5-hexen-4-ol (3.20 g, 0.01 mol). Flash column chromatography 
(petroleum ether/diethyl ether, 20:1) yielded 1-(tert-butyldimethylsilyloxy)-4-
(methoxymethoxy)hex-5-ene (175) (3.80 g, 100%) as a colourless oil. max/cm
–1
 (NaCl) 
2953 (CH), 1642 (C=C), 1472, 1255, 1153, 1037; H (400 MHz, CDCl3) 0.01 (6H, s, 
Si(CH3)2), 0.83 (9H, s, SiC(CH3)3), 1.44–1.66 (4H, m, 2-H2 and 3-H2), 3.32 (3H, s, OCH3), 
3.53–3.63 (2H, m, 1-H2), 3.95 (1H, q, J 6.3 Hz, 4-H), 4.49 (1H, d, J 6.7 Hz, OCHHO), 
4.66 (1H, d, J 6.7 Hz, OCHHO), 5.15 (2H, m, 6-H2), 5.62 (1H, ddd, J 17.1, 10.3, 7.7 Hz, 2-
H); C (100 MHz, CDCl3) –5.3 (2 × CH3), 18.2 (C), 26.4 (3 × CH3), 28.9 (CH2), 31.8 
(CH2), 55.7 (CH3), 63.2 (CH2), 77.7 (CH), 94.1 (CH2), 117.7 (CH2), 138.7 (CH); m/z (CI) 
275.2041 (MH
+
. C14H31O3Si requires 275.2042), 205 (13%), 121 (100), 85 (40). 
4-(Methoxymethoxy)hex-5-en-1-ol (176). 
 
A solution of tetrabutylammonium fluoride (1.0 M in tetrahydrofuran) (16.6 mL, 0.02 mol) 
was added to a solution of 1-(tert-butyldimethylsilyloxy)-4-(methoxymethoxy)hex-5-ene 
(175) (1.48 g, 5.40 mmol) in tetrahydrofuran (40 mL) at 0 C. The reaction was warmed to 
room temperature and stirred overnight. The reaction mixture was then concentrated and 
the resulting residue was re-suspended in diethyl ether (20 mL). The solution was washed 
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with water (30 mL) and the aqueous layer was then extracted with diethyl ether (3 × 30 
mL). The combined organic extracts were dried (MgSO4), concentrated and then purified 
by flash column chromatography (petroleum ether/diethyl ether, 5:2) to give 4-
(methoxymethoxy)hex-5-en-1-ol (176) (2.21 g, 100%) as a colourless oil. max/cm
–1
 
(NaCl) 3423 (OH), 2947 (CH), 1638 (C=C), 1458, 1215; H (400 MHz, CDCl3) 1.62–1.70 
(4H, m, 2-H2 and 3-H2), 1.72 (1H, s, 1-OH), 3.38 (3H, s, OCH3), 3.62–3.73 (2H, m, 1-H2), 
4.04 (1H, q, J 6.9 Hz, 4-H), 4.52 (1H, d, J 6.7 Hz, OCHHO), 4.72 (1H, d, J 6.7 Hz, 
OCHHO), 5.18–5.26 (2H, m, 6-H2), 5.68 (1H, ddd, J 17.1, 10.3, 6.9 Hz, 2-H); C (100 
MHz, CDCl3) 28.6 (CH2), 31.2 (CH2), 55.7 (CH3), 62.6 (CH2), 77.7 (CH), 93.8 (CH2), 
117.6 (CH2), 138.2 (CH) m/z (CI) 161.1178 (MH
+
. C8H17O3 requires 161.1181), 149 
(12%), 129 (88), 99 (100), 81 (24). 
Ethyl (2E)-6-(methoxymethoxy)oct-2,7-dienoate (177). 
 
Reaction was carried out according to general procedure 1, using 4-(methoxymethoxy)hex-
5-en-1-ol (176) (2.20 g, 0.13 mol). Flash column chromatography using (diethyl 
ether/petroleum ether, 2:3) gave the title compound, ethyl (2E)-6-(methoxymethoxy)oct-
2,7-dienoate (177) (2.90 g, 94%) as colourless oil. max/cm
–1
 (NaCl) 2944 (CH), 1709 
(CO), 1654 (C=C), 1466, 1370, 1277, 1149; H (400 MHz, CDCl3) 1.28 (3H, t, J 7.1 Hz, 
OCH2CH3), 1.61–1.82 (2H, m, 4-H2), 2.21–2.39 (2H, m, 5-H2), 3.30 (3H, s, OCH3), 3.94 
(1H, q, J 7.2 Hz, 6-H), 4.11 (2H, q, J 7.1 Hz, OCH2CH3), 4.46 (1H, d, J 6.9 Hz, OCHHO), 
4.63 (1H, d, J 6.9 Hz, OCHHO), 5.12–5.18 (2H, m, 8-H2), 5.55–5.64 (1H, m, 7-H), 5.77 
(1H, dt, J 15.7, 1.6 Hz, 2-H), 6.90 (1H, dt, J 15.7, 6.9 Hz, 3-H); C (100 MHz, CDCl3) 14.2 
(CH3), 28.2 (CH2), 33.8 (CH2), 55.7 (CH3), 60.3 (CH2), 73.9 (CH), 93.8 (CH2), 117.7 
(CH2), 122.0 (CH), 137.6 (CH), 148.8 (CH), 166.7 (C); m/z (CI) 229.1437 (MH
+
. C12H21O4 
requires 229.1440), 197 (36%), 167 (52), 81 (35). 
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(2E)-6-(Methoxymethoxy)oct-2,7-dien-1-ol (178). 
 
The reaction was carried out according to general procedure 2, using ethyl (2E)-6-
(methoxymethoxy)oct-2,7-dienoate (177) (0.66 g, 2.89 mol). Flash column 
chromatography (eluting with petroleum ether/diethyl ether, 1:1) yielded ethyl (2E)-6-
(methoxymethoxy)oct-2,7-dien-1-ol (178) (0.50 g, 93%) as colourless oil. max/cm
–1
 
(NaCl) 3408 (OH), 2937 (CH), 1641 (C=C), 1442, 1373, 1153, 1096, 1036; H (400 MHz, 
CDCl3) 1.48 (1H, s, 1-OH), 1.53–1.63 (1H, m, 4-HH), 1.62–1.77 (1H, m, 4-HH), 2.04–
2.22 (2H, m, 5-H2), 3.79 (3H, s, OCH3), 4.00 (1H, q, J 6.7 Hz, 6-H), 4.10 (2H, d, J 4.0 Hz, 
1-H2), 4.54 (1H, d, J 6.9 Hz, OCHHO), 4.70 (1H, d, J 6.9 Hz, OCHHO), 5.17–5.24 (2H, 
m, 8-H2), 5.61–5.75 (3H, m, 2-H, 3-H and 7-H); C (100 MHz, CDCl3) 28.0 (CH2), 34.7 
(CH2), 55.5 (CH3), 63.7 (CH2), 76.8 (CH), 93.7 (CH2), 117.4 (CH2), 129.4 (CH), 132.4 
(CH), 138.1 (CH); m/z (CI) 169.1224 (M
+–OH. C10H17O2 requires 169.1229), 137 (100%), 
125 (38), 107 (70). 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-4-
(methoxymethoxy)cyclohex-2-ene (181). 
 
The reaction was carried out according general procedure 4 using (2E)-6-
(methoxymethoxy)oct-2,7-dien-1-ol (178) (0.06 g, 0.32 mmol) and 
bis(acetonitrile)palladium(II) chloride (0.01 g, 0.03 mmol) as a catalyst for the Overman 
rearrangement. Purification by flash column chromatography (petroleum 
ether/diethylether, 2:1) gave mixture of two diastereomers (1R*,4S* and 1S*,4S*)-1-
(2′,2′,2′-trichloromethylcarbonylamino)-4-(methoxymethoxy)cyclohex-2-ene (181) (0.06 
g, 59% combined yield over 3 steps) as a white solid. NMR spectra showed a 1:1 mixture 
of diastereomers, where most signals of each overlapped. Mp 41–44 oC; max/cm
–1
 (NaCl) 
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3326 (NH), 2935 (CH), 1699 (C=C), 1641, 1450, 1153, 1096, 1036; H (400 MHz, CDCl3) 
1.67–2.30 (4H, m, 6-H2 and 5-H2), 3.40 (3H, s, OCH3), 4.08–4.22 (1H, m, 1-H), 4.39–4.58 
(1H, m, 4-H), 4.68–4.77 (2H, m, OCH2O), 5.72–5.84 (1H, m, 3-H), 5.96–6.07 (1H, m, 2-
H), 6.60 (1H, br s, NH); C (100 MHz, CDCl3) 24.8 (CH2), 26.7 (CH2), 47.2 (CH), 55.3 
(CH3), 69.2 (CH), 92.7 (C), 95.9 (CH2), 129.2 (CH), 132.7 (CH), 161.6 (C); m/z (CI) 
323.9935 (MNa
+
. C10H14
35
Cl3NO3Na requires 323.9937), 281 (100%), 279 (70), 240 (28), 
137 (30), 83 (25). 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-4-
(methoxymethoxy)cyclohex-2-ene (181). 
The reaction was carried out according general procedure 4 using (2E)-6-
(methoxymethoxy)oct-2,7-dien-1-ol (178) (0.10 g, 0.54 mmol) and 
bis(acetonitrile)palladium(II) chloride (0.01 g, 0.05 mmol) as a catalyst for the Overman 
rearrangement. Grubb’s catalyst (2nd Generation) (0.015 g, 0.02 mmol) was then added and 
the reaction mixture was heated under reflux for 12 h. A further quantity of Grubb’s 
catalyst (2
nd
 Generation) (0.015 g, 0.02 mmol) were added and the reaction mixture stirred 
for a further 12 h. Concentration of the filtrate followed by flash column chromatography 
(petroleum ether/diethylether, 2:1) gave (1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-
trichloromethylcarbonylamino)-4-(methoxymethoxy)cyclohex-2-ene (181) (0.14 g, 93% 
combined yield over 3 steps) as a white solid. Spectroscopic data as reported above. 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclohex-2-en-4-ol 
(182). 
 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-4-(methoxymethoxy) 
cyclohex-2-ene (181) (0.15 g, 0.51 mmol) was dissolved in methanol (5 mL) and 0.5 N 
hydrochloric acid (5 mL) was added to the reaction mixture. The reaction mixture was 
stirred for 24 h at 40 C. The mixture was cooled and neutralised with a saturated solution 
of sodium hydrogencarbonate (10 mL) and then extracted with ethyl acetate (4 × 20 mL). 
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The organic layer was dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (elution with petroleum ether/ethyl acetate, 10:1) gave (1R*,4S* 
and 1S*,4S*)-1-(2′,2′,2′-trichloromethylcarbonylamino) cyclohex-2-en-4-ol (182) (0.09 g, 
72%) as a white solid. NMR spectra showed a 1:1 mixture of diastereomers, signals for 
only one diastereomer was recorded. Mp 109–111 C; max/cm
–1
 (NaCl) 3420 (OH), 2945 
(CH), 1677 (CO), 1450, 1248, 1073; H (400 MHz, CDCl3) 1.43–1.93 (3H, m, 6-HH, 5-HH 
and 4-OH), 1.96–2.26 (2H, m, 6-HH and 5-HH), 4.14–4.28 (1H, m, 1-H), 4.30–4.57 (1H, 
m, 4-H), 5.62–5.75 (1H, m, 2-H), 5.86–5.98 (1H, m, 3-H), 6.50 (1H, br s, NH); C (100 
MHz, CDCl3) 24.6 (CH2), 28.7 (CH2), 46.9 (CH), 64.3 (CH), 92.5 (C), 128.3 (CH), 134.1 
(CH), 161.4 (C); m/z (CI) 257.9848 (MH
+
. C8H11
35
Cl3NO2 requires 257.9855), 242 (82%), 
206 (33), 137 (8), 81 (21).  
1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclohex-2-en-4-one (130). 
 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclohexa-2-ene-4-ol 
(182) (0.08 g, 0.30 mmol) was dissolved in dichloromethane (20 mL) and cooled to 0 C. 
Tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1H)-one (0.21 g, 0.49 mmol) was then 
added to the solution and stirred for 2 h before warming to room temperature. The reaction 
mixture was concentrated in vacuo, and diluted with a 10% sodium sulfite solution (10 
mL) and the organics were extracted with dichloromethane (3 × 20 mL). The combined 
organic layer was dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (elution with petroleum ether/diethyl ether, 1:5) gave 1-(2′,2′,2′-
trichloromethylcarbonylamino)cyclopent-2-en-4-one (130) (0.06 g, 83%) as a white solid. 
Mp 92–94 C; max/cm
–1
 (NaCl) 3318 (NH), 2950 (CH), 1689 (CO), 1519, 1481, 1249, 
1073; H (400 MHz, CDCl3) 1.95–2.08 (1H, m, 6-HH), 2.31–2.42 (1H, m, 6-HH), 2.43–
2.59 (2H, m 5-H2), 4.73–4.81 (1H, m, 1-H), 6.03 (1H, dd, J 10.2, 2.1 Hz, 3-H), 6.77 (1H, 
dt, J 10.2, 2.1 Hz, 2-H), 7.03 (1H, d, J 7.8 Hz, NH); C (100 MHz, CDCl3) 29.2 (CH2), 
35.9 (CH2), 47.9 (CH), 92.2 (C), 131.1 (CH), 148.4 (CH), 161.7 (C), 197.8 (C); m/z (CI) 
257.9665 (MH
+
. C8H9
35
Cl2
37
ClNO2 requires 257.9670), 222 (78%), 186 (32), 152 (18), 69 
(49). 
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1-(tert-Butyldimethylsilyloxy)pent-4-ene (184).
183 
 
A mixture of pent-4-en-1-ol (183) (4.20 g, 0.05 mol), tert-butyldimethylsilyl chloride 
(11.04 g, 0.07 mol) and imidazole (4.90 g, 0.07 mol) in tetrahydrofuran (150 mL) were 
stirred overnight at room temperature. The reaction mixture was filtered through Celite

, 
washed with diethyl ether (70 mL). The filtrate was concentrated and purified by flash 
column chromatography (elution with petroleum ether/diethyl ether, 20:1) which gave 1-
(tert-butyldimethylsilyloxy)pent-4-ene (184) (9.77 g, 99%) as a colourless oil. 
Spectroscopic data is entirely consistent with the literature.
183
 max/cm
–1
 (Neat) 2931 (CH), 
1465, 1365, 1249, 1059; H (400 MHz, CDCl3) 0.01 (6H, s, Si(CH3)2), 0.84 (9H, s, 
Si(CH3)3), 1.51–1.60 (2H, m, 2-H2), 2.02–2.08 (2H, m, 3-H2), 3.57 (2H, t, J 6.4 Hz, 1-H2), 
4.88–4.99 (2H, m, 5-H2), 5.77 (1H, ddt, J 16.9, 10.2, 6.6 Hz, 4-H); C (100 MHz, CDCl3) –
5.2 (2 × CH3), 18.3 (C), 25.9 (3 × CH3), 30.0 (CH2), 31.9 (CH2), 62.5 (CH2), 114.5 (CH2), 
138.6 (CH); m/z (CI) 201.1674 (MH
+
. C11H25OSi requires 201.1674), 165 (8%), 97 (25), 
81 (60), 69 (96). 
1-(tert-Butyldimethylsilyloxy)pent-4-en-3-ol (185). 
 
To a suspension of selenium dioxide (0.72 g, 6.54 mmol) in dichloromethane (25 mL) was 
added tert-butyl hydroperoxide (5.0–6.0 M in decane) (3.65 mL, 32.70 mmol). The 
mixture was stirred for 1 h. Then, a solution of 1-(tert-butyldimethylsilyloxy)pent-4-ene 
(184) (1.31 g, 6.54 mmol) in dichloromethane (25 mL) was added and stirred for 72 h. The 
mixture was evaporated, diethyl ether (50 mL) and 2.0 M sodium hydroxide (30 mL) were 
added to the evaporated mixture, and the organic phase was separated and aqueous layer 
was extracted with diethyl ether (2 × 50 mL). The combined organic layers were washed 
with 1.0 M hydrochloric acid (20 mL), sodium hydrogencarbonate (20 mL) and then dried 
(MgSO4). After filtration the organic solution was concentrated in vacuo. Flash column 
chromatography (petroleum ether/diethyl ether, 10:1) gave 1-(tert-
butyldimethylsilyloxy)pent-4-en-3-ol (185) (1.40 g, 70%) as a yellow oil. max/cm
–1 
(NaCl) 
3424 (OH), 2929 (CH), 1472, 1256, 1099, 921; H (400 MHz, CDCl3) 0.01 (6H, s, 
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Si(CH3)2), 0.82 (9H, s, Si(CH3)3), 1.59–1.74 (2H, m, 2-H2), 3.30 (1H, br s, 3-OH), 3.70–
3.76 (1H, m, 1-HH), 3.79–3.84 (1H, m, 1-HH), 4.25–4.32 (1H, m, 3-H), 5.04 (1H, d, J 10.4 
Hz, 5-HH), 5.22 (1H, d, J 17.0 Hz, 5-HH), 5.80 (1H, ddd, J 17.0, 10.4, 5.4 Hz, 4-H); C 
(100 MHz, CDCl3) –5.5 (2 × CH3), 18.1 (C), 25.8 (3 × CH3), 31.2 (CH2), 61.9 (CH2), 72.5 
(CH), 114.1 (CH2), 140.5 (CH); m/z (CI) 217 (MH
+
, 98%), 199 (26), 145 (26), 85 (15), 79 
(52). 
1-(tert-Butyldimethylsilyloxy)-3-(methoxymethoxy)pent-4-ene. 
 
Reaction was carried out according to general procedure 3, using 1-(tert-
butyldimethylsilyloxy)pent-4-en-3-ol (185) (2.46 g, 0.01 mol). Flash column 
chromatography (petroleum ether/diethyl ether, 20:1) yielded 1-(tert-
butyldimethylsilyloxy)-3-(methoxymethoxy)pent-4-ene (3.80 g, 100%) as a colourless oil. 
max/cm
–1
 (NaCl) 2954 (CH), 1468 (CH), 1442, 1216, 905; H (400 MHz, CDCl3) 0.04 
(6H, s, Si(CH3)2), 0.89 (9H, s, SiC(CH3)3), 1.65–1.74 (1H, m, 2-HH), 1.78–1.87 (1H, m, 2-
HH), 3.36 (3H, s, OCH3), 3.63–3.76 (2H, m, 1-H2), 4.16 (1H, q, J 7.4 Hz, 3-H), 4.55 (1H, 
d, J 6.6 Hz, OCHHO), 4.7 (1H, d, J 6.6 Hz, OCHHO), 5.15–5.24 (2H, m, 5-H2), 5.64–5.74 
(1H, ddd, J 17.3, 10.2, 7.6 Hz, 4-H); C (100 MHz, CDCl3) –5.3 (2 × CH3), 18.2 (C), 25.9 
(3 × CH3), 38.7 (CH2), 55.3 (CH3), 59.3 (CH2), 74.4 (CH), 93.9 (CH2), 116.9 (CH2), 138.4 
(CH); m/z (CI) 261.1881 (MH
+
. C13H29O3Si requires 261.1886), 229 (65%), 199 (75), 145 
(50), 69 (100). 
3-(Methoxymethoxy)pent-4-en-1-ol (186). 
 
A solution of tetrabutylammonium fluoride (1.0 M in tetrahydrofuran) (12.8 mL, 0.01 mol) 
was added to a solution of 1-(tert-butyldimethylsilyloxy)-3-(methoxymethoxy)pent-4-ene 
(2.79 g, 0.01 mol) in tetrahydrofuran (200 mL) at 0 C. The reaction was warmed to room 
temperature and stirred overnight. The reaction mixture was then concentrated and the 
resulting residue was re-suspended in diethyl ether (40 mL). The solution was washed with 
water (30 mL) and the aqueous layer was then extracted with diethyl ether (3 × 30 mL). 
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The combined organic extracts were dried (MgSO4), concentrated and then purified by 
flash column chromatography (petroleum ether/diethyl ether, 5:2) to give 3-
(methoxymethoxy)pent-4-en-1-ol (186) (1.5 g, 96%) as a colourless oil. max/cm
–1
 (Neat) 
3433 (OH), 2947 (CH), 1419, 1219, 1149; H (400 MHz, CDCl3) 1.69–1.77 (2H, m, 2-H2), 
2.17 (1H, br s, 1-OH), 3.30 (3H, s, OCH3), 3.62–3.77 (2H, m, 1-H2), 4.16 (1H, q, J 6.9 Hz, 
3-H), 4.46 (1H, d, J 6.7 Hz, OCHHO), 4.61 (1H, d, J 6.7 Hz, OCHHO), 5.09–5.19 (2H, m, 
5-H2), 5.63 (1H, ddd, J 17.3, 10.4, 7.5 Hz, 4-H); C (100 MHz, CDCl3) 37.7 (CH2), 55.6 
(CH3), 60.1 (CH2), 76.3 (CH), 94.0 (CH2), 117.4 (CH2), 137.6 (CH); m/z (CI) 147.1022 
(MH
+
. C7H15O3 requires 147.1021), 115 (100%), 85 (38), 69 (44). 
Ethyl (2E)-5-(methoxymethoxy)hept-2,6-dienoate (187). 
 
Reaction was carried out according to general procedure 1, using 3-
(methoxymethoxy)pent-4-en-1-ol (186) (0.80 g, 5.48 mmol). Purification by flash column 
chromatography using (diethyl ether/petroleum ether, 2:3) gave the title compound (187) 
(0.8 g, 69%) as colourless oil. max/cm
–1
 (Neat) 3020 (CH), 1714 (CO), 1464, 1215, 1150; 
H (400 MHz, CDCl3) 1.28 (3H, t, J 7.1 Hz, OCH2CH3), 2.40–2.55 (2H, m, 4-H2), 3.36 
(3H, s, OCH3), 4.12–4.22 (3H, m, 5-H and OCH2CH3), 4.20 (2H, q, J 7.1 Hz, OCH2CH3), 
4.54 (1H, d, J 6.7 Hz, OCHHO), 4.70 (1H, d, J 6.7 Hz, OCHHO), 5.21–5.28, (2H, m, 7-
H2), 5.70 (1H, ddd, J 17.2, 10.4, 7.6 Hz, 6-H), 5.89 (1H, dt, J 15.7, 1.5 Hz, 2-H), 6.96 (1H, 
dt, J 15.7, 7.4 Hz, 3-H); C (100 MHz, CDCl3) 14.3 (CH3), 38.3 (CH2), 55.5 (CH3), 60.2 
(CH2), 75.8 (CH), 93.8 (CH2), 117.9 (CH2), 123.7 (CH), 137.2 (CH), 144.5 (CH), 166.3 
(C); m/z (CI) 215.1286 (MH
+
. C11H19O4 requires 215.1283), 183 (100%), 153 (28), 113 
(28), 85 (78). 
(2E)-5-(Methoxymethoxy)hept-2,6-dien-1-ol (188). 
 
Reaction was carried out according to general procedure 2, using ethyl (2E)-5-
(methoxymethoxy)hept-2,6-dienoate (187) (0.67g, 3.13 mmol). Flash column 
chromatography (eluting with petroleum ether/diethyl ether, 1:1) yielded (2E)-5-
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(methoxymethoxy)hept-2,6-dien-1-ol (188) (0.53 g, 100%) as a colourless oil. max/cm
–1
 
(Neat) 3394 (OH), 2916 (CH), 1427, 1273, 1018; H (400 MHz, CDCl3) 1.26 (1H, t, J 5.9 
Hz, 1-OH), 2.28–2.42 (2H, m, 4-H2), 3.40 (3H, s, OCH3), 4.06 (1H, q, J 6.7 Hz, 5-H), 
4.09–4.13 (2H, m, 1-H2), 4.50 (1H, d, J 6.7 Hz, OCHHO), 4.70 (1H, d, J 6.7 Hz, 
OCHHO), 5.18–5.25 (2H, m, 7-H2), 5.65–5.75 (3H, m, 2-H, 3-H and 6-H); C (100 MHz, 
CDCl3) 38.3 (CH2), 55.4 (CH3), 63.6 (CH2), 76.8 (CH), 93.8 (CH2), 117.4 (CH2), 128.3 
(CH), 131.8 (CH), 137.7 (CH); m/z (CI) 173.1174 (MH
+
. C9H17O3 requires 173.1174), 155 
(100%), 125 (100), 101 (100), 85 (100). 
 (1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-4-
(methoxymethoxy)cyclopent-2-ene (191). 
 
The reaction was carried out according general procedure 4 using (2E)-5-
(methoxymethoxy)hept-2,6-dien-1-ol (188) (0.11 g, 0.65 mmol) and 
bis(acetonitrile)palladium(II) chloride (0.02 g, 0.07 mmol) as a catalyst for the Overman 
rearrangement. Grubb’s catalyst (2nd Generation) (0.008 g, 0.01 mmol) was then added and 
the reaction mixture was heated under reflux for 12 h. Concentration of the filtrate 
followed by flash column chromatography (petroleum ether/diethylether, 2:1) gave 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-trichloromethylcarbonylamino)-4-(methoxymethoxy) 
cyclopent-2-ene (191) (0.05 g, 25% combined yield over 3 steps) as a colourless oil. NMR 
spectra showed a 1:1 mixture of diastereomers, signals for only one diastereomer was 
recorded. max/cm
–1
 (Neat) 3410 (NH), 2926 (CH), 1693 (CO), 1464, 1365, 1168; H (400 
MHz, CDCl3) 2.00 (1H, ddd, J 14.5, 7.3, 4.1 Hz, 5-HH), 2.40 (1H, ddd, J 14.5, 7.7, 3.2 Hz, 
5-HH), 3.37 (3H, s, OCH3), 4.67 (1H, d, J 6.9 Hz, OCHHO), 4.70 (1H, d, J 6.9 Hz, 
OCHHO), 4.85–4.90 (1H, m, 4-H), 5.08–5.16 (1H, m, 1-H), 5.99 (1H, ddd, J 5.6, 2.1, 1.1 
Hz, 2-H), 6.16 (1H, dt, J 5.6, 1.9 Hz, 3-H), 6.54 (1H, br s, NH); C (100 MHz, CDCl3) 38.8 
(CH2), 55.4 (CH3), 56.7 (CH), 81.3 (CH), 96.1 (CH2), 133.8 (CH2), 136.9 (CH), 161.5 (C); 
m/z (CI) 287.9954 (MH
+
. C9H13
35
Cl3NO3 requires 287.9961), 226 (100%), 192 (78), 158 
(12), 107 (15), 69 (28). 
Experimental  124 
 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-4-
(methoxymethoxy)cyclopent-2-ene (191). 
(2E)-5-(Methoxymethoxy)hept-2,6-dien-1-ol (188) (0.16 g, 0.93 mmol) was dissolved in 
dichloromethane (30 mL) and cooled to 0 C. 1,8-Diazabicyclo[5.4.0]undec-7-ene (0.19 
mL, 0.93 mmol) was added to the solution followed by trichloroacetonitrile (0.14 mL, 1.39 
mmol). The solution was then warmed to room temperature and stirred for 24 h. The 
reaction mixture was filtered through a short pad of silica gel and washed with diethyl 
ether (100 mL). The resulting filtrate was then concentrated to give the allylic 
trichloroacetimidate, which was used without further purification. The allylic 
trichloroacetimidate was then dissolved in toluene (20 mL) and potassium carbonate (0.20 
g, 0.93 mmol) was added to the solution and the reaction mixture was stirred at 130 
o
C for 
12 h. The reaction mixture was then filtered through Celite

, concentrated and dissolved in 
dichloromethane (30 mL). Grubb’s catalyst (2nd Generation) (0.04 g, 0.05 mmol) was then 
added and the reaction mixture was heated under reflux for 24 h. The mixture was cooled 
to room temperature and then filtered through a short pad of Celite

 and washed with 
diethyl ether (100 mL). Concentration of the filtrate followed by flash column 
chromatography (petroleum ether/diethylether, 2:1) gave (1R*,4S* and 1S*,4S*)-1-
(2′,2′,2′-trichloromethylcarbonylamino)-4-(methoxymethoxy)cyclopenta-2-ene (191) (0.83 
g, 83% combined yield over 3 steps) as a colourless oil. Spectroscopic data as described 
above. 
1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclopent-2-en-4-one (193). 
 
(1R*,4S* and 1S*,4S*)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-4-(methoxymethoxy) 
cyclopent-2-ene (191) (0.05 g, 0.17 mmol) was dissolved in methanol (4 mL) and 0.5 N 
hydrochloric acid (4 mL) was added to the reaction mixture. The reaction mixture was 
stirred for 18 h at 40 °C. The mixture was cooled and neutralised with a saturated solution 
of sodium hydrogencarbonate (5 mL) and then extracted with ethyl acetate (3 × 20 mL). 
The organic layer was dried (MgSO4) and concentrated in vacuo, to give (1R*,4S* and 
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1S*,4S*)-1-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent-2-en-4-ol (192) as a white 
solid. It was dissolved in dichloromethane and cooled to 0 C. 1,1,1-Tris(acetyloxy)-1,1-
dihydro-1,2-benziodoxol-3-(1H)-one (0.09 g, 0.20 mmol) was then added to the solution 
and stirred for 2 h before warming to room temperature. The reaction mixture was 
concentrated and diluted with a 10% sodium sulphite solution (10 mL) and the organic 
layer was extracted with dichloromethane (3 × 15 mL). The combined organic layer was 
dried (MgSO4) and concentrated in vacuo. Purification by flash column chromatography 
(elution with petroleum ether/diethyl ether, 1:5) gave 1-(2′,2′,2′-
trichloromethylcarbonylamino) cyclopent-2-en-4-one (193) (0.03 g, 73% over two steps) 
as a white solid. Mp 141–143 C; max/cm
–1
 (Neat) 3284 (NH), 2929 (CH), 1711 (CO), 
1681 (CO), 1589 (C=C), 1429, 1165; H (400 MHz, CDCl3) 2.28 (1H, dd, J 18.9, 2.6 Hz, 
5-HH), 2.97 (1H, dd, J 18.9, 7.0 Hz, 5-HH), 5.19–5.28 (1H, m, 1-H), 6.39 (1H, dd, J 5.7, 
1.8 Hz, 3-H), 6.93 (1H, br s, NH), 7.60 (1H, dd, J 5.7, 2.5 Hz, 2-H); C (100 MHz, CDCl3) 
41.2 (CH2), 51.6 (CH), 92.4 (C), 136.8 (CH), 159.6 (CH), 161.7 (C), 205.1 (C); m/z 
241.9530 (MH
+
. C7H7
35
Cl3NO2 requires 241.9542), 219 (25%), 149 (27), 95 (20), 58 
(100). 
5.3.2 Synthesis of Polyhydroxylated Aminocyclohexanes 
(1S)-1-(2′,2′,2′)-Trichloromethylcarbonylaminocyclohex-2-ene (131).38 
 
The reaction was carried out according general procedure 4 using (2E)-oct-2,7-dien-1-ol 
(128) (0.50 g, 3.97 mmol) by using (S)-COP-Cl (0.59 g, 0.40 mmol) as the rearrangement 
catalyst. Purification by flash column chromatography (elution with petroleum 
ether/diethyl ether, 97:3) gave (1S)-1-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-2-
ene (131) (0.83 g, 90% yield over 3 steps) as a white solid. 88% ee determined by HPLC 
analysis using CHIRALPAK IB column (0.5% iso-propanol/hexane at 0.75 mL/min), 
retention time: tS= 8.2 min, and tR= 9.2 min. []D
23
 –95.3 (c 2.1, CHCl3). All other 
spectroscopic data as previously reported for 1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohex-2-ene (129) above. 
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(1S,2S,3R)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3-dihydroxycyclohexane 
(206).
140
 
 
(1S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclohex-2-ene (131) (0.06 g, 0.25 mmol) 
was dissolved in dichloromethane (5 mL) at –78 C. Tetramethylethylenediamine (0.04 g, 
0.27 mmol) was added and the reaction mixture stirred for 0.1 h before the addition of 
osmium tetroxide (0.06 g, 0.26 mmol). The dark coloured solution was stirred for 1 h at –
78 C before warming to room temperature and stirred for a further 1 h. The solvent was 
removed in vacuo and the dark coloured solid was redissolved in methanol (5 mL). 
Concentrated hydrochloric acid (5 drops) was added and the reaction mixture stirred for 2 
h. The solvent was removed in vacuo to afford a dark solid. Flash column chromatography 
(elution with petroleum ether/diethyl ether, 1:4) afforded (1S,2S,3R)-1-(2′,2′,2′-
trichloromethylcarbonylamino)-2,3-dihydroxycyclohexane (206) (0.06 g, 93%) as a 
colourless oil. Spectroscopic data is entirely consistent with the literature.
140
 max/cm
–1
 
(NaCl) 3407 (NH/OH), 2942 (CH), 1700 (CO), 1512, 1042, 821; []D
25
 –3.8 (c 1.0, 
CHCl3); H (400 MHz, CDCl3) 1.30–1.43 (1H, m, 5-HH), 1.59–1.80 (5H, m, 4-H2, 5-HH 
and 6-H2), 2.56 (1H, br s, OH), 2.90 (1H, br s, OH), 3.83–3.93 (2H, m, 2-H and 3-H), 
3.95–4.05 (1H, m, 1-H), 7.73 (1H, br s, NH); C (100 MHz, CDCl3) 18.3 (CH2), 26.1 
(CH2), 28.4 (CH2), 52.1 (CH), 70.4 (CH), 70.9 (CH), 92.7 (C), 161.8 (C); m/z (CI) 
275.9960 (MH
+
. C8H13
35
Cl3NO3 requires 275.9961), 242 (35%), 179 (12), 123 (89), 109 
(88), 73 (100). 
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2′,2′,2′-Trichloro-N-[(1S,2S,3R)-oxabicyclo[4.1.0]hept-2-yl]acetamide (207).141 
 
(1S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)cyclohex-2-ene (131) (0.24 g, 0.97 mmol) 
was dissolved in dichloromethane (15 mL) along with sodium hydrogencarbonate (0.16 g, 
1.95 mmol). To the stirred suspension was added meta-chloroperoxybenzoic acid (0.34 g, 
1.95 mmol) and stirred at room temperature. The resulting suspension was stirred 
vigorously for 19 h. A 20% aqueous solution of sodium sulfite (10 mL) was added and the 
resulting two-phase mixture was stirred vigorously for 0.25 h. The two layers were 
separated and the aqueous layer was extracted with dichloromethane (2 × 20 mL). The 
combined organic layers were washed with a 20% aqueous solution of sodium sulphite (10 
mL) and a 5% aqueous solution of sodium hydrogencarbonate (2 × 20 mL), dried (Na2SO4) 
and evaporated under reduced pressure. Purification by flash column chromatography 
(elution with petroleum ether/diethyl ether, 2:5) gave 2′,2′,2′-trichloro-N-[(1S,2S,3R)-
oxabicyclo[4.1.0]hept-2-yl]acetamide (207) (0.24 g, 95%) as white solid. Spectroscopic 
data is entirely consistent with the literature.
141 
Mp 75–77 C; max/cm
–1
 (NaCl) 3421 
(NH), 3020 (CH), 1712 (CO), 1363, 1217, 757; []D
25
 –26.8 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 1.20–1.59 (4H, m, 5-H2 and 6-H2), 1.82–1.20 (2H, m, 4-H2), 3.25 (1H, t, J 3.4 Hz, 
2-H), 3.30 (1H, td, J 3.8, 3.4, Hz 3-H), 4.25–4.32 (1H, m, 1-H), 7.02 (1H, br s, NH); C 
(100 MHz, CDCl3) 17.6 (CH2), 23.1 (CH2), 25.8 (CH2), 47.5 (CH), 53.0 (CH), 54.6 (CH), 
92.7 (C), 161.8 (C); m/z (CI) 257.9852 (MH
+
. C8H11
35
Cl3NO2 requires 257.9855), 224 
(28%), 191 (6), 137 (21), 107 (45), 73 (100). 
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(1S,2S,3S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3-dihydroxycyclohexane 
(208). 
 
2′,2′,2′-Trichloro-N-[(1S,2S,3R)-7-oxabicyclo[4.1.0]hept-2-yl]acetamide (207) (0.04 g, 
0.14 mmol) was added to a 1:1 mixture of 0.2 M sulfuric acid/1,4-dioxane (15 mL) and the 
reaction mixture was stirred at room temperature for 0.75 h. The reaction was then diluted 
with a saturated solution of sodium hydrogencarbonate (10 mL) and extracted with ethyl 
acetate (3 × 20 mL). The organic layers were combined, dried (MgSO4) and concentrated 
in vacuo. Purification by flash column chromatography (elution with petroleum 
ether/diethyl ether, 10:1) gave (1S,2S,3S)-1-(2′,2′,2′-trichloromethylcarbonylamino)-2,3-
dihydroxycyclohexane (208) (0.03 g, 75%) as a colourless oil. max/cm
–1
 (NaCl) 3408 
(OH), 2942 (CH), 1700 (CO), 1512, 821; []D
25
 +9.9 (c 1.0, CHCl3); H (400 MHz, CDCl3) 
1.45–1.55 (2H, m, 4-HH and 5-HH), 1.58–1.77 (2H, m, 5-HH and 6-HH), 1.84–1.95 (2H, 
m, 4-HH and 6-HH), 3.01 (1H, br s, OH), 3.22 (1H, br s, OH), 3.77 (1H, dd, J 6.0, 3.6 Hz, 
2-H), 3.82–3.89 (1H, m, 3-H), 4.15–4.21 (1H, m, 1-H), 7.16 (1H, d, J 7.6 Hz, NH); C (100 
MHz, CDCl3) 18.6 (CH2), 26.3 (CH2), 28.5 (CH2), 51.0 (CH), 70.5 (CH), 72.1 (CH), 92.7 
(C), 162.1 (C); m/z (CI) 275.9959 (MH
+
. C8H13
35
Cl3NO3 requires 275.9961), 242 (59%), 
208 (30), 158 (16), 113 (33), 69 (100). 
(1S,2S,3S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2-hydroxy-3-iodocyclohexane 
(211). 
 
To a solution of (1S)-1-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-2-ene (131) (0.29 
g, 1.20 mmol) in chloroform (15 mL), N-iodosuccinimide (0.40 g, 1.81 mmol) was added 
and the mixture stirred for 18 h. The solvent was then removed in vacuo. The resulting 
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residue was dissolved in ethyl acetate (20 mL) and the organic phase washed with water (4 
× 30 mL). The organic layer was then dried (MgSO4) and the solvent removed in vacuo to 
give (3aS,4S,7aS)-4-iodo-2-(trichloromethyl)benzoxazole (210) (0.37 g, 85% yield) as a 
colourless oil which was used without further purification. H (400 MHz, CDCl3) 1.50–
1.69 (2H, m, 5-H2), 1.90–2.23 (4H, m, 4-H2 and 6-H2), 4.17–4.30 (2H, m, 1-H and 3-H), 
5.16 (1H, t, J 7.5 Hz, 2-H). To a solution of (3aS,4S,7aS)-4-iodo-2-
(trichloromethyl)benzoxazole (0.03 g, 0.14 mmol) in methanol (5 mL) was added 2.0 M 
hydrochloric acid (3 mL) and the reaction mixture was stirred at room temperature for 0.75 
h. The reaction mixture was then diluted with a saturated solution of sodium 
hydrogencarbonate (10 mL) and extracted with ethyl acetate (3 × 20 mL). The organic 
layers were combined, dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/diethyl ether, 10:1) gave (1S,2S,3S)-1-(2′,2′,2′-
trichloromethylcarbonylamino)-2-hydroxy-3-iodocyclohexane (211) (0.03 g, 76%) as a 
white solid. Mp 103–105 C; max/cm
–1
 (NaCl) 3402 (OH), 2941 (CH), 1695 (CO), 1509, 
1155, 821; []D
25
 +60.8 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.58–1.66 (1H, m, 6-HH), 
1.68–1.98 (4H, m, 4-H2, 5-HH, 6-HH), 2.08–2.18 (1H, m, 5-HH), 2.32 (1H, br s, OH), 4.13 
(1H, t, J 4.1 Hz, 2-H), 4.41 (1H, q, J 4.1 Hz, 3-H), 4.46–4.54 (1H, m, 1-H), 7.02 (1H, br s, 
NH); C (100 MHz, CDCl3) 21.4 (CH2), 26.2 (CH2), 29.0 (CH2), 32.9 (CH), 49.4 (CH), 
72.8 (CH), 92.7 (C), 161.5 (C); m/z (CI) 387.8958 (MH
+
. C8H12
35
Cl2
37
ClINO2 requires 
387.8950), 352 (32%), 260 (100), 224 (64), 154 (42), 81 (21). 
(1S,2R)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2-hydroxycyclohex-3-ene (213).  
 
To a solution of (1S)-1-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-2-ene (131) (4.00 
g, 16.5 mmol) in chloroform (100 mL), N-iodosuccinimide (5.52 g, 25.00 mmol) was 
added and the mixture stirred for 18 h. The solvent was then removed in vacuo. The 
resulting residue was dissolved in ethyl acetate (120 mL) and the organic phase washed 
with water (3 × 50 mL), dried (MgSO4) and the solvent removed in vacuo. The residue 
obtained was dissolved in toluene (100 mL) and 1,8-diazabicyclo[5,4,0]undec-7-ene (3.70 
mL, 24.8 mmol) was added. The reaction mixture was heated under reflux for 12 h. The 
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reaction mixture was then cooled and the solvent was removed in vacuo. The resulting 
dark coloured solid was dissolved in methanol (80 mL). 2.0 M Hydrochloric acid (80 mL) 
was added and reaction mixture was stirred at room temperature for 1 h. The reaction 
mixture was then diluted with a saturated solution of sodium hydrogencarbonate (10 mL) 
and extracted with ethyl acetate (3 × 70 mL). The organic layers were combined, dried 
(MgSO4) and concentrated in vacuo. Purification by flash column chromatography (elution 
with petroleum ether/diethyl ether, 1:4) gave (1S,2R)-1-(2′,2′,2′-
trichloromethylcarbonylamino)-2-hydroxycyclohex-3-ene (213) (2.54 g, 60%) as white 
solid. Mp 105–109 C; max/cm
–1
 (NaCl) 3404 (OH), 2940 (CH), 1699 (CO), 1506, 1096, 
909, 822; []D
25
 –71.9 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.50 (1H, br s, OH), 1.64–
1.75 (1H, m, 6-HH), 1.86–1.94 (1H, m, 6-HH), 2.20–2.26 (2H, m, 5-H2), 3.97 (1H, ddd, J 
11.9, 7.6, 3.6 Hz, 1-H), 4.14–4.21 (1H, m, 2-H), 5.85–5.91 (1H, m, 3-H), 6.00 (1H, dt, J 
9.8, 3.6 Hz, 4-H), 7.36 (1H, br s, NH); C (100 MHz, CDCl3) 22.4 (CH2), 24.8 (CH2), 51.4 
(CH), 64.7 (CH), 92.5 (C), 127.2 (CH), 133.4 (CH), 162.5 (C); m/z (CI) 257.9857 (MH
+
. 
C8H11
35
Cl3NO2 requires 257.9855), 224 (98%), 190 (36), 153 (48), 113 (59), 81 (100). 
(1S,2S,3S,4S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3,4-trihydroxycyclohexane 
(214).
 
 
 
(1S,2R)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2-hydroxycyclohex-3-ene (213) (1.00 
g, 3.89 mmol) was dissolved in dichloromethane (50 mL) at –78 C. 
Tetramethylethylenediamine (0.68 mL, 4.54 mmol) was added and the reaction mixture 
stirred for 0.1 h before the addition of osmium tetroxide (1.00 g 3.90 mmol). The dark 
coloured solution was stirred for 1 h at –78 C before warming to room temperature and 
stirred for 1 h. The solvent was removed in vacuo and the dark coloured solid was 
dissolved in methanol (50 mL). Concentrated hydrochoric acid (1 mL) was added and the 
reaction stirred for 2 h. The solvent was removed in vacuo to afford a dark solid. Flash 
column chromatography (elution with petroleum ether/diethyl ether, 1:4) afforded 
(1S,2S,3S,4S)-1-(2′,2′,2′-trichloromethylcarbonylamino)-2,3,4-trihydroxycyclohexane 
(214) (0.60 g, 53%) as a white solid. Mp 151–153 C; max/cm
–1
 (NaCl) 3360 (OH), 2947 
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(CH), 1653 (CO), 1456, 1420, 1024; []D
25
 –27.6 (c 0.9, MeOH); H (400 MHz, CD3OD) 
1.63–1.83 (4H, m, 5-H2 and 6-H2), 3.83–3.92 (3H, m, 2-H, 3-H and 4-H), 4.10 (1H, ddd, J 
10.6, 4.4, 2.9 Hz, 1-H); C (100 MHz, CDCl3) 24.7 (CH2), 27.4 (CH2), 50.6 (CH), 68.4 
(CH), 72.3 (CH), 74.0 (CH), 93.8 (C), 163.0 (C); m/z (CI) 291.9908 (MH
+
. C8H13
35
Cl3NO4 
requires 291.9910), 258 (100%), 224 (50), 148 (22), 85 (12). 
(1S,2S,3S,4S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3,4-trihydroxycyclohexane 
(214) Upjohn Reaction.
 
 
A solution of (1S,2R)-1-(2′,2′,2′-trichloromethylcarbonylamino)-2-hydroxy-3-cyclohexene 
(213) (1.00 g, 3.89 mmol) in tetrahydrofuran (25 mL), N-methylmorpholine-N-oxide (0.60 
g, 5.10 mmol) and osmium tetraoxide (0.06 g, 0.23 mmol) was added to a stirred solution 
of sodium hydrogencarbonate (0.40 g, 4.76 mmol) in tert-butyl alcohol (15 mL) and water 
(4 mL). The reaction was stirred at room temperature for 24 h and then a 10% sodium 
sulfite solution (20 mL) was added and the reaction mixture was extracted with ethyl 
acetate (3 × 30 mL). The organic layers were combined, dried (MgSO4) and concentrated 
in vacuo. Purification by flash column chromatography (elution with petroleum 
ether/diethyl ether, 1:4) gave (1S,2S,3S,4S,)-1-(2′,2′,2′-trichloromethylcarbonylamino)-
2,3,4-trihydroxycyclohexane 214 (0.63 g, 56%) as a white solid. Spectroscopic data as 
described above. 
(1S,2S,3S,4S)-1-Aminocyclohexane-2,3,4-triol (133).
171
 
 
(1S,2S,3S,4S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3,4-trihydroxycyclohexane 
(214) (0.15 g, 0.52 mmol) was dissolved in methanol (15.0 mL) and 2.0 M sodium 
hydroxide (3.0 mL) was added. The reaction mixture was stirred for 12 h at room 
temperature and then concentrated in vacuo. Purification by ion exchange column 
chromatography (Dowex 50 W), eluting with 0.5 M ammonia solution gave (1S,2S,3S,4S)-
1-aminocyclohexane-2,3,4-triol (133) (0.05 g, 68%) as a white solid. Mp 96–97 C, lit.171 
95–97 C; max/cm
–1
 (NaCl) 3326 (NH/OH), 2945 (CH), 1653, 1451, 1411, 1118, 1022; 
[]D
25
+10.8 (c 1.0, MeOH); H (400 MHz, CD3OD) 1.51–1.67 (4H, m, 5-H2 and 6-H2), 
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3.09–3.14 (1H, m, 1-H), 3.73–3.76 (1H, m, 3-H), 3.77–3.83 (2H, m, 2-H and 4-H); C (100 
MHz, CD3OD) 25.8 (CH2), 27.1 (CH2), 49.9 (CH), 68.7 (CH), 72.5 (CH), 73.7 (CH); m/z 
(CI) 148.0971 (MH
+
. C6H14NO3 requires 148.0974), 128 (6%), 112 (7), 85 (13), 79 (42). 
2′,2′,2′-Trichloro-N-[(1S,2S,3S,4R)-2-hydroxyoxabicyclo[4.1.0]hept-2-yl]acetamide 
(216). 
 
(1S,2R)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2-hydroxycyclohex-3-ene (213) (0.07 
g, 0.27 mmol) was dissolved in dichloromethane (10 mL) along with sodium 
hydrogencarbonate (0.05 g, 0.54 mmol). To the stirred suspension was added meta-
chloroperoxybenzoic acid (0.09 g, 0.54 mmol) and stirred at room temperature. The 
resulting suspension was stirred vigorously for 24 h. A 20% solution of sodium sulfite (10 
mL) was added and the resulting two-phase mixture was stirred vigorously for 0.25 h. The 
two layers were separated and the aqueous layer was extracted with dichloromethane (2 × 
20 mL). The combined dichloromethane layers were washed with a 20% solution of 
sodium sulfite (10 mL) and a 5% solution of sodium hydrogencarbonate (2 × 20 mL), dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography (elution with petroleum ether/diethyl ether, 2:5) gave 
2’,2’,2’-trichloro-N-[(1S,2S,3S,4R)-2-hydroxyoxabicyclo[4.1.0]hept-2-yl]acetamide (216) 
(0.05 g, 69%) as a white solid. Mp 122–125 C; max/cm
–1
 (NaCl) 3389 (OH), 2951 (CH), 
1705 (CO), 1510, 1223, 1078, 827, 756; []D
25
 –125.3 (c 1.5, CHCl3); H (400 MHz, 
CDCl3) 1.53–1.67 (2H, m, 6-H2), 1.96–2.06 (1H, m, 5-HH), 2.20 (1H, dt, J 15.7, 5.4 Hz, 5-
HH), 2.40 (1H, d, J 9.0 Hz, OH), 3.44–3.48 (2H, m, 3-H and 4-H), 3.83–3.91 (1H, m, 1-
H), 4.14–4.21 (1H, m, 2-H), 7.51 (1H, br d, J 5.3 Hz, NH); C (100 MHz, CDCl3) 20.2 
(CH2), 22.1 (CH2), 50.6 (CH), 54.5 (CH), 55.2 (CH), 64.9 (CH), 92.6 (C), 161.8 (C); m/z 
(CI) 273.9804 (MH
+
. C8H11
35
Cl3NO3 requires 273.9805), 240 (100%), 206 (31), 172 (8), 
156 (9), 137 (14), 121 (17), 71 (25). 
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(1S,2S,3R,4S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3,4-
trihydroxycyclohexane (217). 
 
2′,2′,2′-Trichloro-N-[(1S,2S,3S,4R)-2-hydroxyoxabicyclo[4.1.0]hept-2-yl]acetamide (216) 
(0.03 g, 0.12 mmol) was added to a 1:1 mixture of 0.2 M sulfuric acid/1,4-dioxane (8 mL) 
and the reaction mixture was stirred at room temperature for 8 h. The reaction mixture was 
diluted with a saturated solution of sodium hydrogencarbonate (10 mL) and extracted with 
ethyl acetate (3 × 20 mL). The organic layers were combined, dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (elution with 
petroleum ether/diethyl ether, 1:10) gave (1S,2S,3R,4S)-1-(2′,2′,2′-
trichloromethylcarbonylamino)-2,3,4-trihydroxycyclohexane (217) (0.03 g, 87%) as a 
white solid. Mp 112–114 C; max/cm
–1
 (NaCl) 3440 (OH), 2946 (CH), 1647 (CO), 1450, 
1411, 1016; []D
24
 +6.4 (c 2.2, MeOH); H (400 MHz, CD3OD) 1.34–1.43 (1H, m, 5-HH), 
1.73–1.80 (2H, m, 6-H2), 1.86–1.95 (1H, m, 5-HH), 3.50–3.54 (1H, m, 3-H), 3.79 (1H, td, 
J 7.8, 4.1 Hz, 4-H), 3.88–3.94 (1H, m, 1-H), 3.95 (1H, t, J 3.0 Hz, 2-H); C (100 MHz, 
CD3OD) 24.5 (CH2), 30.9 (CH2), 54.1 (CH), 70.6 (2 × CH), 76.2 (CH), 94.0 (C), 163.3 
(C); m/z (CI) 291.9904 (MH
+
. C8H13
35
Cl3NO4 requires 291.9910), 258 (19%), 224 (5), 197 
(5), 147 (14), 123 (12), 107 (100). 
(1S,2S,3R,4S)-1-Aminocyclohexane-2,3,4-triol (132) 
 
(1S,2S,3R,4S)-1-(2′,2′,2′-Trichloromethylcarbonylamino)-2,3,4-trihydroxycyclohexane 
(217) (0.15 g, 0.52 mmol) was dissolved in methanol (15 mL) and 2.0 M sodium 
hydroxide (3.0 mL) was added. The reaction mixture was stirred at room temperature for 
12 h and then concentrated in vacuo. Purification by ion exchange column chromatography 
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(Dowex 50 W), eluting with 0.5 M ammonia solution gave (1S,2S,3R,4S)-1-
aminocyclohexane-2,3,4-triol (132) (0.075 g, 98%) as a white solid. Mp 64–66 C; 
max/cm
–1
 (NaCl) 3355 (OH), 3263 (NH), 2957 (CH), 1947, 1669, 1445, 1214, 1016; 
[]D
22
 +23.1 (c 0.9, MeOH); H (400 MHz, CD3OD) 1.11–1.25 (1H, m, 5-HH), 1.46–1.58 
(2H, m, 6-H2), 1.79 (1H, ddt, J 12.4, 8.4, 4.0 Hz, 5-HH), 2.71–2.79 (1H, m, 1-H), 3.18 
(1H, dd, J 8.8, 2.5 Hz, 3-H), 3.53–3.61 (1H, m, 4-H), 3.70 (1H, t, J 2.5 Hz, 2-H); C (100 
MHz, CD3OD) 27.2 (CH2), 30.6 (CH2), 53.0 (CH), 70.4 (CH), 73.9 (CH), 77.2 (CH); m/z 
(CI) 148.0975 (MH
+
. C6H14NO3 requires 148.0974), 137 (5%), 97 (41), 81 (68), 71 (100). 
5.3.3 Studies towards γ-Lycorane and Pancratistatin Analogues 
(2R)-1-(tert-Butyldimethylsilyloxy)-2,3-epoxypropane (240).
184
  
 
A mixture of (S)-glycidol (236) (3.10 g, 0.04 mol), tert-butyldimethylsilyl chloride (9.40 g, 
0.06 mol) and imidazole (4.20 g, 0.06 mol) in tetrahydrofuran (70 mL) were stirred 
overnight at room temperature. A white precipitate was removed by filtration and washed 
with diethyl ether (70 mL). The combined filtrate was concentrated and purified by flash 
column chromatography (elution with petroleum ether/diethyl ether, 10:1) to give (2R)-1-
(tert-butyldimethylsilyloxy)-2,3-epoxypropane (240) (7.70 g, 98%) as a colourless oil. 
Spectroscopic data is entirely consistent with the literature. []D
24
 +2.7 (c 1.0, CHCl3), 
lit.
184
 +2.9 (c 1.0, CHCl3); max/cm
–1
 (Neat) 2930 (CH), 1253, 1161, 983, 835; H (400 
MHz, CDCl3) 0.09 (3H, s, SiCH3), 0.10 (3H, s, SiCH3), 0.92 (9H, s, SiC(CH3)3), 2.66 (1H, 
dd, J 4.6, 2.4 Hz, 1-HH), 2.79 (1H, dd, J 5.2, 4.6 Hz, 1-HH), 3.10–3.14 (1H, m, 2-H), 3.68 
(1H, dd, J 11.8, 4.8 Hz, 3-HH), 3.87 (1H, dd, J 11.8, 3.2 Hz, 3-HH); C (100 MHz, CDCl3) 
–5.4 (2 × CH3), 18.4 (C), 26.0 (3 × CH3), 45.0 (CH2), 52.5 (CH) and 63.9 (CH2); m/z (CI) 
189.1309 (MH
+
. C9H21O2Si requires 189.1311), 145 (35%), 131 (50), 89 (62), 73 (12). 
Experimental  135 
 
(2R)-1-(tert-Butyldimethylsilyloxy)hex-5-en-2-ol (241).
185
  
 
A solution of allyl magnesium bromide (1.0 M in diethyl ether) (100.0 mL, 100.0 mmol) 
was added drop-wise to a solution of copper(I) bromide dimethylsulfide complex (0.69 g, 
3.40 mmol) in tetrahydrofuran (150 mL) at –78 C and the white suspension was stirred for 
0.5 h. (2R)-1-(tert-Butyldimethylsilyloxy)-2,3-epoxypropane (240) (12.70 g, 67.0 mmol) in 
tetrahydrofuran (60 mL) was then added and the reaction mixture was warmed to 0 C and 
stirred for 2 h. The reaction was quenched by the addition of a saturated ammonium 
chloride solution (100 mL) and extracted with ethyl acetate (3 × 100 mL). The organic 
layers were combined, dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (elution with petroleum ether/diethyl ether, 10:1) gave (2R)-1-
(tert-butyldimethylsilyloxy)hex-5-en-2-ol (241) (13.90 g, 90%) as a colourless oil. 
Spectroscopic data is entirely consistent with the literature.
185
 max/cm
–1
 (Neat) 3460 (OH), 
2929 (CH), 1641 (C=C), 1472, 1252, 1088, 909; []D
24
 –6.7 (c 1.2, CHCl3); H (400 MHz, 
CDCl3) 0.01 (6H, s, Si(CH3)2), 0.82 (9H, s, SiC(CH3)3), 1.35–1.55 (2H, m, 3-H2), 2.00–
2.22 (2H, m, 4-H2), 2.35 (1H, br d, J 3.3 Hz, OH), 3.33 (1H, dd, J 9.9, 7.1 Hz, 1-HH), 
3.53–3.62 (2H, m, 1-HH and 2-H), 4.88–4.92 (1H, m, 6-HH), 4.94–5.00 (1H, m, 6-HH), 
5.76 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 5-H); C (100 MHz, CDCl3) –5.4 (2 × CH3), 18.3 (C), 
25.9 (3 × CH3), 29.8 (CH2), 32.0 (CH2), 67.2 (CH2), 71.2 (CH), 114.8 (CH2), 138.4 (CH); 
m/z (CI) 231.1776 (MH
+
. C12H27O2Si requires 231.1780), 173 (8), 81 (15). 
(2R)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)hex-5-ene (242). 
 
The reaction was carried out according to general procedure 3 using (2R)-1-(tert-
butyldimethylsilyloxy)hex-5-en-2-ol (241) (4.00 g, 17.00 mmol). Flash column 
chromatography (elution with petroleum ether/diethyl ether, 20:1) yielded (2R)-1-(tert-
butyldimethylsilyloxy)-2-(methoxymethoxy)hex-5-ene (242) (4.70 g, 100%) as a 
colourless oil. (Found: C, 61.4; H, 11.0. C14H30O3Si requires C, 61.3; H, 11.0%); max/cm
–1
 
(NaCl) 2929 (CH), 1642 (C=C), 1472, 1255, 1110, 1040; []D
24
 +28.8 (c 1.5, CHCl3); H 
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(400 MHz, CDCl3) 0.01 (6H, s, Si(CH3)2), 0.82 (9H, s, SiC(CH3)3), 1.35–1.54 (2H, m, 3-
H2), 2.00–2.21 (2H, m, 4-H2), 3.34 (3H, s, OCH3), 3.50–3.62 (3H, m, 1-H2 and 2-H), 4.60 
(1H, d, J 6.8 Hz, OCHHO), 4.72 (1H, d, J 6.8 Hz, OCHHO), 4.89–4.94 (1H, m, 6-HH), 
4.95–5.01 (1H, m, 6-HH), 5.77 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 5-H); C (100 MHz, CDCl3) 
–5.4 (2 × CH3), 18.3 (C), 25.9 (3 × CH3), 29.6 (CH2), 31.0 (CH2), 55.5 (CH3), 65.7 (CH2), 
77.7 (CH), 96.4 (CH2), 114.6 (CH2), 138.5 (CH); m/z (CI) 243 (M
+–OCH4, 48%), 231 (8), 
133 (11), 81 (18).  
(2R)-2-(Methoxymethoxy)hex-5-en-1-ol (243). 
 
A solution of tetrabutylammonium fluoride (1M in tetrahydrofuran) (57.10 mL, 57.10 
mmol) was added to a solution of (2R)-1-(tert-butyldimethylsilyloxy)-2-
(methoxymethoxy)hex-5-ene (242) (13.09 g, 47.70 mmol) in tetrahydrofuran (100 mL) at 0 
C. The reaction was warmed to room temperature and stirred overnight. The reaction 
mixture was then concentrated and the resulting residue was re-suspended in diethyl ether 
(50 mL). The solution was washed with water (50 mL) and the aqueous layer was then 
extracted with diethyl ether (3 × 50 mL). The combined organic extracts were dried 
(MgSO4), concentrated and then purified by flash column chromatography (elution with 
petroleum ether/diethyl ether, 5:2) to give (2R)-2-(methoxymethoxy)hex-5-en-1-ol (243) 
(7.63 g, 100%) as a colourless oil. (Found: C, 59.9; H, 10.2. C8H16O3 requires C, 60.0; H, 
10.0%); max/cm
–1
 (NaCl) 3432 (OH), 2947 (CH), 1641 (C=C), 1450, 1212, 1028; []D
24
 –
66.8 (c 0.6, CHCl3); H (400 MHz, CDCl3) 1.49–1.70 (2H, m, 3-H2), 2.07–2.24 (2H, m, 4-
H2), 3.14 (1H, br s, 3.4 Hz, 1-OH), 3.44 (3H, s, OCH3), 3.47–3.64 (3H, m, 1-H2 and 2-H), 
4.69 (1H, d, J 6.9 Hz, OCHHO), 4.75 (1H, d, J 6.9 Hz, OCHHO), 4.96–5.07 (2H, m, 6-
H2), 5.80 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 5-H); C (100 MHz, CDCl3) 29.7 (CH2), 30.8 
(CH2), 55.7 (CH3), 66.7 (CH2), 81.9 (CH), 97.1 (CH2), 115.1 (CH2), 138.0 (CH); m/z (CI) 
161 (MH
+
, 15%), 129 (10), 99 (14), 81 (40), 69 (38).  
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Ethyl (2E,4R)-4-(methoxymethoxy)oct-2,7-dienoate (244). 
 
Reaction was carried out according to general procedure 1, using (2R)-2-
(methoxymethoxy)hex-5-en-1-ol (243) (0.50 g, 3.10 mmol). Flash column chromatography 
(elution with petroleum ether/diethyl ether, 5:1) yielded ethyl (2E,4R)-4-
(methoxymethoxy)oct-2,7-dienoate (244) (0.71 g, 99% yield) as a yellow oil. (Found: C, 
63.2; H, 8.9. C12H20O4 requires C, 63.2; H, 8.8%); max/cm
–1
 (NaCl) 2941 (CH), 1720 
(CO), 1658 (C=C), 1446, 1369, 1269, 1154; []D
24
 +79.2 (c 1.3, CHCl3); H (400 MHz, 
CDCl3) 1.30 (3H, t, J 7.1 Hz, OCH2CH3), 1.59–1.80 (2H, m, 5-H2), 2.09–2.21 (2H, m, 6-
H2), 3.39 (3H, s, OCH3), 4.18–4.25 (3H, m, 4-H and OCH2CH3), 4.59 (1H, d, J 6.9 Hz, 
OCHHO), 4.64 (1H, d, J 6.9 Hz, OCHHO), 4.97–5.08 (2H, m, 8-H2), 5.81 (1H, ddt, J 17.1, 
10.3, 6.6 Hz, 7-H), 5.99 (1H, dd, J 15.7, 1.2 Hz, 2-H), 6.82 (1H, dd, J 15.7, 6.5 Hz, 3-H); 
C (100 MHz, CDCl3) 14.2 (CH3), 29.3 (CH2), 34.0 (CH2), 55.7 (CH3), 60.5 (CH2), 74.6 
(CH), 94.7 (CH2), 115.2 (CH2), 122.1 (CH), 137.7 (CH), 147.6 (CH), 166.2 (C); m/z (CI) 
229 (MH
+
, 35%), 199 (28), 197 (32), 167 (100), 81 (51), 69 (64).  
(2E,4R)-4-(Methoxymethoxy)oct-2,7-dien-1-ol (134). 
 
The reaction was carried out according to general procedure 2, using ethyl (2E,4R)-4-
(methoxymethoxy)oct-2,7-dienoate (244) (1.30 g, 5.70 mmol). Flash column 
chromatography (elution with petroleum ether/diethyl ether, 2:3) yielded, (2E,4R)-4-
(methoxymethoxy)oct-2,7-dien-1-ol (134) (1.05 g, 99% yield) as a colourless oil. (Found: 
C, 64.5; H, 9.7. C10H18O3 requires C, 64.5; H, 9.7%); max/cm
–1
 (NaCl) 3408 (OH), 2937 
(CH), 1641 (C=C), 1442, 1373, 1153, 1096, 1036; []D
24
 +126.8 (c 1.3, CHCl3); H (400 
MHz, CDCl3) 1.54–1.64 (2H, m, 5-HH and OH), 1.68–1.78 (1H, m, 5-HH), 2.06–2.22 
(2H, m, 6-H2), 3.38 (3H, s, OCH3), 4.02–4.09 (1H, m, 4-H), 4.17 (2H, dd, J 5.2, 1.4 Hz, 1-
H2), 4.54 (1H, d, J 6.9 Hz, OCHHO), 4.70 (1H, d, J 6.9 Hz, OCHHO), 4.95–5.06 (2H, m, 
8-H2), 5.58 (1H, ddt, J 15.6, 7.8, 1.4 Hz, 3-H), 5.79–5.87 (2H, m, 2-H and 7-H); C (100 
MHz, CDCl3) 29.6 (CH2), 34.7 (CH2), 55.5 (CH3), 62.9 (CH2), 75.7 (CH), 93.7 (CH2), 
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114.9 (CH2), 131.2 (CH), 132.3 (CH), 138.2 (CH); m/z (CI) 204 (MNH4
+
, 100%), 174 (31), 
142 (29), 125 (14), 58 (16).  
(1R,2S)-1-(Methoxymethoxy)-2-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-3-
ene (135a) and (1R,2R)-1-(methoxymethoxy)-2-(2′,2′,2′-
trichloromethylcarbonylamino)cyclohex-3-ene (135b).
 
 
The reaction was carried out according general procedure 4 using (2E,4R)-4-
(methoxymethoxy)oct-2,7-dien-1-ol (134) (1.10 g, 3.40 mmol). 
Bis(acetonitrile)palladium(II) chloride (0.09 g, 0.34 mmol) was used to catalyse the 
Overman rearrangement, which was stirred at room temperature overnight before addition 
of Grubbs first generation catalyst (0.28 g, 0.34 mmol). Purification by flash column 
chromatography (elution with petroleum ether/diethyl ether, 7:1) gave (1R,2S)-1-
(methoxymethoxy)-2-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-3-ene (135a) 
followed by (1R,2R)-1-(methoxymethoxy)-2-(2′,2′,2′-trichloromethylcarbonylamino) 
cyclohex-3-ene (135b), as a yellow oil (0.46 g, 45% combined yield over 3 steps) and in a 
5:1 ratio (135a : 135b). max/cm
–1
 (NaCl) 3421 (NH), 2930 (CH), 1709 (CO), 1654 (C=C), 
1500, 1148, 1102, 1036. Data for (1R,2S)-1-(methoxymethoxy)-2-(2′,2′,2′-
trichloromethylcarbonylamino)cyclohex-3-ene (135a): []D
20
 +79.1 (c 1.9, CHCl3); H 
(400 MHz, CDCl3) 1.73–1.82 (1H, m, 6-HH), 2.00–2.13 (2H, m, 5-HH and 6-HH), 2.17–
2.28 (1H, m, 5-HH), 3.42 (3H, s, OCH3), 4.05 (1H, td, J 5.6, 1.3 Hz, 1-H), 4.60–4.66 (1H, 
m, 2-H), 4.72 (1H, d, J 6.9 Hz, OCHHO), 4.76 (1H, d, J 6.9 Hz, OCHHO), 5.51–5.56 (1H, 
m, 3-H), 5.91–5.97 (1H, m, 4-H), 7.31 (1H, br d, J 7.0 Hz, NH); C (100 MHz, CDCl3) 
20.2 (CH2), 24.2 (CH2), 48.6 (CH), 55.0 (CH3), 70.9 (CH), 91.9 (C), 94.5 (CH2), 123.4 
(CH), 129.9 (CH), 160.7 (C). Data for (1R,2R)-1-(methoxymethoxy)-2-(2′,2′,2′-
trichloromethylcarbonylamino)cyclohex-3-ene (135b): H (400 MHz, CDCl3) 1.75–1.87 
(1H, m, 6-HH), 1.90–1.99 (1H, m, 6-HH), 2.11–2.29 (2H, m, 5-H2), 3.39 (3H, s, OCH3), 
3.71–3.79 (1H, m, 1-H), 4.49–4.56 (1H, m, 2-H), 4.70 (1H, d, J 6.9 Hz, OCHHO), 4.74 
(1H, d, J 6.9 Hz, OCHHO), 5.58–5.62 (1H, m, 3-H), 5.91–5.97 (1H, m, 4-H), 6.78 (1H, br 
d, J 7.1 Hz, NH); C (100 MHz, CDCl3) 23.3 (CH2), 26.0 (CH2), 52.5 (CH), 55.7 (CH3), 
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74.9 (CH), 92.6 (C), 95.3 (CH2), 124.1 (CH), 131.4 (CH), 161.6 (C); m/z (CI) 306.0056 
(MH
+
. C10H15
35
Cl
37
Cl2NO3 requires 306.0062), 268 (100%), 234 (45), 208 (7), 137 (9), 69 
(22). 
(1R,2S)-1-(Methoxymethoxy)-2-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-3-
ene (135a) and (1R,2R)-1-(methoxymethoxy)-2-(2′,2′,2′-
trichloromethylcarbonylamino)cyclohex-3-ene (135b) using toluene as solvent.
 
The reaction was carried out according general procedure 4 using (2E,4R)-4-
(methoxymethoxy)-oct-2,7-dien-1-ol (134) (0.10 g, 0.54 mmol). 
Bis(acetonitrile)palladium(II) chloride (0.014 g, 0.05 mmol) was used to catalyse the 
Overman rearrangement, which was stirred in toluene (10 mL) initially at 0 C and slowly 
warmed to room temperature over 24 h before addition of Grubbs first generation catalyst 
(0.04 g, 0.05 mmol). Purification by flash column chromatography (elution with petroleum 
ether/diethyl ether, 7:1) gave (1R,2S)-1-(methoxymethoxy)-2-(2′,2′,2′-
trichloromethylcarbonylamino)cyclohex-3-ene (135a) followed by (1R,2R)-1-
(methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohex-3-ene (135b), as a 
yellow oil (0.11 g, 60% combined yield over 3 steps) and in a 10 : 1 ratio (135a : 135b). 
Spectroscopic data as described above. 
(3aR,4R,7R,7aS)-3,3,4-Trichloro-7-(methoxymethoxy)octahydroindol-2-one (237). 
 
(1R,2S)-1-(Methoxymethoxy)-2-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-3-ene 
(135a) (0.45 g, 1.49 mmol) was dissolved in p-xylene (10 mL) which was then de-gassed 
for 1h. Powdered molecular sieves (4Å, activated) (0.1 g) and 
dichlorotris(triphenylphosphine)ruthenium(II) (0.07 g, 0.07 mmol) were then added and 
the reaction mixture was heated at 155 C in a sealed tube for 2 h. The reaction mixture 
was then concentrated in vacuo and purified by flash column chromatography (elution with 
petroleum ether/diethyl ether, 1:4) to give (3aR,4R,7R,7aS)-3,3,4-trichloro-7-
(methoxymethoxy)octahydroindol-2-one (237) (0.34 g, 75%) as a brown oil. max/cm
–1
 
(NaCl) 3256 (NH), 2953 (CH), 1741 (CO), 1440, 1036; []D
25
 –60.2 (c 0.5, CHCl3); H 
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(400 MHz, CDCl3) 1.50–1.66 (1H, m, 6-HH), 1.71–1.82 (1H, m, 6-HH), 1.89–1.96 (1H, m, 
5-HH), 2.29–2.36 (1H, m, 5-HH), 3.19 (1H, dd, J 8.6, 5.3 Hz, 3a-H), 3.39 (3H, s, OCH3), 
3.83–3.93 (2H, m, 4-H and 7-H), 4.23–4.27 (1H, m, 7a-H), 4.67 (1H, d, J 6.9 Hz, 
OCHHO), 4.72 (1H, d, J 6.9 Hz, OCHHO), 6.20 (1H, br s, NH); C (100 MHz, CDCl3) 
24.5 (CH2), 32.7 (CH2), 54.0 (CH), 54.7 (CH), 55.0 (CH3), 59.0 (CH), 73.0 (CH), 84.4 (C), 
94.4 (CH2), 167.7 (C); m/z (CI) 302.0115 (MH
+
. C10H15
35
Cl3NO3 requires 302.0118), 268 
(30%), 222 (18), 198 (10), 140 (12). 
(3aR,7R,7aS)-7-(Methoxymethoxy)octahydroindol-2-one (249). 
 
(3aR,4R,7R,7aS)-3,3,4-Trichloro-7-(methoxymethoxy)octahydroindol-2-one (237) (0.05 g, 
0.17 mmol) was dissolved in tetrahydrofuran (10 mL) which was then added to a slurry of 
activated Raney

-Nickel (1.00 g). The reaction was heated under reflux for 24 h and then a 
further portion of Raney

-Nickel was added (1.00 g). The reaction mixture was heated for 
a further 24 h then cooled, diluted with diethyl ether (10 mL) and filtered through a short 
silica plug. The plug was washed with diethyl ether (100 mL), then the washings were 
dried (MgSO4) and concentrated. Purification by flash column chromatography (elution 
with ethyl acetate) gave (3aR,7R,7aS)-7-(methoxymethoxy)octahydroindol-2-one (249) 
(0.03 g, 85%) as a yellow oil. max/cm
–1
 (NaCl) 3423 (NH), 2935 (CH), 1686 (CO), 1448, 
1035; []D
25
 +46.1 (c 0.8, CHCl3); H (400 MHz, CDCl3) 1.18–1.29 (2H, m, 5-H2), 1.41–
1.52 (1H, m, 6-HH), 1.59–1.67 (1H, m, 6-HH), 1.69–1.83 (2H, m, 4-H2), 2.00 (1H, d, J 
16.0, Hz, 3-HH), 2.32–2.41 (1H, m, 3a-H), 2.49 (1H, dd, J 16.0, 6.6 Hz, 3-HH), 3.38 (3H, 
s, OCH3), 3.67 (1H, dt, J 11.5, 4.4 Hz, 7-H), 3.95 (1H, t, J 4.4 Hz, 7a-H), 4.65 (1H, d, J 6.9 
Hz, OCHHO), 4.71 (1H, d, J 6.9 Hz, OCHHO), 5.70 (1H, br s, NH); C (100 MHz, CDCl3) 
21.9 (CH2), 25.8 (CH2), 27.1 (CH2), 35.1 (CH), 39.6 (CH2), 55.6 (CH3), 56.6 (CH), 74.9 
(CH), 94.9 (CH2), 177.9 (C); m/z (CI) 200.1288 (MH
+
. C10H18NO3 requires 200.1287), 168 
(10%), 138 (5), 69 (8). 
Experimental  141 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methoxymethoxy)octahydroindol-2-
one (238). 
 
(3aR,7R,7aS)-7-(Methoxymethoxy)octahydroindol-2-one (249) (0.05 g, 0.25 mmol) was 
dissolved in tetrahydrofuran (2.0 mL) and cooled to 0 C. Sodium hydride (60% in mineral 
oil) (0.012 g, 0.300 mmol) was added and the solution was stirred for 5 minutes before 
piperonyl bromide (0.09 g, 0.45 mmol) in tetrahydrofuran (1.0 mL) was slowly added. 
Sodium iodide (0.07 g, 0.45 mmol) was then added and the reaction was heated to 50 C 
for 2 h. The reaction mixture was cooled and then a saturated solution of ammonium 
chloride (2.0 mL) was added. The solution was extracted with ethyl acetate (3 × 20 mL), 
dried (MgSO4) and concentrated in vacuo. Purification by flash column chromatography 
(elution with ethyl acetate) gave (3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-
(methoxymethoxy)-octahydroindol-2-one (238) (0.08 g, 97% yield) as a colourless oil. 
max/cm
–1
 (NaCl) 2937 (CH), 1668 (CO), 1488, 1252; []D
25
 –32.1 (c 1.0, CHCl3); H (400 
MHz, CDCl3) 1.15–1.30 (2H, m, 5-H2), 1.42–1.70 (3H, m, 4-H2 and 6-HH), 1.73–1.83 
(1H, m, 6-HH), 2.16 (1H, dd, J 14.6, 7.5 Hz, 3-HH), 2.24–2.34 (1H, m, 3a-H), 2.39 (1H, 
dd, J 14.6, 10.4 Hz, 3-HH), 3.22 (1H, dd, J 6.5, 3.9 Hz, 7-H), 3.27 (3H, s, OCH3), 3.74 
(1H, d, J 14.8 Hz, N-CHH), 3.81–3.85 (1H, m, 7a-H), 4.39 (1H, d, J 7.0 Hz, OCHHO), 
4.54 (1H, d, J 7.0 Hz, OCHHO), 4.94 (1H, d, J 14.8 Hz, N-CHH), 5.85 (2H, s, OCH′2O), 
6.61–6.68 (3H, m, Ph); C (100 MHz, CDCl3) 15.7 (CH2), 25.8 (CH2), 26.9 (CH2), 32.6 
(CH), 36.5 (CH2), 43.8 (CH2), 55.6 (CH3), 56.2 (CH), 72.2 (CH), 95.3 (CH2), 101.0 (CH2), 
108.1 (CH), 108.5 (CH), 121.3 (CH), 131.1 (C), 146.9 (C), 147.9 (C), 176.6 (C); m/z (CI) 
334.1652 (MH
+
. C18H24NO5 requires 334.1654), 302 (7%), 200 (6), 135 (15), 69 (16). 
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(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-hydroxyoctahydroindol-2-one (251). 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methoxymethoxy)octahydroindol-2-one 
(238) (0.20 g, 0.60 mmol) was dissolved in 1:1 mixture of methanol (5.0 mL) and 2.0 M 
hydrochloric acid solution (5.0 mL). The reaction mixture was heated to 35 C and stirred 
for 48 h, then cooled and neutralised with a 6.0 M solution of potassium carbonate (10.0 
mL). The heterogeneous mixture was extracted with ethyl acetate (4 × 50 mL), the organic 
layer was then dried (MgSO4) and concentrated to give (3aR,7R,7aS)-1-(3,4-
methylenedioxybenzyl)-7-hydroxyoctahydroindol-2-one (251) as a white solid (0.17 g, 
100%). Mp 170–172 C; max/cm
–1
 (NaCl) 3370 (OH), 2934 (CH), 1663 (CO), 1489, 1442, 
1243; []D
25
 –22.6 (c 1.4, CHCl3); H (400 MHz, CDCl3) 1.25–1.39 (2H, m, 5-H2), 1.51–
1.61 (1H, m, 4-HH), 1.67–1.87 (3H, m, 4-HH and 6-H2), 1.95 (1H, br s, OH), 2.23 (1H, dd, 
J 15.0, 7.8 Hz, 3-HH), 2.36–2.45 (1H, m, 3a-H), 2.51 (1H, dd, J 15.0, 11.3 Hz, 3-HH), 
3.28 (1H, dd, J 7.0, 3.8 Hz, 7-H), 3.95–4.00 (1H, m, 7a-H), 4.17 (1H, d, J 14.8 Hz, N-
CHH), 4.71 (1H, d, J 14.8 Hz, N-CHH), 5.95 (2H, s, OCH2O), 6.75–6.82 (3H, m, Ph); C 
(100 MHz, CDCl3) 14.6 (CH2), 25.8 (CH2), 29.4 (CH2), 32.4 (CH), 36.4 (CH2), 44.9 
(CH2), 60.1 (CH), 65.8 (CH), 101.1 (CH2), 108.4 (CH), 108.5 (CH), 121.4 (CH), 131.3 
(C), 147.1 (C), 148.1 (C), 176.8 (C); m/z (CI) 290.1391 (MH
+
. C16H20NO4 requires 
290.1392), 289 (12%), 85 (52), 51 (55), 49 (75). 
(3aR,7aS)-1-(3,4-Methylenedioxybenzyl)octahydroindol-2,7-dione (252). 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-hydroxyoctahydroindol-2-one (0.04 g, 0.14 
mmol) was dissolved in dichloromethane (10 mL) and cooled to 0 C. 1,1,1-
Tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1H)-one (0.10 g, 0.23 mmol) was then 
added to the solution and stirred for 2 h before warming to room temperature. The reaction 
mixture was concentrated in vacuo and diluted with a 10% sodium sulphite solution and 
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extracted with dichloromethane (3 × 10 mL). The combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification by flash column chromatography (elution 
with diethyl ether/ethyl acetate 1:5) gave (3aR,7aS)-1-(3,4-
methylenedioxybenzyl)octahydroindol-2,7-dione (252) as a white solid (0.038 g, 95%). 
Mp 115–117 C; max/cm
–1
 (Neat) 2983 (CH), 1737 (CO), 1697 (CO), 1491, 1373, 1045; 
[]D
27
 +0.7 (c 1.4, CHCl3); H (400 MHz, CDCl3) 1.54–1.65 (1H, m, 5-HH), 1.69–1.81 
(1H, m, 4-HH), 1.82–1.94 (2H, m, 5-HH and 4-HH), 2.11 (1H, dd, J 16.3, 10.6 Hz, 3-HH) 
2.25 (2H, t, J 6.3 Hz, 6-H2), 2.34 (1H, dd, J 16.3, 8.0 Hz, 3-HH), 2.74–2.78 (1H, m, 3a-H), 
3.70 (1H, d, J 8.8 Hz, 7a-H), 4.01 (1H, d, J 14.7 Hz, N-CHH), 4.99 (1H, d, J 14.7 Hz, N-
CHH), 5.87 (2H, s, OCH2O), 6.57–6.67 (3H, m, Ph); C (100 MHz, CDCl3) 22.3 (CH2), 
26.8 (CH2), 35.4 (CH2), 36.9 (CH), 39.7 (CH2), 45.8 (CH2), 64.5 (CH), 101.1 (CH2), 108.3 
(CH), 108.8 (CH), 121.9 (CH), 130.2 (C), 147.1 (C), 148.0 (C), 173.8 (C), 209.7 (C); m/z 
(CI) 288.1235 (MH
+
. C16H18NO4 requires 288.1235), 207 (4%), 167 (5), 135 (8), 85 (62), 
83 (100), 47 (15). 
(3aR,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(trifluoromethanesulfonate)-3,3a,4,5,7a-
hexahydroindole-2-one (239). 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)octahydroindol-2,7-dione (252) (0.02 g, 0.07 
mmol) was dissolved in tetrahydrofuran (1 mL) and cooled to –78 C. Lithium 
bis(trimethylsilyl)amide (0.10 mL, 0.10 mmol) was added to the solution and stirred for 1 
h followed by the addition of 2-[N,N′-bis(trifluoromethanesulfonyl)amino]-5-
chloropyridine (0.04 g, 0.10 mmol) in tetrahydrofuran (1 mL) and stirred further for 4 h. 
The reaction was quenched by addition of 10% sodium hydroxide (1 mL) and extracted 
with ethyl acetate (3 × 3 mL). The combined organic layers were dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (elution with ethyl 
acetate) gave the (3aR,7aS)-1-(3,4-methylenedioxybenzyl)-7-(trifluoromethanesulfonate)-
3,3a,4,5,7a-hexahydroindole-2-one (239) as a white solid (2.4 mg, 8%). Mp 60.5–62.5 C; 
max/cm
–1
 (NaCl) 2931 (CH), 1697 (CO), 1519, 1496, 1419, 1219; []D
24
 +4.4 (c 0.2, 
CHCl3); H (400 MHz, CDCl3) 1.65–1.80 (2H, m, 5-H2), 2.25–2.41 (3H, m, 3-HH and 4-
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H2), 2.48 (1H, dd, J 16.5, 8.2 Hz, 3-HH), 2.64–2.74 (1H, m, 3a-H), 4.05–4.15 (2H, m, 7a-H 
and N-CHH), 5.01 (1H, d, J 15.7 Hz, N-CHH), 5.94 (2H, s, OCH2O), 6.01 (1H, dd, J 4.8, 
3.7 Hz, 6-H), 6.71–6.76 (3H, m, Ph); C (100 MHz, CDCl3) 21.1 (CH2), 22.7 (CH2), 33.5 
(CH), 34.1 (CH2), 45.4 (CH2), 56.2 (CH), 101.1 (CH2), 108.2 (CH), 108.3 (CH), 121.4 
(CH), 122.4 (CH), 130.1 (C), 147.1 (C), 147.9 (C), 153.5 (C), 172.0 (C), 174.2 (C); m/z 
(CI) 420.0732 (MH
+
. C17H17F3NSO6 requires 420.0729), 334 (3%), 285 (45), 270 (45), 219 
(3), 165 (5), 137 (13), 115 (43), 85 (64).  
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methoxymethoxy)octahydroindole 
(253). 
 
Lithium aluminium hydride (0.18 g, 4.68 mmol) was dissolved in tetrahydrofuran (20 mL) 
and cooled to 0 C. (3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-(methoxymethoxy) 
octahydroindol-2-one (238) (0.31 g, 0.94 mmol) in tetrahydrofuran (5 mL) was added to 
the stirred slurry and heated under reflux for 4 h. The solution was cooled to room 
temperature and quenched by the addition of a saturated solution of sodium sulfate (3 mL) 
with vigorous stirring over 1 h. A 5% sodium hydroxide solution (2 mL) was then added. 
The organic layer was separated, and the aqueous layer was extracted with ethyl acetate (3 
× 10 mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification by flash column chromatography (elution with ethyl acetate) gave 
(3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-(methoxymethoxy)octahydroindol (253) as 
a colourless oil (0.24 g, 85%). max/cm
–1
 (NaCl) 2931 (CH), 1589 (C=C), 1496, 1249, 
1073; []D
25
 –42.1 (c 0.6, CHCl3); H (400 MHz, CDCl3) 1.15–1.40 (4H, m, 4-H2 and 5-
H2), 1.54–1.62 (1H, m, 6-HH), 1.65–1.75 (2H, m, 3-H2), 1.86 (1H, qd, J 11.8, 3.8 Hz, 6-
HH), 1.93–2.02 (1H, m, 3a-H), 2.14 (1H, ddd, J 14.5, 10.5, 4.2 Hz, 2-HH), 2.83 (1H, t, J 
3.6 Hz, 7a-H), 2.98–3.02 (1H, m, 2-HH), 3.06 (1H, d, J 13.6 Hz, N-CHH), 3.30 (3H, s, 
OCH3), 3.72 (1H, dt, J 11.1, 3.6 Hz, 7-H), 4.48 (1H, d, J 13.6 Hz, N-CHH), 4.59 (1H, d, J 
6.9 Hz, OCHHO), 4.61 (1H, d, J 6.9 Hz, OCHHO), 5.84 (1H, d, J 1.4 Hz, OCH′H′O), 5.85 
(1H, d, J 1.4 Hz, OCH′H′O), 6.62–6.88 (3H, m, Ph); C (100 MHz, CDCl3) 23.8 (CH2), 
26.1 (CH2), 27.8 (CH2), 29.3 (CH2), 40.1 (CH), 52.9 (CH2), 55.3 (CH3), 59.7 (CH2), 65.1 
(CH), 78.8 (CH), 94.7 (CH2), 100.7 (CH2), 107.7 (CH), 109.0 (CH), 120.9 (CH), 135.7 
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(C), 145.8 (C), 147.4 (C); m/z (EI) 319.1787 (M
+
. C18H25NO4 requires 319.1784), 259 
(33%), 216 (45), 135 (100), 46 (24). 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-hydroxyoctahydroindole (254). 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methoxymethoxy)octahydroindole (253) 
(0.05 g, 0.15 mmol) was dissolved in methanol (3 mL) and 2.0 M hydrochloric acid 
solution (3 mL). The reaction mixture was heated to 40 C and stirred for 48 h, then cooled 
and neutralised with a 6.0 M solution of potassium carbonate (5 mL). The solution was 
extracted with ethyl acetate (4 × 20 mL), the organic layer was then dried (MgSO4) and 
concentrated to give (3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-hydroxyoctahydro 
indole (254) as a colourless oil (0.04 g, 100%). max/cm
–1
 (NaCl) 3379 (OH), 2931 (CH), 
1489, 1442, 1243; []D
25
 +2.4 (c 0.5, CHCl3); H (400 MHz, CDCl3) 1.08–1.28 (2H, m, 5-
HH and 6-HH), 1.42–1.53 (1H, m, 4-HH), 1.84–1.93 (4H, m, 3-H2, 4-HH and 5-HH), 
1.84–1.93 (1H, m, 6-HH), 2.05–2.14 (1H, m, 3a-H), 2.27–2.35 (1H, m, 2-HH), 2.58 (1H, 
dd, J 9.3, 4.7 Hz, 7a-H), 2.93–2.99 (1H, m, 2-HH), 3.45–3.48 (1H, m, 7-H), 3.50 (1H, d, J 
12.8 Hz, N-CHH), 3.74 (1H, d, J 12.8 Hz, N-CHH), 5.86 (2H, s, OCH2O), 6.64–6.76 (3H, 
m, Ph); C (100 MHz, CDCl3) 15.2 (CH2), 26.5 (CH2), 28.4 (CH2), 31.3 (CH2), 36.8 (CH), 
53.4 (CH2), 59.3 (CH2), 63.7 (CH), 64.6 (CH), 100.4 (CH2), 107.9 (CH), 109.3 (CH), 
121.9 (CH), 133.2 (C), 146.6 (C), 147.6 (C); m/z (CI) 275.1522 (MH
+
. C16H22NO3 requires 
275.1521), 216 (26%), 135 (74), 82 (100), 46.9 (22). 
(1R,2S)-1-(Methoxymethoxy)-2-aminocyclohex-3-ene. 
 
(1R,2S)-1-(Methoxymethoxy)-2-(2′,2′,2′-trichloromethylcarbonylamino)cyclohex-3-ene 
(135a) (0.53 g, 1.74 mmol) was dissolved in 1:1 mixture of 1.0 M NaOH/methanol (10 
mL) and stirred overnight at room temperature. The reaction mixture was concentrated in 
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vacuo and diluted with ethyl acetate (5 mL). The organic layer was washed with brine 
solution (2 × 10 mL), dried (MgSO4) and concentrated to give (1R,2S)-1-
(methoxymethoxy)-2-aminocyclohex-3-ene (0.26 g, 100%) as a colourless oil. max/cm
–1
 
(NaCl) 3422 (NH), 2934 (CH), 1571, 1457, 1216; []D
24
 +110.8 (c 0.4, CHCl3); H (400 
MHz, CDCl3) 1.50 (2H, br s, NH2), 1.65–1.75 (1H, m, 6-HH), 1.76–1.87 (1H, m, 6-HH), 
2.00–2.22 (2H, m, 5-H2), 3.41 (3H, s, OCH3), 3.41–3.44 (1H, m, 2-H), 3.76 (1H, ddd, J 
9.7, 4.2, 3.1 Hz, 1-H), 4.72 (1H, d, J 7.0 Hz, OCHHO), 4.77 (1H, d, J 7.0 Hz, OCHHO), 
5.65–5.71 (1H, m, 3-H), 5.71–5.77 (1H, m, 4-H); C (100 MHz, CDCl3) 23.4 (CH2), 23.8 
(CH2), 48.9 (CH), 55.5 (CH3), 75.5 (CH), 95.3 (CH2), 128.6 (CH), 129.4 (CH); m/z (CI) 
158.1184 (MH
+
. C8H16NO2 requires 158.1181), 126 (30%), 69 (18). 
6-Bromopiperonal (263).
186
 
 
A solution of bromine (1.90 mL, 36.66 mmol) in acetic acid (5 mL) was added dropwise to 
a stirred solution of piperanal (262) (5.0 g, 36.66 mmol) in acetic acid (10 mL) and stirred 
for 72 h at room temperature. The reaction mixture was then diluted with chloroform (30 
mL) and washed with saturated aqueous sodium carbonate (3 × 40 mL). The organic layers 
were combined, dried (MgSO4) and concentrated in vacuo. Crystallization from methanol 
afforded 6-bromopiperonal (263) (7.29 g, 96%) as white solid. Spectroscopic data is 
entirely consistent with the literature. Mp 125–128 C, lit.186 132–135 C; max/cm
–1
 (Neat) 
3060 (CH), 1684 (CO), 1601, 1410, 1345, 1249, 977; H (400 MHz, CDCl3) 6.08 (2H, s, 
OCH2O), 7.06 (1H, s, Ph-H), 7.37 (1H, s, Ph-H′), 10.18 (1H, s, CHO); C (125 MHz, 
CDCl3) 102.7 (CH2), 108.1 (CH), 113.2 (CH), 121.8 (C), 128.1 (C), 148.4 (C), 153.6 (C), 
190.7 (CH); m/z (CI) 229 (MH
+
. 98%), 226 (85), 198 (18), 84 (69), 49 (54).  
6-bromopiperenoic acid (256).
168
 
 
To the vigorously stirred suspension of 6-bromopiperonal (263) (6.0 g, 26.21 mmol) in 
tert-butanol (40 mL) and water (50 mL) at 83 °C was slowly added potassium 
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permanganate (6.22 g, 39.31 mmol) in water (50 mL) over 45 minutes. The brown 
suspension was stirred overnight at 83 °C, and then potassium hydroxide (10% aq, 20 mL) 
was added, raising the pH to 10-11. The brown suspension was then filtered hot, and the 
cooled filtrate was extracted with diethylether (2 × 40 mL). The aqueous layer was then 
acidified with conc. HCl (8 mL) to give a white chalky solid (5.63 g, 88%). Spectroscopic 
data is entirely consistent with the literature. Mp 201–204 C, lit.168 199–201 C; max/cm
–1
 
(Neat) 2911 (CH), 1677 (CO), 1455, 1413, 1245; H (400 MHz, CDCl3) 6.07 (2H, s, 
OCH2O), 7.14 (1H, s, Ph-H), 7.49 (1H, s, Ph-H′); C (125 MHz, CDCl3) 104.3 (CH2), 
107.8 (CH), 112.0 (C), 115.2 (CH), 115.5 (C), 128.6 (C), 148.9 (C), 152.6 (C); m/z (CI) 
243 (MH
+
. 62%), 226 (28), 167 (32), 149 (83), 84 (100), 49 (81). 
(1R,2S)-1-(Methoxymethoxy)-2-(3,4-methylenedioxy-6-bromobenzamide)cyclohex-3-
ene (257). 
 
In a stirred solution of (1R,2S)-1-(methoxymethoxy)-2-aminocyclohex-3-ene (0.05 g, 0.35 
mmol) in acetonitrile (5 mL) at 0 C was added 4-dimethylaminopyridine (0.01 g, 
0.07mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (0.08 g, 0.53 mmol). To 
this reaction mixture, 6-bromopiperenoic acid (0.08 g, 0.35 mmol) was added and stirred at 
room temperature overnight. The reaction mixture was concentrated in vacuo. The residue 
was diluted with 1.0 M hydrochloric acid (5 mL) and extracted with ethyl acetate (3 × 20 
mL). Purification by flash column chromatography (elution with petroleum ether/diethyl 
ether, 2:8) gave (1R,2S)-1-(methoxymethoxy)-2-(3,4-methylenedioxy-6-
bromobenzamide)cyclohex-3-ene (257) (0.10 g 79%) as a white solid. Mp 100–102 C; 
max/cm
–1
 (NaCl) 3297 (NH), 2912 (CH), 1649 (CO), 1478, 1239, 1033; []D
24
 +101.2 (c 
1.2, CHCl3); H (400 MHz, CDCl3) 1.73–1.85 (1H, m, 6-HH), 1.97–2.12 (2H, m, 5-HH and 
6-HH), 2.17–2.28 (1H, m, 5-HH), 3.37 (3H, s, OCH3), 4.01–4.07 (1H, m, 1-H), 4.72 (1H, 
d, J 6.5 Hz, OCHHO), 4.76 (1H, d, J 6.5 Hz, OCHHO), 4.81–4.89 (1H, m, 2-H), 5.62–5.66 
(1H, m, 4-H), 5.86–5.92 (1H, m, 3-H), 6.02 (2H, s, OCH2O), 6.50 (1H, d, J 9.1 Hz, NH), 
7.00 (1H, s, Ph), 7.05 (1H, s, Ph); C (100 MHz, CDCl3) 21.5 (CH2), 25.5 (CH2), 47.9 
(CH), 55.8 (CH3), 72.7 (CH), 95.8 (CH2), 102.3 (CH2), 109.5 (CH), 110.7 (C), 113.2 (CH), 
Experimental  148 
 
125.7 (CH), 129.8 (CH), 131.1 (C), 147.4 (C), 149.6 (C), 166.6 (C); m/z 84.0457 (MH
+
. 
C16H19
79
BrNO5 requires 384.0447), 216 (26%), 135 (74), 89 (100), 46.9 (22). 
(4R,4aS,10bS)-3,4,4a,10b-Tetrahydro-4-(methoxymethoxy)-8,9-methylenedioxyl[4,5-
j]phenanthridin-6-one (137). 
 
(1R,2S)-1-(Methoxymethoxy)-2-(3,4-methylenedioxy-6(bromobenzamide)cyclohex-3-ene 
(257) (0.16 g, 0.42 mmol) was dissolved in N,N′-dimethylformamide (12 mL) and 
degassed for 1 h. Triphenylphosphine (0.04 g, 0.18 mmol), palladium(II) acetate, (0.02 g, 
0.08 mmol) and diisopropylethylamine (0.14 mL, 0.84 mmol) were then added and the 
reaction mixture was heated at 155 C in a sealed tube for 48 h. The reaction mixture was 
then concentrated in vacuo and purified by flash column chromatography (elution with 
ethyl acetate) to give (4R,4aS,10bS)-3,4,4a,10b-tetrahydro-4-(methoxymethoxy)-8,9-
methylenedioxyl[4,5-j]phenanthridin-6-one (137) as a white solid (0.09 g, 78%). Mp 140–
142 C; max/cm
–1
 (NaCl) 3397 (NH), 2894 (CH), 1660 (CO), 1460, 1258, 1145; []D
25
 
+136.9 (c 1.5, MeOH); H (400 MHz, CDCl3) 2.24–2.45 (2H, m, 3-H2), 3.40 (3H, s, 
OCH3), 3.50–3.56 (1H, m, 10b-H), 4.03 (1H, ddd, J 9.9, 6.5, 3.0 Hz, 4-H), 4.25 (1H, t, J 
3.0 Hz, 4a-H), 4.72 (1H, d, J 7.0 Hz, OCHHO), 4.74 (1H, d, J 7.0 Hz, OCHHO), 5.27–5.32 
(1H, m, 2-H), 5.63 (1H, ddt, J 10.0, 5.1, 2.6 Hz, 1-H), 5.89 (1H, br s, NH), 6.01 (1H, d, J 
1.3 Hz, OCH′H′O), 6.02 (1H, d, J 1.3 Hz, OCH′H′O), 6.67 (1H, s, 10-H), 7.52 (1H, s, 7-
H); C (100 MHz, CDCl3) 26.9 (CH2), 39.9 (CH), 51.3 (CH), 55.8 (CH3), 72.5 (CH), 95.0 
(CH2), 101.7 (CH2), 107.0 (CH), 108.0 (CH), 122.2 (C), 124.1 (CH), 126.9 (CH), 135.8 
(C), 147.3 (C), 151.3 (C), 165.2 (C); m/z (CI) 304.1181 (MH
+
. C16H18NO5 requires 
304.1185), 262 (18%), 244 (6), 166 (3), 81 (8). 
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(4R,4aS,10bS)-3,4,4a,10b-Tetrahydro-4-hydroxy-8,9-methylenedioxy[4,5-
j]phenanthridin-6-one (268). 
 
(4R,4aS,10bS)-3,4,4a,10b-Tetrahydro-4-(methoxymethoxy)-8,9-methylenedioxyl[4,5-
j]phenanthridin-6-one (137) (0.07 g, 0.22 mmol) was dissolved in 1:1 ratio of methanol 
and 1.6 N hydrochloric acid solution (5.0 mL). The reaction mixture was heated to 40 C 
and stirred for 12 h, then cooled and neutralised with a 6 M solution of potassium 
hydrogencarbonate (5.0 mL). The two layers were separated and the aqueous layer was 
extracted with ethyl acetate (4 × 15 mL). The combined organic layers were then dried 
(MgSO4), concentrated in vacuo and purified by flash column chromatography (elution 
with ethyl acetate) to give (4R,4aS,10bS)-3,4,4a,10b-tetrahydro-4-hydroxy-8,9-
methylenedioxy[4,5-j]phenanthridin-6-one (268) as a colourless oil (0.06 g, 97%). Mp 
237–239 C; max/cm
–1
 (NaCl) 3356 (OH), 2951 (CH), 1651 (CO), 1462, 1246, 1018; 
[]D
28
 +159.0 (c 0.2, MeOH); H (400 MHz, CD3OD) 2.04–2.17 (1H, m, 3-HH), 2.20–2.29 
(1H, m, 3-HH), 3.49–3.56 (1H, m, 10b-H), 3.94–4.03 (2H, m, 4a-H and 4-H), 5.17–5.22 
(1H, m, 2-H), 5.54 (1H, ddt, J 10.1, 5.3, 2.6 Hz, 1-H), 5.92 (1H, d, J 1.0 Hz, OCHHO), 
5.93 (1H, d, J 1.0 Hz, OCHHO), 6.73 (1H, s, 10-H), 7.23 (1H, s, 7-H); C (100 MHz, 
CD3OD) 29.6 (CH2), 40.9 (CH), 54.7 (CH), 68.0 (CH), 103.3 (CH2), 108.0 (CH), 108.4 
(CH), 122.7 (C), 125.3 (CH), 128.0 (CH), 138.4 (C), 148.7 (C), 153.2 (C), 167.7 (C); m/z 
(CI) 260.0924 (MH
+
. C14H14NO4 requires 260.0923), 195 (3%), 113 (3), 81 (12). 
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(4R,4aS,10bS)-1,2,3,4,4a,10b-Hexahydro-4-hydroxy-8,9-methylenedioxy[4,5-
j]phenanthridin-6-one (259). 
 
To a solution of (4R,4aS,10bS)-3,4,4a,10b-tetrahydro-4-hydroxy-8,9-methylenedioxy[4,5-
j]phenanthridin-6-one (268) (0.0027 g, 0.01 mmol) in methanol (5 mL) was added 10% 
palladium on carbon (0.001 g). The reaction mixture was allowed to stir under an 
atmosphere of hydrogen at room temperature for 12 h. The reaction mixture was filtered 
through a short pad of Celite
®
, which was washed with methanol (10 mL) and concentrated 
in vacuo to give (4R,4aS,10bS)-1,2,3,4,4a,10b-hexahydro-4-hydroxy-8,9-
methylenedioxy[4,5-j]phenanthridin-6-one (259) (0.0023 g, 88% yield) as a white solid. 
Mp 179–181 C; max/cm
–1
 (NaCl) 3363 (OH), 2944 (CH), 1646 (CO), 1448, 1410, 1111, 
1021; []D
21
 –37.7 (c 0.2, MeOH); H (400 MHz, CD3OD) 1.20–1.53 (4H, m, 1-HH, 2-H2 
and 3-HH), 1.63–1.73 (2H, m, 1-HH and 3-HH), 2.69 (1H, dt, J 12.1, 4.2 Hz, 10b-H), 3.74 
(1H, dt, J 11.2, 4.2 Hz, 4-H), 3.80 (1H, t, J 4.2 Hz, 4a-H), 5.90 (1H, d, J 1.1 Hz, OCHHO), 
5.92 (1H, d, J 1.1 Hz, OCHHO), 6.68 (1H, s, 10-H), 7.25 (1H, s, 7-H); C (125 MHz, 
CD3OD) 23.8 (CH2), 29.1 (CH2), 29.9 (CH2), 41.1 (CH), 55.9 (CH), 70.4 (CH), 103.2 
(CH2), 108.1 (CH), 108.2 (CH), 122.6 (C), 141.6 (C), 148.5 (C), 152.9 (C), 168.2 (C); m/z 
(CI) 262.1075 (MH
+
. C14H16NO4 requires 262.1079), 244 (12%), 206 (22), 180 (8), 136 
(4), 85 (21), 69 (40). 
(1R,2S,4R,4aS,10bS)-1,2,3,4,4a,10b-Hexahydro-1,2,4-trihydroxy-8,9-
methylenedioxy[4,5-j]phenanthridin-6-one (139). 
 
(4R,4aS,10bS)-3,4,4a,10b-Tetrahydro-4-hydroxy-8,9-methylenedioxy[4,5-j]phenanthridin-
6-one (268) (0.018 g, 0.06 mmol) was dissolved in dichloromethane (4 mL) at –78 C. 
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Tetramethylethylenediamine (9 μL, 0.61 mmol) was added and the reaction mixture stirred 
for 0.1 h before the addition of osmium tetroxide (0.017 g 0.64 mmol). The dark coloured 
solution was stirred for 4 h at –78 C before warming to room temperature and stirred for 1 
h. The solvent was removed in vacuo and the dark coloured solid was dissolved in 
methanol (10 mL). Concentrated hydrochoric acid (5 drops) was added and the reaction 
stirred for 2 h. The solvent was removed in vacuo to afford a dark solid. Flash column 
chromatography (elution with ethyl acetate/methanol, 1:8) afforded (1R,2S,4R,4aS,10bS)-
1,2,3,4,4a,10b-hexahydro-1,2,4-trihydroxy-8,9-methylenedioxy[4,5-j]phenanthridin-6-one 
(139) (0.016 g, 90%) as a white solid. Mp 240 C (decomposition); max/cm
–1
 (NaCl) 3350 
(NH/OH), 2914 (CH), 1643 (CO), 1465, 1253, 1034; []D
24
 –50.9 (c 0.7, MeOH); H (400 
MHz, CD3OD) 1.87 (1H, ddd, J 14.1, 12.2, 3.6 Hz, 3-HH), 2.00–2.07 (1H, m, 3-HH), 2.99 
(1H, dd, J 10.5, 3.6 Hz, 10b-H), 3.51 (1H, dd, J 10.5, 3.6 Hz, 1-H), 3.95 (1H, td, J 3.6, 1.3 
Hz, 4a-H), 4.00 (1H, q, J 3.6 Hz, 2-H), 4.30 (1H, dt, J 12.2, 3.6 Hz, 4-H), 6.01 (1H, d, J 
1.1 Hz, OCHHO), 6.02 (1H, d, J 1.1 Hz, OCHHO), 6.84 (1H, s, 10-H), 7.84 (1H, s, 7-H); 
C (100 MHz, CD3OD) 35.4 (CH2), 41.4 (CH), 56.6 (CH), 65.2 (CH), 70.5 (CH), 72.0 
(CH), 103.2 (CH2), 108.0 (CH), 111.0 (CH), 123.0 (C), 138.9 (C), 148.8 (C), 152.3 (C), 
168.4 (C); m/z (EI) 293.0898 (M
+
. C14H15NO6 requires 293.0899), 207 (8%), 190 (30), 114 
(100), 70 (76), 96 (14), 44 (42). 
(1R,2S,4R,4aS,10bS)-1,2-Oxiraryl-1,2,3,4,4a,10b-hexahydro-4-hydroxy-8,9-
methylenedioxy[4,5-j]phenanthridin-6-one (138). 
 
(4R,4aS,10bS)-3,4,4a,10b-Tetrahydro-4-hydroxy-8,9-methylenedioxy[4,5-j]phenanthridin-
6-one (268) (0.07 g, 0.27 mmol) was dissolved in dichloromethane (10 mL) along with 
sodium hydrogencarbonate (0.05 g, 0.55 mmol). To the stirred suspension was added meta-
chloroperoxybenzoic acid (0.09 g, 0.55 mmol) and stirred at room temperature. The 
resulting suspension was stirred vigorously for 24 h. A 20% solution of sodium sulfite (10 
mL) was added and the resulting two-phase mixture was stirred vigorously for 0.25 h. The 
two layers were separated and the aqueous layer was extracted with dichloromethane (2 × 
20 mL). The combined dichloromethane layers were washed with a 20% solution of 
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sodium sulfite (10 mL) and a 5% solution of sodium hydrogencarbonate (2 × 20 mL), dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography (petroleum ether/diethyl ether, 2:5) gave 
(1R,2S,4R,4aS,10bS)-1,2-oxiraryl-1,2,3,4,4a,10b-hexahydro-4-hydroxy-8,9-
methylenedioxy[4,5-j]phenanthridin-6-one (138) (0.057 g, 75%) as a white solid. Mp 160–
162 C; max/cm
–1
 (NaCl) 3350 (OH), 2851 (CH), 1654 (CO), 1466, 1249, 1035; []D
24
 –
61.2 (c 0.2, CHCl3); H (400 MHz, CDCl3) 2.08 (1H, ddd, J 14.6, 10.7, 1.8 Hz, 3-HH), 
2.15 (1H, d, J 4.2 Hz, 4-OH), 2.45 (1H, ddd, J 14.6, 5.6, 1.8 Hz, 3-HH), 2.84 (1H, dd, J 
3.6, 1.1 Hz, 1-H), 3.27–3.33 (2H, m, 2-H and 10b-H), 3.88–3.92 (1H, m, 4a-H) 4.05–4.12 
(1H, m, 4-H), 6.02 (1H, d, J 1.3 Hz, OCHHO), 6.03 (1H, d, J 1.3 Hz, OCHHO), 7.51 (1H, 
br s, NH), 6.82 (1H, s, 10-H), 7.55 (1H, s, 7-H); C (125 MHz, CDCl3) 27.4 (CH2), 39.1 
(CH), 52.2 (CH), 53.4 (CH), 54.4 (CH), 65.3 (CH), 101.9 (CH2), 107.7 (CH), 107.8 (CH), 
122.5 (C), 133.4 (C), 147.9 (C), 151.8 (C), 165.6 (C); m/z (CI) 276.0871 (MH
+
. C14H14NO5 
requires 276.0872), 260 (34%), 206 (6), 113 (5), 85 (33), 69 (48). 
(1S,2S,4R,4aS,10bS)-1,2,3,4,4a,10b-hexahydro-1,2,4-trihydroxy-8,9-
methylenedioxy[4,5-j] phenanthridin-6-one (261a) and (1R,2R,4R,4aS,10bS)-
1,2,3,4,4a,10b-hexahydro-1,2,4-trihydroxy-8,9-methylenedioxy[4,5-j] phenanthridin-
6-one (261b). 
 
(1R,2S,4R,4aS,10bS)-1,2-Oxiraryl-1,2,3,4,4a,10b-hexahydro-4-hydroxy-8,9-
methylenedioxy[4,5-j]phenanthridin-6-one (138) (0.013 g, 0.05 mmol) was added to a 1:1 
mixture of 0.2 M sulfuric acid/1,4-dioxane (4 mL) and the reaction mixture was stirred at 
80 C for 72 h. The reaction mixture was diluted with a saturated solution of sodium 
hydrogencarbonate (5 mL) and extracted with ethyl acetate (7 × 5 mL). The organic layers 
were combined, dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (dichloromethane/methanol, 10:1) gave 1:1 mixture of diastereomers of 
(1S,2S,4R,4aS,10bS)-1,2,3,4,4a,10b-hexahydro-1,2,4-trihydroxy-8,9-methylenedioxy[4,5-j] 
phenanthridin-6-one (261a) and (1R,2R,4R,4aS,10bS)-1,2,3,4,4a,10b-hexahydro-1,2,4-
trihydroxy-8,9-methylenedioxy[4,5-j] phenanthridin-6-one (261b) (4.7 mg, 34%). Mp 
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160–162 C; max/cm
–1
 (NaCl) 3340, 3306 (NH/OH), 2924 (CH), 1735 (CO), 1462, 1249, 
1076; NMR Signals for both diastereomer were recorded. H (400 MHz, CD3OD) 1.76–
1.88 (2H, m, 3-H2), 2.06–2.16 (2H, m, 3′-H′2), 2.61 (1H, dd, J 10.1, 3.5 Hz, 10b′-H′), 3.15 
(1H, t, J 4.0 Hz, 10b-H), 3.49–3.57 (2H, m, 2-H and 4a-H), 3.61 (1H, t, J 3.5 Hz, 4a′-H′), 
3.93–3.98 (2H, m, 1H and 1′H′), 4.01–4.07 (2H, m, 4-H and 4′-H′), 4.3 (1H, dt, J 12.2, 4.5 
Hz, 2′H′), 6.04 (1H, d, J 1.1 Hz, OCHHO), 6.05 (1H, d, J 1.1 Hz, OCHHO), 6.07 (2H, s, 
OCH′2O), 6.82 (1H, s, Ph), 6.86 (1H, s, Ph′), 7.41 (1H, s, Ph), 7.42 (1H, s, Ph′); C (100 
MHz, CDCl3) 30.9 (CH2), 37.3 (CH2), 39.9 (CH), 49.7 (CH), 54.4 (CH), 57.1 (CH), 65.4 
(CH), 68.0 (CH), 71.2 (CH), 72.9 (CH), 76.1 (CH), 76.2 (CH), 103.1 (CH2), 103.3 (CH2), 
107.9 (CH), 108.3 (CH), 111.3 (CH), 115.7 (CH), 123.2 (C), 126.2 (C), 137.2 (C), 137.7 
(C), 148.5 (C), 149.1 (C), 152.4 (C), 152.9 (C), 168.3 (C), 168.8 (C); m/z (EI) 293.0891 
(M
+
. C14H15NO6 requires 293.0899), 274 (20%), 217 (32), 190 (100), 77 (28). 
5.3.4 Synthesis of Balanol Core 
N-(tert-butoxycarbonyl)glycine methyl ester (279).
175
 
 
A stirred suspension of glycine (278) (0.5 g, 6.67 mmol) in methanol (30 mL) was cooled 
to 0 °C before chlorotrimethylsilane (1.86 mL, 14.67 mmol) was added dropwise. The 
reaction mixture was stirred at 0 °C for 1.5 h and then at room temperature for 24 h before 
being cooled again to 0 °C. Triethylamine (2.04 mL, 14.67 mmol) was added slowly, 
followed by di-tert-butyl dicarbonate (1.59 g, 7.33 mmol). The reaction mixture was stirred 
at room temperature for a further 12 h before being concentrated in vacuo. The residue was 
suspended in diethyl ether (30 mL) and filtered, and the filtrate was concentrated in vacuo 
and purified by flash column chromatography (petroleum ether/diethyl ether, 2:5) to give 
N-(tert-butoxycarbonyl)glycine methyl ester (279) (1.26 g, 100%) as colourless oil. 
Spectroscopic data is entirely consistent with the literature.
175
 max/cm
–1
 (NaCl) 3356 
(NH), 1805 (CO), 1755, 1438, 1369, 1261, 1165; H (400 MHz, CDCl3) 1.53 (9H, s, O
t
Bu), 
3.75 (3H, s, OCH3), 3.92 (2H, d, J 5.5 Hz, 2-H2), 5.02 (1H, br s, 1-NH); C (100 MHz, 
CDCl3) 27.4 (3 × CH3), 28.3 (CH3), 42.3 (CH2), 52.3 (C), 85.2 (C), 146.8 (C); m/z (CI) 
190.1081 (MH
+
. C8H16NO4 requires 190.1079), 178 (8%), 134 (100), 120 (25), 90 (54), 69 
(24). 
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N-(2′-(tert-Butyldiphenylsilyloxy)ethyl)but-3-en-1-amine (296). 
 
Sodium iodide (0.55 g, 3.70 mmol) was added to a solution of 4-bromo-1-butene (280) 
(5.00 g, 37.10 mmol) and ethanol amine (8.85 mL, 185.32 mmol) in methanol (80 mL). 
The reaction mixture was heated under reflux for 2 h, then cooled to room temperature and 
evaporated in vacuo. The residue was partitioned between saturated aqueous ammonium 
chloride solution (20 mL) and ethyl acetate (20 mL). The aqueous layer was basified with 
40% sodium hydroxide and extracted with ethyl acetate (3 × 15 mL). The combined 
organic layers were dried (MgSO4) and concentrated to afford N-(2′-(hydroxy)ethyl)but-3-
en-1-amine (293) (4.26 g, 100% yield) as a colourless oil. This oil was dissolved in 
tetrahydrofuran (200 mL), tert-butyldiphenylsilyl chloride (14.44 mL, 55.56 mmol) and 
imidazole (5.04 g, 74.08 mmol) were added and the reaction mixture was stirred overnight 
at room temperature. A white precipitate was removed by filtration and washed with 
diethyl ether (70 mL). The combined filtrate was concentrated, dried and purified by flash 
column chromatography on silica gel (elution with dichloromethane/ethyl acetate) to give 
N-(2′-(tert-butyldimethylsilyloxy)ethyl)but-3-en-1-amine (296) (9.43 g, 86%) as a 
colourless oil. max/cm
–1
 (Neat) 2931 (CH), 1465, 1080, 825; H (400 MHz, CDCl3) 1.08 
(9H, s, SiC(CH3)3), 2.27–2.34 (2H, m, 2-H2), 2.72 (2H, t, J 6.8 Hz, 1-H2), 2.79 (2H, t, J 5.4 
Hz, 1′-H2), 3.81 (2H, t, J 5.4 Hz, 2′-H2), 5.06–5.18 (2H, m, 4-H2), 5.17 (1H, ddt, J 17.1, 
10.2, 6.8 Hz, 3-H), 7.38–7.48 (6H, m, Ph), 7.68–7.72 (4H, m, Ph); C (100 MHz, CDCl3) 
19.2 (C), 26.8 (3 × CH3), 34.4 (CH2), 48.6 (CH2), 51.5 (CH2), 62.5 (CH2), 116.4 (CH2), 
128.0 (4 × CH), 129.6 (2 × CH), 133.7 (2 × C), 135.6 (4 × CH), 136.5 (CH); m/z (CI) 
354.2254 (MH
+
. C22H32NOSi requires 354.2253), 257 (8%), 193 (5), 137 (7), 113 (28), 85 
(89), 69 (100). 
N-(2′-(tert-Butyldiphenylsilyloxy)ethyl)-N-(tert-butoxycarbonyl)but-3-en-1-amine 
(297). 
 
To a solution of N-(2′-(tert-butyldimethylsilyloxy)ethyl)but-3-en-1-amine (296) (4.0 g, 
11.3 mmol) in dichloromethane (100 mL) at 0 C was added triethylamine (3.31 mL, 23.70 
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mmol), 4-dimethylaminopyridine (0.14 g, 1.30 mmol) and di-tert-butyl dicarbonate (4.93 
g, 22.60 mmol). The reaction was warmed to room temperature and stirred overnight. The 
reaction mixture was washed with brine (2 × 30 mL), dried (MgSO4) and concentrated in 
vacuo. Purification by flash column chromatography (elution with ethyl acetate/diethyl 
ether, 1:10) gave N-(2′-(tert-butyldiphenylsilyloxy)ethyl)-N-(tert-butoxycarbonyl)but-3-en-
1-amine (297) (5.1 g, 100%) as a colourless oil. max/cm
–1
 (Neat) 2931 (CH), 1689 (CO), 
1473, 1111, 825; NMR spectra showed a 1:1 mixture of rotomers, only signals for one 
rotomer is recorded. H (400 MHz, CDCl3) 1.05 (9H, s, SiC(CH3)3), 1.41 (9H, s, C(CH3)3), 
2.20–2.29 (2H, m, 2-H2), 3.25–3.40 (4H, m, 1-H2 and 1′-H2), 3.25–3.39 (2H, m, 2′-H2), 
4.96–5.06 (2H, m, 4-H2), 5.66–5.81 (1H, m, 3-H2), 7.33–7.44 (6H, m, Ph), 7.63–7.67 (4H, 
m, Ph); C (100 MHz, CDCl3) 19.2 (C), 26.8 (3 × CH3), 28.4 (3 × CH3), 32.2 (CH2), 45.6 
(CH2), 49.4 (CH2), 62.5 (CH2), 82.9 (C), 116.4 (CH2), 127.3 (4 × CH), 129.7 (4 × CH), 
133.6 (2 × C), 135.3 (2 × CH), 135.8 (CH), 155.3 (C); m/z (CI) 454.2772 (MH
+
. 
C27H40NO3Si requires 454.2777), 398 (18%), 354 (28), 257 (8), 179 (5), 139 (6), 85 (87), 
69 (100). 
N-(2′-(hydroxy)ethyl)-N-(tert-butoxycarbonyl)but-3-en-1-amine (282). 
 
A solution of tetrabutylammonium fluoride (1.0 M in tetrahydrofuran) (13.60 mL, 13.60 
mmol) was added to a solution of N-(2′-(tert-butyldiphenylsilyloxy)ethyl)-N-(tert-
butoxycarbonyl)but-3-en-1-amine (297) (5.12 g, 11.30 mmol) in tetrahydrofuran (100 mL) 
at 0 C. The reaction was warmed to room temperature and stirred overnight. The reaction 
mixture was then concentrated and the resulting residue was re-suspended in diethyl ether 
(80 mL). The solution was washed with water (40 mL) and the aqueous layer was then 
extracted with diethyl ether (3 × 40 mL). The combined organic extracts were dried 
(MgSO4), concentrated and then purified by flash column chromatography (petroleum 
ether/diethyl ether, 1:5) to give N-(2′-(hydroxy)ethyl)-N-(tert-butoxycarbonyl)but-3-en-1-
amine (282) (2.42 g, 100%) as a colourless oil. max/cm
–1
 (Neat) 3742 (OH), 2978 (CH), 
1743 (CO), 1473, 1157, 910; NMR spectra showed a 1:1 mixture of rotomers, only signals 
for one rotomer is recorded. H (400 MHz, CDCl3) 1.48 (9H, s, C(CH3)3), 2.30 (2H, q, J 
6.8 Hz, 2-H2), 3.25–3.35 (2H, m, 1-H2), 3.40 (2H, t, J 4.8 Hz, 1′-H2), 3.79–3.72 (2H, m, 2′-
H2), 5.03–5.12 (2H, m, 4-H2), 5.71–5.84 (1H, m, 3-H2); C (100 MHz, CDCl3) 28.4 (3 × 
CH3), 33.3 (CH2), 48.5 (CH2), 50.6 (CH2), 62.7 (CH2), 80.2 (C), 116.8 (CH2), 135.2 (CH), 
Experimental  156 
 
155.5 (C); m/z (CI) 216.1603 (MH
+
. C11H22NO3 requires 216.1600), 174 (8%), 160 (100), 
69 (28). 
Ethyl (2′E)-N-(butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-enoate (283). 
 
Reaction was carried out according to general procedure 1, using N-(2′-(hydroxy)ethyl)-N-
(tert-butoxycarbonyl)but-3-en-1-amine (282) (2.86 g, 13.30 mmol). Flash column 
chromatography using (diethyl ether/petroleum ether, 2:3) gave the ethyl (2′E)-N-(butyl-3-
en-1-yl)-N-(tert-butoxycarbonyl)but-2′-enoate (283) (2.9 g, 94%) as colourless oil. 
max/cm
–1
 (NaCl) 2978 (CH), 1689 (CO), 1465, 1165, 1149, 910; NMR spectra showed a 
1:1 mixture of rotomers, only signals for one rotomer is recorded. H (400 MHz, CDCl3) 
1.32 (3H, t, J 7.3 Hz, OCH2CH3), 1.49 (9H, s, C(CH3)3), 2.25–2.35 (2H, m, 2-H2), 3.19–
3.36 (2H, m, 1-H2), 3.93–4.06 (2H, m, 1′-H2), 4.23 (2H, q, J 7.3 Hz, OCH2CH3), 5.02–5.14 
(2H, m, 1-H), 5.71–5.80 (1H, m, 3-H), 5.88 (1H, dt, J 15.6, 1.8 Hz, 3′-H), 6.89 (1H, dt, J 
15.6, 4.7 Hz, 2′-H); C (100 MHz, CDCl3) 14.2 (CH3), 28.2 (3 × CH3), 33.1 (CH2), 46.7 
(CH2), 47.7 (CH2), 60.4 (CH2), 80.0 (C), 116.9 (CH2), 121.8 (CH), 135.1 (CH), 144.2 
(CH), 155.1 (C), 166.7 (C); m/z (CI) 284.1862 (MH
+
. C15H26NO4 requires 284.1862), 228 
(94%), 184 (62), 113 (32), 71 (100). 
(2′E)-N-(Butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-en-4′-ol (140). 
 
A stirred solution of (2′E)-N-(butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-enoate (283) 
(0.25 g, 0.90 mmol) in dichloromethane (30 mL) was cooled to –78 °C before boron 
trifluoride diethyl etherate (0.15 mL, 1.17 mmol) was added dropwise. The mixture was 
stirred at –78 °C for 0.5 h before diisobutylaluminium hydride solution (1.0 M in hexanes, 
2.7 mL, 2.7 mmol) was added dropwise. The reaction mixture was then stirred at –78 °C 
for 3 h before being quenched by the addition of 5.0 M acetic acid solution in 
dichloromethane (10mL). The mixture was poured into 10% aqueous tartaric acid solution 
(10 mL), and the organic layers were extracted using dichloromethane (2 × 20 mL). The 
combined organic phases were washed with a saturated aqueous solution of sodium 
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hydrogen carbonate (15 mL) before being dried (MgSO4), filtered, and concentrated in 
vacuo. The crude product was purified by flash column chromatography (petroleum 
ether/diethyl ether, 2:5) to give (2′E)-N-(butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-
en-4′-ol (140) (0.08 g 37%) as a colourless oil. max/cm
–1
 (Neat) 3433 (OH), 2978 (CH), 
1674 (CO), 1473, 1242, 918; H (400 MHz, CDCl3) 1.38 (9H, s, C(CH3)3), 2.18 (2H, q, J 
7.5 Hz, 2-H2), 3.06–3.22 (2H, m, 1-H2), 3.66–3.79 (2H, m, 1′-H2), 4.13 (2H, d, J 4.1 Hz, 
4′-H2), 4.89–5.02 (2H, m, 4-H2), 5.49–5.76 (3H, m, 3-H, 2′-H and 3′-H); C (100 MHz, 
CDCl3) 28.4 (3 × CH3), 32.5 (CH2), 46.2 (CH2), 48.3 (CH2), 63.1 (CH2), 79.5 (C), 116.5 
(CH2), 127.8 (CH), 131.0 (CH), 135.5 (CH), 155.4 (C); m/z (CI) 242.1752 (MH
+
. 
C13H24NO3 requires 242.1756), 200 (8%), 186 (100), 168 (72), 85 (28), 73 (38).  
N-(2′-(Oxoethyl)-N-(tert-butoxycarbonyl)but-3-en-1-amine (300). 
 
Dimethyl sulfoxide (4.20 mL, 59.20 mmol) was added to a stirred solution of oxalyl 
chloride (3.10 mL, 35.50 mmol) in dichloromethane (50 mL) at –78 C. The reaction 
mixture was stirred for 0.3 h before the N-(2′-(hydroxy)ethyl)-N-(tert-butoxycarbonyl)but-
3-en-1-amine (282) (5.10 g, 23.70 mmol) in dichloromethane (25 mL) was slowly added. 
The mixture was stirred for a further 0.3 h before triethylamine (16.50 mL, 118.40 mmol) 
was added. This reaction mixture was stirred for 0.5 h at –78 C and then allowed to warm 
to room temperature and stirred for a further 2 h. The Swern solution was concentrated in 
vacuo, and then purified by flash column chromatography (petroleum ether/diethyl ether, 
2:5) to give N-(2′-(oxoethyl)-N-(tert-butoxycarbonyl)but-3-en-1-amine (300) (4.74 g, 94%) 
as a colourless oil. max/cm
–1
 (Neat) 3020 (CH), 1735 (CO), 1685 (CO), 1423, 1215, 906; 
NMR spectra showed a 1:1 mixture of rotomers, only signals for one rotomer is recorded. 
H (400 MHz, CDCl3) 1.45 (9H, s, C(CH3)3), 2.23–2.33 (2H, m, 2-H2), 3.30 (2H, t, J 7.1 
Hz, 1-H2), 3.80 (2H, br s, 1′-H2), 5.02–5.11 (2H, m, 4-H2), 5.68–5.83 (1H, m, 3-H2), 9.57 
(1H, d, J 4.7 Hz, 2′-H); C (100 MHz, CDCl3) 28.2 (3 × CH3), 32.9 (CH2), 48.2 (CH2), 57.5 
(CH2), 80.6 (C), 117.1 (CH2), 135.0 (CH), 154.9 (C), 199.2 (C); m/z (CI) 214.1440 (MH
+
. 
C11H20NO3 requires 214.1443), 196 (8%), 200 (10), 158 (100), 69 (12). 
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(2′E)-N-(Butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-en-4′-al (301). 
 
To a solution of ethyl N-(2′-(oxoethyl)-N-(tert-butoxycarbonyl)but-3-en-1-amine (300) 
(1.6 g, 7.51 mmol) in toluene (80 mL) was added (triphenylphosphoranylidene) 
acetaldehyde (3.42 g, 11.26 mmol) and reaction mixture was heated at 80 C and stirred 
for 24 h. The solution was allowed to cool to room temperature and concentrated in vacuo. 
The crude product was purified with flash column chromatography (petroleum 
ether/diethyl ether, 2:5) to give (2′E)-N-(butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-
en-4′-al (301) (1.26 g, 71%) as colourless oil. max/cm
–1
 (Neat) 3016 (CH), 1678 (CO), 
1466, 1215, 918; NMR spectra showed a mixture of E and Z alkenes in a ratio of 5:1, only 
signals for E is recorded. H (400 MHz, CDCl3) 1.51 (9H, s, C(CH3)3), 2.26–2.36 (2H, m, 
2-H2), 3.22–3.38 (2H, m, 1-H2), 4.05–4.19 (2H, m, 1′-H2), 5.05–5.15 (2H, m, 4-H2), 5.71–
5.85 (1H, m, 3-H), 6.17 (1H, ddt, J 15.8, 7.9, 1.6 Hz, 3′-H), 3′-H), 6.72–6.86 (1H, m, 2′-H), 
9.62 (1H, d, J 7.9 Hz, 4’-H); C (100 MHz, CDCl3) 28.2 (3 × CH3), 32.9 (CH2), 46.9 
(CH2), 48.2 (CH2), 80.2 (C), 117.1 (CH2), 125.3 (CH), 129.1 (CH), 132.3 (CH), 153.3 (C), 
193.7 (C); m/z (CI) 240.1595 (MH
+
. C13H22NO3 requires 240.1600), 236 (19%), 184 (100), 
158 (40), 116 (58), 69 (12). 
(2′E)-N-(Butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-en-4′-ol (140). 
 
To a solution of (2′E)-N-(butyl-3-en-1-yl)-N-(tert-butoxycarbonyl)but-2′-en-4′-al (301) 
(0.30 g, 1.28 mmol) in methanol (35 mL) at 0 C was added sodium borohydride (0.09 g, 
2.56 mmol) and stirred for 1 h. The reaction mixture was quenched with 1.0 M 
hydrochloric acid (5 mL) and then concentrated in vacuo. The residue was dissolved in 
dichloromethane (20 mL), washed with saturated sodium hydrogencarbonate solution (10 
mL), dried (MgSO4), and then concentrated in vacuo. The crude product was purified by 
flash column chromatography (petroleum ether/diethyl ether, 2:5) to give (2′E)-N-(butyl-3-
en-1-yl)-N-(tert-butoxycarbonyl)but-2′-en-4′-ol (140) (0.26 g 88%) as a colourless oil. 
Spectroscopic data as reported above. 
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1-(tert-Butoxycarbonyl)-3-(2′,2′,2′-trichloromethylamino)azapin-4-ene (303). 
 
The reaction was carried out according general procedure 4 using (2E)-N-(butyl-3-en-1-
yl)-N-(tert-butoxycarbonyl)but-2′-en-4′-ol (140) (0.13 g, 0.54 mmol) and 
bis(acetonitrile)palladium(II) chloride (0.014 g, 0.05 mmol) as a catalyst for Overmann 
rearrangement. Purification by flash column chromatography (petroleum 
ether/diethylether, 2:1) gave (1-(tert-butoxycarbonyl)-3-(2′,2′,2′-trichloromethylamino) 
azapin-4-ene (303) (0.09 g, 49% over three steps) as a white solid. Mp 103–105 C; 
max/cm
–1
 (NaCl) 3330 (NH), 2978 (CH), 1689 (CO), 1419, 1356, 821. NMR spectra 
showed a 1:1 mixture of rotomers, only signals for one rotomer is recorded: H (400 MHz, 
CDCl3) 1.40 (9H, s, C(CH3)3), 2.17–2.42 (2H, m, 6-H2), 3.03–3.16 (1H, m, 7-HH), 3.24 
(1H, d, J 14.1 Hz, 2-HH), 3.72–3.81 (1H, m, 7-HH), 4.05 (1H, d, J 14.1 Hz, 2-HH), 4.43–
4.59 (1H, m, 3-H), 5.53–5.93 (2H, m, 4-H and 5-H), 8.30 (1H, br s, NH); C (100 MHz, 
CDCl3) 27.9 (CH2), 28.4 (3 × CH3), 47.7 (CH2), 48.7 (CH2), 54.4 (CH), 80.8 (C), 92.6 (C), 
128.6 (CH), 129.3 (CH), 157.3 (C), 161.7 (C); m/z (CI) 359.0511 (MH
+
. C13H20
35
Cl2
37
Cl 
N2O3 requires 359.0512), 301 (100%), 267 (34), 257 (18), 163 (8), 85 (13), 69(19). 
2′,2′,2′-Trichloro-N-[(3S*,3aS*,4aR*)-1-aza-4-oxobicyclo[5.1.0]octa-3a-yl]acetamide 
(304). 
 
1-(tert-Butoxycarbonyl)-3-(2′,2′,2′-trichloromethylamino)azapin-4-ene (303) (0.19 g, 0.53 
mmol) was dissolved in dichloromethane (15 mL) and to the stirred suspension was added 
meta-chloroperoxybenzoic acid (0.18 g 1.05 mmol) at room temperature. The resulting 
suspension was stirred vigorously for 19 h. A 20% aqueous solution of sodium sulphite (10 
mL) was added and the resulting two-phase mixture was stirred vigorously for 0.25 h. The 
two layers were separated and the aqueous layer was extracted with dichloromethane (2 × 
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20 mL). The combined organic layers were washed with a 20% aqueous solution of 
sodium sulphite (10 mL) and a 5% aqueous solution of sodium hydrogencarbonate (2 × 20 
mL), dried (MgSO4) and evaporated under reduced pressure. Purification by flash column 
chromatography (elution with petroleum ether/diethyl ether, 2:5) gave 2′,2′,2′-trichloro-N-
[(3S*,3aS*,4aR*)-1-aza-4-oxobicyclo[5.1.0]octa-3a-yl]acetamide (304) (0.10 g, 51%) as 
white solid. Mp 160–162 C; max/cm
–1
 (NaCl) 3293 (NH), 2974 (CH), 1697 (CO), 1518, 
1413, 1165, 821; NMR spectra showed a 1:0.6 mixture of rotomers, only signals for major 
rotomer is recorded. H (400 MHz, CDCl3) 1.50 (9H, s, C(CH3)3), 2.21–2.37 (2H, m, 5-H2), 
2.78–2.93 (1H, m, 2-H2), 3.18–3.33 (2H, m, 6-H2), 3.80–3.92 (2H, m, 3a-H and 4a-H), 
4.58 (1H, td, J 10.8, 4.5 Hz, 3-H), 6.90 (1H, d, J 8.2 Hz, NH); C (100 MHz, CDCl3) 27.3 
(CH2), 28.4 (3 × CH3), 43.1 (CH2), 46.5 (CH2), 50.7 (CH), 55.4 (CH), 58.7 (CH), 80.4 (C), 
92.3 (C), 154.3 (C), 161.4 (C); m/z (CI) 373.0502 (MH
+
. C13H20
35
Cl3N2O4 requires 
373.0489), 319 (100%), 283 (76), 211 (8), 155 (10), 69 (11). 
(3aS*,8aR*)-5-(tert-Butoxycarbonyl)octahydro-1-oxo-3,5-diaza-azulen-2-one (305). 
 
2′,2′,2′-Trichloro-N-[(3S*,3aS*,4aR*)-1-aza-4-oxobicyclo[5.1.0]octa-3a-yl]acetamide 
(304) (0.02 g, 0.05 mmol ) was dissolved in tetrahydrofuran (4 mL) and cooled to 0 C. 
Lithium aluminium hydride (0.005 g, 0.12 mmol) was then added. The stirred slurry was 
heated under refluxed for 12 h. The solution was cooled to room temperature and quenched 
by the addition of a saturated solution of ammonium chloride (2 mL) with vigorous stirring 
over 0.15 h. The organic layer was separated, and the aqueous layer was extracted with 
ethyl acetate (3 × 10 mL). The combined organic layers were dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (elution with ethyl 
acetate) gave (3aS*,8aR*)-5-(tert-butoxycarbonyl)octahydro-1-oxo-3,5-diaza-azulen-2-one 
(305) (0.008 g, 56%). max/cm
–1
 (NaCl) 3271 (NH), 2960 (CH), 1689 (CO), 1670 (CO), 
1413, 1166, 943; NMR spectra showed a 1:0.8 mixture of rotomers, only signals for major 
rotomer is recorded. H (500 MHz, CDCl3) 1.48 (9H, s, C(CH3)3), 2.10–2.28 (2H, m, 7-
H2), 2.58–2.85 (3H, m, 4-H2 and 8-HH), 3.12–3.29 (2H, m, 6-H2), 3.57–3.89 (2H, m, 8-HH 
and 8a-H), 4.61–4.74 (1H, m, 3a-H), 5.70–5.74 (1H, m, NH); C (125 MHz, CDCl3) 27.7 
(CH2), 28.5 (3 × CH3), 29.6 (CH2), 43.3 (CH2), 47.8 (CH2), 55.5 (CH), 59.5 (CH), 80.6 
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(C), 154.4 (C), 160.3 (C); m/z (CI) 257.1506 (MH
+
. C12H21N2O4 requires 257.1501), 201 
(100%), 157 (62), 113 (12), 69, (24).  
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7 Appendix 
Crystal data and structure refinement for 199 
Identification code  199 
Empirical formula  C8 H11 Cl3 I N O2 
Formula weight  386.43 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 8.06780(10) Å = 90°. 
 b = 16.6957(2) Å = 99.4370(10)°. 
 c = 9.65370(10) Å  = 90°. 
Volume 1282.73(3) Å3 
Z 4 
Density (calculated) 2.001 Mg/m3 
Absorption coefficient 3.102 mm-1 
F(000) 744 
Theta range for data collection 2.14 to 27.47°. 
Index ranges -10<=h<=10, -21<=k<=21, -12<=l<=12 
Reflections collected 11006 
Independent reflections 5835 [R(int) = 0.0335] 
Completeness to theta = 27.47° 99.9 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5835 / 1 / 273 
Goodness-of-fit on F2 0.977 
Final R indices [I>2sigma(I)] R1 = 0.0313, wR2 = 0.0553 
R indices (all data) R1 = 0.0449, wR2 = 0.0585 
Absolute structure parameter -0.042(13) 
Largest diff. peak and hole 0.559 and -0.654 e.Å-3 
  
Appendix  171 
Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
199. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
 x y z U(eq) 
I(2) 16111(1) -2034(1) 2653(1) 26(1) 
I(1) 3175(1) 341(1) 1513(1) 34(1) 
Cl(1) 9241(1) -1522(1) -2677(1) 33(1) 
Cl(4) 8508(1) -37(1) 4735(1) 28(1) 
Cl(3) 11926(1) -1731(1) -355(1) 27(1) 
Cl(2) 8984(2) -2752(1) -651(2) 38(1) 
Cl(6) 10675(2) 1316(1) 4515(1) 33(1) 
Cl(5) 10293(2) 694(1) 7245(1) 38(1) 
O(4) 13361(4) 192(2) 6035(3) 34(1) 
O(1) 6024(4) 489(2) -1932(3) 25(1) 
O(3) 11056(3) -2210(2) 3582(3) 26(1) 
N(1) 7884(4) -653(2) -488(4) 19(1) 
O(2) 9216(3) -1335(2) 1384(3) 24(1) 
N(2) 11788(4) -787(2) 4854(4) 22(1) 
C(12) 13876(5) -2537(2) 3322(5) 21(1) 
C(1) 5434(5) 181(3) -717(4) 21(1) 
C(10) 14929(6) -2485(3) 5924(5) 30(1) 
C(7) 8907(5) -1208(3) 116(5) 19(1) 
C(16) 10416(6) 438(3) 5480(4) 25(1) 
C(9) 13567(5) -1853(3) 6100(4) 28(1) 
C(6) 6990(5) -88(3) 301(4) 18(1) 
C(4) 7126(5) 1237(3) 1548(4) 19(1) 
C(2) 4495(5) 846(3) -96(5) 21(1) 
C(5) 8115(5) 613(2) 846(4) 20(1) 
C(14) 13171(5) -1350(3) 4778(4) 20(1) 
C(3) 5626(5) 1524(3) 508(4) 21(1) 
C(15) 12005(5) -87(3) 5491(4) 23(1) 
C(11) 14326(5) -3016(3) 4651(5) 25(1) 
C(13) 12638(5) -1856(3) 3457(4) 22(1) 
C(8) 9722(5) -1771(3) -873(4) 22(1) 
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 Bond lengths [Å] for 199 
I(2)-C(12)  2.181(4) 
I(1)-C(2)  2.191(4) 
Cl(1)-C(8)  1.770(4) 
Cl(4)-C(16)  1.776(5) 
Cl(3)-C(8)  1.768(4) 
Cl(2)-C(8)  1.769(4) 
Cl(6)-C(16)  1.769(5) 
Cl(5)-C(16)  1.775(4) 
O(4)-C(15)  1.225(5) 
O(1)-C(1)  1.432(5) 
O(1)-H(1)  0.8200 
O(3)-C(13)  1.430(5) 
O(3)-H(3)  0.8200 
N(1)-C(7)  1.312(5) 
N(1)-C(6)  1.473(5) 
N(1)-H(1A)  0.8600 
O(2)-C(7)  1.228(5) 
N(2)-C(15)  1.319(6) 
N(2)-C(14)  1.471(5) 
N(2)-H(2)  0.8600 
C(12)-C(11)  1.505(6) 
C(12)-C(13)  1.533(6) 
C(12)-H(12)  0.9800 
C(1)-C(2)  1.521(6) 
C(1)-C(6)  1.529(5) 
C(1)-H(1B)  0.9800 
C(10)-C(11)  1.529(6) 
C(10)-C(9)  1.553(6) 
C(10)-H(10A)  0.9700 
C(10)-H(10B)  0.9700 
C(7)-C(8)  1.559(6) 
C(16)-C(15)  1.551(6) 
C(9)-C(14)  1.517(6) 
C(9)-H(9A)  0.9700 
C(9)-H(9B)  0.9700 
C(6)-C(5)  1.521(6) 
C(6)-H(6)  0.9800 
C(4)-C(3)  1.518(6) 
C(4)-C(5)  1.535(6) 
C(4)-H(4A)  0.9700 
C(4)-H(4B)  0.9700 
C(2)-C(3)  1.511(6) 
C(2)-H(2A)  0.9800 
C(5)-H(5A)  0.9700 
C(5)-H(5B)  0.9700 
C(14)-C(13)  1.531(6) 
C(14)-H(14)  0.9800 
C(3)-H(3A)  0.9700 
C(3)-H(3B)  0.9700 
C(11)-H(11A)  0.9700 
C(11)-H(11B)  0.9700 
C(13)-H(13)  0.9800
Bond angles [°] for 199 
C(1)-O(1)-H(1) 109.5 
C(13)-O(3)-H(3) 109.5 
C(7)-N(1)-C(6) 123.2(3) 
C(7)-N(1)-H(1A) 118.4 
C(6)-N(1)-H(1A) 118.4 
C(15)-N(2)-C(14) 123.1(4) 
C(15)-N(2)-H(2) 118.4 
C(14)-N(2)-H(2) 118.4 
C(11)-C(12)-C(13) 113.0(3) 
C(11)-C(12)-I(2) 111.2(3) 
C(13)-C(12)-I(2) 108.7(3) 
C(11)-C(12)-H(12) 107.9 
C(13)-C(12)-H(12) 107.9 
I(2)-C(12)-H(12) 107.9 
O(1)-C(1)-C(2) 108.3(3) 
O(1)-C(1)-C(6) 106.5(3) 
C(2)-C(1)-C(6) 111.8(3) 
O(1)-C(1)-H(1B) 110.1 
C(2)-C(1)-H(1B) 110.1 
C(6)-C(1)-H(1B) 110.1 
C(11)-C(10)-C(9) 110.1(4) 
C(11)-C(10)-H(10A) 109.6 
C(9)-C(10)-H(10A) 109.6 
C(11)-C(10)-H(10B) 109.6 
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C(9)-C(10)-H(10B) 109.6 
H(10A)-C(10)-H(10B) 108.1 
O(2)-C(7)-N(1) 125.1(4) 
O(2)-C(7)-C(8) 118.0(4) 
N(1)-C(7)-C(8) 116.8(4) 
C(15)-C(16)-Cl(6) 107.6(3) 
C(15)-C(16)-Cl(5) 107.8(3) 
Cl(6)-C(16)-Cl(5) 109.6(2) 
C(15)-C(16)-Cl(4) 114.3(3) 
Cl(6)-C(16)-Cl(4) 109.0(2) 
Cl(5)-C(16)-Cl(4) 108.4(2) 
C(14)-C(9)-C(10) 109.8(3) 
C(14)-C(9)-H(9A) 109.7 
C(10)-C(9)-H(9A) 109.7 
C(14)-C(9)-H(9B) 109.7 
C(10)-C(9)-H(9B) 109.7 
H(9A)-C(9)-H(9B) 108.2 
N(1)-C(6)-C(5) 110.9(3) 
N(1)-C(6)-C(1) 106.0(3) 
C(5)-C(6)-C(1) 112.1(3) 
N(1)-C(6)-H(6) 109.3 
C(5)-C(6)-H(6) 109.3 
C(1)-C(6)-H(6) 109.3 
C(3)-C(4)-C(5) 109.8(3) 
C(3)-C(4)-H(4A) 109.7 
C(5)-C(4)-H(4A) 109.7 
C(3)-C(4)-H(4B) 109.7 
C(5)-C(4)-H(4B) 109.7 
H(4A)-C(4)-H(4B) 108.2 
C(3)-C(2)-C(1) 113.0(3) 
C(3)-C(2)-I(1) 110.3(3) 
C(1)-C(2)-I(1) 109.3(3) 
C(3)-C(2)-H(2A) 108.0 
C(1)-C(2)-H(2A) 108.0 
I(1)-C(2)-H(2A) 108.0 
C(6)-C(5)-C(4) 110.5(3) 
C(6)-C(5)-H(5A) 109.5 
C(4)-C(5)-H(5A) 109.5 
C(6)-C(5)-H(5B) 109.5 
C(4)-C(5)-H(5B) 109.5 
H(5A)-C(5)-H(5B) 108.1 
N(2)-C(14)-C(9) 111.6(3) 
N(2)-C(14)-C(13) 106.4(3) 
C(9)-C(14)-C(13) 112.8(4) 
N(2)-C(14)-H(14) 108.6 
C(9)-C(14)-H(14) 108.6 
C(13)-C(14)-H(14) 108.6 
C(2)-C(3)-C(4) 112.6(3) 
C(2)-C(3)-H(3A) 109.1 
C(4)-C(3)-H(3A) 109.1 
C(2)-C(3)-H(3B) 109.1 
C(4)-C(3)-H(3B) 109.1 
H(3A)-C(3)-H(3B) 107.8 
O(4)-C(15)-N(2) 125.3(4) 
O(4)-C(15)-C(16) 117.8(4) 
N(2)-C(15)-C(16) 116.8(4) 
C(12)-C(11)-C(10) 112.2(4) 
C(12)-C(11)-H(11A) 109.2 
C(10)-C(11)-H(11A) 109.2 
C(12)-C(11)-H(11B) 109.2 
C(10)-C(11)-H(11B) 109.2 
H(11A)-C(11)-H(11B) 107.9 
O(3)-C(13)-C(14) 106.9(3) 
O(3)-C(13)-C(12) 107.7(3) 
C(14)-C(13)-C(12) 112.4(3) 
O(3)-C(13)-H(13) 109.9 
C(14)-C(13)-H(13) 109.9 
C(12)-C(13)-H(13) 109.9 
C(7)-C(8)-Cl(3) 108.0(3) 
C(7)-C(8)-Cl(2) 107.5(3) 
Cl(3)-C(8)-Cl(2) 110.1(2) 
C(7)-C(8)-Cl(1) 114.5(3) 
Cl(3)-C(8)-Cl(1) 108.5(2) 
Cl(2)-C(8)-Cl(1) 108.2(2) 
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Anisotropic displacement parameters (Å2x 103)for 199. The anisotropic displacement factor 
exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12] 
 U11 U22 U33 U23 U13 U12 
I(2) 23(1)  30(1) 29(1)  1(1) 12(1)  -1(1) 
I(1) 26(1)  26(1) 55(1)  2(1) 22(1)  1(1) 
Cl(1) 36(1)  42(1) 22(1)  -5(1) 6(1)  9(1) 
Cl(4) 22(1)  32(1) 29(1)  0(1) 3(1)  3(1) 
Cl(3) 16(1)  34(1) 31(1)  -8(1) 7(1)  1(1) 
Cl(2) 33(1)  20(1) 64(1)  -3(1) 22(1)  -5(1) 
Cl(6) 36(1)  27(1) 39(1)  4(1) 8(1)  2(1) 
Cl(5) 43(1)  47(1) 27(1)  -12(1) 14(1)  -2(1) 
O(4) 24(2)  36(2) 37(2)  -12(2) -5(1)  -1(2) 
O(1) 27(2)  32(2) 17(2)  1(2) 2(1)  1(2) 
O(3) 14(1)  32(2) 30(2)  4(2) 3(1)  -1(1) 
N(1) 20(2)  21(2) 17(2)  -1(2) 4(2)  6(2) 
O(2) 22(2)  29(2) 23(2)  4(1) 8(1)  6(1) 
N(2) 16(2)  25(2) 24(2)  -2(2) 3(2)  1(2) 
C(12) 19(2)  17(2) 29(2)  -6(2) 12(2)  -6(2) 
C(1) 18(2)  19(3) 25(2)  -4(2) 5(2)  -3(2) 
C(10) 27(2)  38(3) 22(2)  9(2) -1(2)  5(2) 
C(7) 15(2)  23(2) 22(2)  -1(2) 11(2)  -6(2) 
C(16) 34(2)  22(3) 21(2)  -3(2) 6(2)  1(2) 
C(9) 26(2)  41(3) 18(2)  0(2) 4(2)  4(2) 
C(6) 17(2)  21(2) 19(2)  2(2) 8(2)  3(2) 
C(4) 21(2)  21(2) 16(2)  1(2) 3(2)  1(2) 
C(2) 18(2)  21(2) 25(2)  5(2) 2(2)  3(2) 
C(5) 13(2)  24(2) 21(2)  0(2) 1(2)  4(2) 
C(14) 20(2)  23(2) 18(2)  -1(2) 6(2)  5(2) 
C(3) 21(2)  18(2) 26(2)  0(2) 9(2)  -1(2) 
C(15) 27(2)  25(2) 16(2)  0(2) 4(2)  1(2) 
C(11) 21(2)  23(2) 31(3)  8(2) 7(2)  0(2) 
C(13) 20(2)  24(3) 22(2)  2(2) 6(2)  -2(2) 
C(8) 18(2)  21(2) 26(2)  -2(2) 5(2)  -1(2) 
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Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 199 
 x  y  z  U(eq) 
H(1) 5334 390 -2634 38 
H(3) 10386 -2129 2859 39 
H(1A) 7728 -617 -1389 23 
H(2) 10790 -920 4466 26 
H(12) 13344 -2900 2583 25 
H(1B) 4685 -276 -977 25 
H(10A) 15961 -2216 5801 35 
H(10B) 15161 -2813 6763 35 
H(9A) 12556 -2121 6279 34 
H(9B) 13968 -1510 6896 34 
H(6) 6637 -368 1096 22 
H(4A) 6744 1001 2358 23 
H(4B) 7848 1687 1867 23 
H(2A) 3651 1064 -848 26 
H(5A) 8557 860 73 23 
H(5B) 9056 421 1520 23 
H(14) 14176 -1044 4664 24 
H(3A) 4982 1899 974 25 
H(3B) 6024 1807 -252 25 
H(11A) 15203 -3396 4536 30 
H(11B) 13350 -3318 4817 30 
H(13) 12517 -1514 2621 26 
_________________________________________________________________________ 
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Crystal data and structure refinement for 202 
Identification code  202 
Empirical formula  C8 H12 Cl3 N O4 
Formula weight  292.54 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2 
Unit cell dimensions a = 39.705(2) Å = 90°. 
 b = 5.8312(3) Å = 91.296(2)°. 
 c = 20.2162(14) Å  = 90°. 
Volume 4679.4(5) Å3 
Z 16 
Density (calculated) 1.661 Mg/m3 
Absorption coefficient 0.781 mm-1 
F(000) 2400 
Theta range for data collection 3.02 to 27.48°. 
Index ranges -51<=h<=51, -7<=k<=7, -26<=l<=25 
Reflections collected 13482 
Independent reflections 9273 [R(int) = 0.1025] 
Completeness to theta = 27.48° 96.6 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9273 / 1 / 589 
Goodness-of-fit on F2 1.059 
Final R indices [I>2sigma(I)] R1 = 0.0752, wR2 = 0.1056 
R indices (all data) R1 = 0.1714, wR2 = 0.1434 
Absolute structure parameter 0.13(10) 
Largest diff. peak and hole 0.724 and -0.760 e.Å-3 
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Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
202. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
 x y z U(eq) 
Cl(1) 2737(1) 82(4) 9740(1) 29(1) 
Cl(2) 2842(1) 4328(4) 9049(1) 30(1) 
Cl(11) 7210(1) 9607(4) 5235(1) 32(1) 
Cl(9) 2103(1) 6870(4) 8519(1) 34(1) 
Cl(4) 2793(1) 5903(4) 7334(1) 30(1) 
Cl(10) 6912(1) 9494(4) 6519(1) 29(1) 
Cl(8) 1783(1) 10893(5) 9067(1) 33(1) 
Cl(5) 2814(1) 1820(4) 6537(1) 33(1) 
Cl(12) 7170(1) 13761(4) 6005(1) 34(1) 
Cl(3) 3036(1) 19(4) 8447(1) 32(1) 
Cl(7) 2115(1) 11156(4) 7815(1) 34(1) 
Cl(6) 3121(1) 6031(5) 6078(1) 36(1) 
O(1) 3456(1) 338(13) 9940(4) 48(2) 
O(9) 1509(2) 8960(12) 7353(3) 30(2) 
O(13) 6561(1) 11377(13) 4885(3) 32(2) 
O(6) 3478(2) 4530(12) 7622(3) 33(2) 
O(10) 813(2) 5922(11) 9143(3) 31(2) 
O(3) 4537(2) 4165(12) 10200(3) 33(2) 
O(12) 194(1) 1680(12) 7940(3) 37(2) 
O(11) 289(2) 6667(12) 7642(3) 38(2) 
N(4) 6402(2) 12753(14) 5881(4) 30(2) 
C(25) 6967(2) 11153(17) 5795(4) 22(2) 
O(4) 4925(1) 5952(14) 9156(3) 37(2) 
O(2) 3903(2) 7405(12) 9286(4) 50(2) 
O(7) 4003(2) 152(12) 5811(3) 38(2) 
N(1) 3572(2) 3239(14) 9234(4) 29(2) 
C(2) 3371(2) 1689(17) 9508(5) 26(2) 
C(1) 3003(2) 1540(14) 9210(4) 19(2) 
C(26) 6615(2) 11781(16) 5469(5) 24(2) 
C(6) 4563(2) 5628(18) 9089(5) 29(2) 
C(18) 1544(2) 8647(17) 7949(5) 24(2) 
C(9) 3042(2) 4320(17) 6775(5) 27(2) 
C(10) 3387(2) 3665(17) 7112(5) 24(2) 
N(3) 1321(2) 7567(14) 8333(4) 32(2) 
C(17) 1871(2) 9375(16) 8322(5) 26(2) 
C(5) 4413(2) 5864(17) 9750(4) 26(2) 
C(3) 3930(2) 3331(17) 9362(5) 26(2) 
C(13) 4276(2) -1789(16) 7354(5) 34(3) 
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C(20) 722(2) 6818(17) 8501(5) 28(2) 
N(2) 3559(2) 2143(17) 6774(5) 48(3) 
C(11) 3907(2) 1469(17) 6934(5) 30(2) 
C(4) 4028(2) 5597(16) 9688(5) 28(2) 
C(27) 6063(2) 13437(18) 5673(5) 33(3) 
C(24) 1093(2) 3887(17) 7927(5) 34(3) 
C(19) 1016(2) 6458(16) 8054(5) 24(2) 
C(15) 4117(2) 1678(17) 6329(5) 30(2) 
C(8) 4106(2) 3013(17) 8713(5) 32(3) 
C(22) 483(2) 3035(16) 8138(5) 29(2) 
C(14) 4478(2) 905(18) 6481(5) 33(2) 
C(21) 408(2) 5564(18) 8236(5) 31(3) 
C(23) 764(2) 2746(16) 7661(5) 33(3) 
C(30) 5444(2) 16011(18) 5850(4) 26(2) 
O(14) 5118(1) 16866(12) 5635(3) 32(2) 
C(31) 5667(4) 16380(30) 5214(10) 20(4) 
O(15) 5551(3) 14830(20) 4696(6) 22(3) 
C(32) 6027(4) 15610(30) 5379(10) 21(4) 
O(16) 6159(3) 17290(30) 5838(7) 32(3) 
C(29) 5456(4) 13740(30) 6090(9) 13(4) 
C(30A) 5444(2) 16011(18) 5850(4) 26(2) 
O(14A) 5118(1) 16866(12) 5635(3) 32(2) 
C(31A) 5713(5) 17040(40) 5504(11) 34(5) 
O(15A) 5653(3) 16620(20) 4798(7) 33(3) 
C(32A) 6068(5) 16200(40) 5681(10) 24(4) 
O(16A) 6113(3) 17050(20) 6358(7) 34(3) 
C(29A) 5449(5) 13270(40) 5783(12) 38(6) 
O(50) 4774(3) -2870(20) 6836(6) 19(3) 
O(50A) 4870(3) -1690(30) 6856(7) 34(4) 
C(12) 3913(2) -990(19) 7206(6) 41(3) 
C(7) 4489(2) 3296(18) 8783(5) 34(3) 
O(8) 4626(2) 2410(12) 6971(3) 40(2) 
C(51) 5810(2) 12810(20) 6184(8) 75(5) 
C(16) 4481(2) -1530(20) 6736(6) 40(3) 
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Bond lengths [Å] for 202 
Cl(1)-C(1)  1.742(9) 
Cl(2)-C(1)  1.774(9) 
Cl(11)-C(25)  1.753(9) 
Cl(9)-C(17)  1.768(9) 
Cl(4)-C(9)  1.777(10) 
Cl(10)-C(25)  1.772(9) 
Cl(8)-C(17)  1.788(10) 
Cl(5)-C(9)  1.776(10) 
Cl(12)-C(25)  1.767(10) 
Cl(3)-C(1)  1.786(9) 
Cl(7)-C(17)  1.765(9) 
Cl(6)-C(9)  1.760(10) 
O(1)-C(2)  1.217(11) 
O(9)-C(18)  1.224(11) 
O(13)-C(26)  1.219(10) 
O(6)-C(10)  1.194(10) 
O(10)-C(20)  1.438(10) 
O(3)-C(5)  1.425(10) 
O(12)-C(22)  1.443(10) 
O(11)-C(21)  1.432(10) 
N(4)-C(26)  1.328(12) 
N(4)-C(27)  1.457(11) 
C(25)-C(26)  1.575(11) 
O(4)-C(6)  1.451(9) 
O(2)-C(4)  1.416(10) 
O(7)-C(15)  1.439(10) 
N(1)-C(2)  1.335(12) 
N(1)-C(3)  1.439(10) 
C(2)-C(1)  1.571(11) 
C(6)-C(5)  1.482(12) 
C(6)-C(7)  1.520(13) 
C(18)-N(3)  1.347(12) 
C(18)-C(17)  1.546(11) 
C(9)-C(10)  1.566(12) 
C(10)-N(2)  1.319(12) 
N(3)-C(19)  1.473(10) 
C(5)-C(4)  1.536(11) 
C(3)-C(8)  1.512(13) 
C(3)-C(4)  1.524(13) 
C(13)-C(16)  1.512(14) 
C(13)-C(12)  1.540(12) 
C(20)-C(19)  1.506(12) 
C(20)-C(21)  1.531(12) 
N(2)-C(11)  1.465(10) 
C(11)-C(15)  1.502(13) 
C(11)-C(12)  1.536(14) 
C(27)-C(32)  1.41(2) 
C(27)-C(51)  1.503(15) 
C(27)-C(32A)  1.61(2) 
C(24)-C(23)  1.550(12) 
C(24)-C(19)  1.552(12) 
C(15)-C(14)  1.528(12) 
C(8)-C(7)  1.532(11) 
C(22)-C(23)  1.501(13) 
C(22)-C(21)  1.518(13) 
C(14)-O(8)  1.439(10) 
C(14)-C(16)  1.509(14) 
C(30)-C(29)  1.410(19) 
C(30)-O(14)  1.444(9) 
C(30)-C(31)  1.59(2) 
C(31)-O(15)  1.45(2) 
C(31)-C(32)  1.53(2) 
C(32)-O(16)  1.44(2) 
C(29)-C(51)  1.514(18) 
C(31A)-O(15A)  1.46(2) 
C(31A)-C(32A)  1.53(3) 
C(32A)-O(16A)  1.46(2) 
C(29A)-C(51)  1.65(2) 
O(50)-C(16)  1.413(13) 
O(50A)-C(16)  1.560(16) 
Bond angles [°] for 202 
C(26)-N(4)-C(27)  122.3(8) 
C(26)-C(25)-Cl(11) 110.1(6) 
C(26)-C(25)-Cl(12) 107.1(7) 
Cl(11)-C(25)-Cl(12) 110.2(5) 
C(26)-C(25)-Cl(10) 110.3(6) 
Cl(11)-C(25)-Cl(10) 109.5(5) 
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Cl(12)-C(25)-Cl(10) 109.6(5) 
C(2)-N(1)-C(3) 123.1(8) 
O(1)-C(2)-N(1) 125.3(8) 
O(1)-C(2)-C(1) 118.7(8) 
N(1)-C(2)-C(1) 115.9(8) 
C(2)-C(1)-Cl(1) 111.2(6) 
C(2)-C(1)-Cl(2) 110.3(6) 
Cl(1)-C(1)-Cl(2) 109.9(5) 
C(2)-C(1)-Cl(3) 105.9(6) 
Cl(1)-C(1)-Cl(3) 110.2(4) 
Cl(2)-C(1)-Cl(3) 109.3(5) 
O(13)-C(26)-N(4) 126.1(9) 
O(13)-C(26)-C(25) 119.7(8) 
N(4)-C(26)-C(25) 114.2(8) 
O(4)-C(6)-C(5) 108.8(7) 
O(4)-C(6)-C(7) 109.7(8) 
C(5)-C(6)-C(7) 111.8(8) 
O(9)-C(18)-N(3) 125.0(8) 
O(9)-C(18)-C(17) 121.1(9) 
N(3)-C(18)-C(17) 113.9(8) 
C(10)-C(9)-Cl(6) 108.5(6) 
C(10)-C(9)-Cl(5) 110.7(7) 
Cl(6)-C(9)-Cl(5) 110.3(5) 
C(10)-C(9)-Cl(4) 110.2(6) 
Cl(6)-C(9)-Cl(4) 109.0(5) 
Cl(5)-C(9)-Cl(4) 108.1(5) 
O(6)-C(10)-N(2) 125.7(8) 
O(6)-C(10)-C(9) 121.0(9) 
N(2)-C(10)-C(9) 113.3(8) 
C(18)-N(3)-C(19) 122.1(8) 
C(18)-C(17)-Cl(7) 110.2(7) 
C(18)-C(17)-Cl(9) 108.1(6) 
Cl(7)-C(17)-Cl(9) 109.0(5) 
C(18)-C(17)-Cl(8) 111.6(6) 
Cl(7)-C(17)-Cl(8) 108.6(5) 
Cl(9)-C(17)-Cl(8) 109.3(5) 
O(3)-C(5)-C(6) 111.7(8) 
O(3)-C(5)-C(4) 108.1(7) 
C(6)-C(5)-C(4) 109.7(7) 
N(1)-C(3)-C(8) 108.3(8) 
N(1)-C(3)-C(4) 110.7(8) 
C(8)-C(3)-C(4) 111.2(8) 
C(16)-C(13)-C(12) 109.2(8) 
O(10)-C(20)-C(19) 107.9(7) 
O(10)-C(20)-C(21) 109.2(7) 
C(19)-C(20)-C(21) 111.0(7) 
C(10)-N(2)-C(11) 124.1(8) 
N(2)-C(11)-C(15) 109.7(8) 
N(2)-C(11)-C(12) 109.7(8) 
C(15)-C(11)-C(12) 111.3(8) 
O(2)-C(4)-C(3) 108.2(7) 
O(2)-C(4)-C(5) 107.9(7) 
C(3)-C(4)-C(5) 111.6(8) 
C(32)-C(27)-N(4) 116.9(11) 
C(32)-C(27)-C(51) 116.6(11) 
N(4)-C(27)-C(51) 111.3(9) 
C(32)-C(27)-C(32A) 26.4(9) 
N(4)-C(27)-C(32A) 105.0(10) 
C(51)-C(27)-C(32A) 104.2(11) 
C(23)-C(24)-C(19) 107.8(7) 
N(3)-C(19)-C(20) 110.5(7) 
N(3)-C(19)-C(24) 108.9(7) 
C(20)-C(19)-C(24) 113.0(8) 
O(7)-C(15)-C(11) 111.7(8) 
O(7)-C(15)-C(14) 104.1(8) 
C(11)-C(15)-C(14) 110.4(8) 
C(3)-C(8)-C(7) 112.6(8) 
O(12)-C(22)-C(23) 111.0(7) 
O(12)-C(22)-C(21) 114.2(8) 
C(23)-C(22)-C(21) 110.1(8) 
O(8)-C(14)-C(16) 109.8(8) 
O(8)-C(14)-C(15) 109.0(8) 
C(16)-C(14)-C(15) 110.2(8) 
O(11)-C(21)-C(22) 112.9(9) 
O(11)-C(21)-C(20) 109.2(8) 
C(22)-C(21)-C(20) 110.4(7) 
C(22)-C(23)-C(24) 111.1(8) 
C(29)-C(30)-O(14) 116.8(9) 
C(29)-C(30)-C(31) 112.8(11) 
O(14)-C(30)-C(31) 102.8(9) 
O(15)-C(31)-C(32) 104.8(15) 
O(15)-C(31)-C(30) 109.1(13) 
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C(32)-C(31)-C(30) 108.6(15) 
C(27)-C(32)-O(16) 107.9(14) 
C(27)-C(32)-C(31) 116.1(15) 
O(16)-C(32)-C(31) 105.6(15) 
C(30)-C(29)-C(51) 113.9(12) 
O(15A)-C(31A)-C(32A) 107.7(17) 
O(16A)-C(32A)-C(31A) 101.6(16) 
O(16A)-C(32A)-C(27) 110.5(14) 
C(31A)-C(32A)-C(27) 107.9(16) 
C(11)-C(12)-C(13) 111.0(8) 
C(6)-C(7)-C(8) 108.4(8) 
C(27)-C(51)-C(29) 117.4(11) 
C(27)-C(51)-C(29A) 102.1(12) 
C(29)-C(51)-C(29A) 24.3(10) 
O(50)-C(16)-C(14) 124.7(10) 
O(50)-C(16)-C(13) 106.4(9) 
C(14)-C(16)-C(13) 112.1(9) 
O(50)-C(16)-O(50A) 30.3(7) 
C(14)-C(16)-O(50A) 96.2(10) 
C(13)-C(16)-O(50A) 114.4(10)
Anisotropic displacement parameters (Å2x 103)for 202. The anisotropic displacement factor 
exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12] 
 U11 U22 U33 U23 U13 U12 
Cl(1) 26(1)  29(2) 32(2)  3(1) 6(1)  -3(1) 
Cl(2) 22(1)  28(1) 39(2)  5(1) -1(1)  5(1) 
Cl(11) 25(1)  36(2) 35(2)  -3(1) 2(1)  9(1) 
Cl(9) 26(1)  26(1) 48(2)  5(1) -4(1)  0(1) 
Cl(4) 24(1)  36(2) 29(1)  -5(1) 3(1)  6(1) 
Cl(10) 27(1)  32(2) 29(1)  9(1) 2(1)  4(1) 
Cl(8) 26(1)  41(2) 33(1)  -14(1) 0(1)  -5(1) 
Cl(5) 22(1)  30(2) 47(2)  -7(1) -2(1)  -2(1) 
Cl(12) 30(1)  26(2) 46(2)  -4(1) -2(1)  -8(1) 
Cl(3) 36(1)  33(2) 29(1)  -10(1) 8(1)  -7(1) 
Cl(7) 35(1)  36(2) 31(1)  6(1) -2(1)  -7(1) 
Cl(6) 37(1)  38(2) 32(1)  7(1) 4(1)  4(1) 
O(1) 24(3)  62(6) 60(5)  40(5) 2(3)  6(4) 
O(9) 29(3)  40(5) 20(4)  -9(3) -4(3)  6(3) 
O(13) 24(3)  50(5) 20(4)  -9(4) 2(3)  5(3) 
O(6) 30(3)  39(4) 29(4)  -3(4) -5(3)  2(3) 
O(10) 34(4)  29(4) 29(4)  -6(3) -3(3)  6(3) 
O(3) 29(3)  38(4) 31(4)  7(3) -13(3)  -4(3) 
O(12) 25(3)  47(5) 38(4)  10(4) -5(3)  -10(3) 
O(11) 31(4)  57(5) 26(4)  7(4) -10(3)  -4(4) 
N(4) 19(4)  42(5) 30(5)  -14(4) 3(4)  11(4) 
C(25) 25(4)  30(6) 12(5)  -2(4) -2(4)  1(4) 
O(4) 15(3)  66(5) 28(4)  8(4) 1(3)  -7(3) 
O(2) 39(5)  25(4) 86(7)  15(4) -5(4)  4(3) 
O(7) 31(4)  47(5) 37(4)  -17(4) -7(3)  12(3) 
N(1) 15(4)  31(5) 40(5)  16(4) -9(4)  0(4) 
C(2) 27(5)  26(6) 23(5)  -2(4) 5(4)  8(5) 
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C(1) 23(4)  12(5) 21(5)  -1(4) 3(4)  -10(4) 
C(26) 27(5)  21(5) 25(6)  0(4) 3(4)  -11(4) 
C(6) 17(4)  40(7) 29(6)  13(5) -4(4)  -5(5) 
C(18) 21(5)  22(5) 29(6)  -7(5) -10(4)  6(4) 
C(9) 31(5)  29(6) 19(5)  2(5) -5(4)  -1(5) 
C(10) 17(4)  24(5) 29(6)  -2(5) -5(4)  0(4) 
N(3) 31(5)  34(5) 30(5)  -5(4) -16(4)  -5(4) 
C(17) 25(5)  17(5) 37(6)  3(5) 1(4)  -2(4) 
C(5) 31(5)  29(6) 18(5)  7(4) 0(4)  -1(5) 
C(3) 17(5)  33(6) 28(6)  3(5) -13(4)  -9(4) 
C(13) 51(6)  21(6) 30(6)  0(4) -2(5)  14(5) 
C(20) 19(4)  30(6) 34(6)  -2(5) 1(4)  4(4) 
N(2) 19(4)  77(7) 48(6)  -35(6) -9(4)  18(5) 
C(11) 16(4)  33(6) 40(6)  -10(5) 0(4)  6(4) 
C(4) 12(4)  32(6) 41(6)  11(5) 8(4)  6(4) 
C(27) 35(6)  36(6) 26(6)  -13(5) -19(5)  8(5) 
C(24) 26(5)  35(7) 42(7)  -21(5) 8(5)  1(5) 
C(19) 14(4)  29(6) 28(5)  -9(4) -5(4)  -14(4) 
C(15) 33(5)  31(6) 27(6)  -2(5) -11(4)  -4(5) 
C(8) 39(6)  29(6) 28(6)  4(5) -9(5)  -9(5) 
C(22) 23(5)  37(6) 27(6)  -4(5) -2(4)  -16(4) 
C(14) 24(5)  40(7) 36(6)  -7(5) -4(4)  -8(5) 
C(21) 20(5)  45(7) 29(6)  13(5) -4(4)  1(5) 
C(23) 37(6)  30(6) 31(6)  -10(5) -8(5)  -9(5) 
C(30) 13(4)  46(7) 20(5)  -13(5) 3(4)  13(5) 
O(14) 13(3)  46(5) 36(4)  -4(4) 2(3)  5(3) 
C(30A) 13(4)  46(7) 20(5)  -13(5) 3(4)  13(5) 
O(14A) 13(3)  46(5) 36(4)  -4(4) 2(3)  5(3) 
C(12) 35(6)  47(8) 40(7)  -5(6) 12(5)  -4(6) 
C(7) 16(5)  59(7) 27(6)  -4(5) 5(4)  6(5) 
O(8) 27(4)  59(5) 32(4)  -6(4) -6(3)  -13(3) 
C(51) 12(5)  71(10) 141(14)  53(9) -6(7)  -11(6) 
C(16) 28(5)  56(8) 38(7)  3(6) 4(5)  20(5) 
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Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 202 
 x  y  z  U(eq) 
H(10) 718 6664 9428 46 
H(53) 4736 4411 10287 49 
H(12) 30 2519 7890 55 
H(511) 332 5862 7322 57 
H(44) 6466 12987 6284 36 
H(54A) 5004 6168 8790 55 
H(52) 3771 8185 9497 75 
H(7) 3886 865 5542 58 
H(1) 3483 4231 8967 35 
H(6) 4470 6822 8797 34 
H(43) 1357 7524 8753 38 
H(5) 4466 7388 9928 31 
H(3A) 3994 2071 9660 31 
H(13A) 4375 -875 7709 41 
H(13B) 4276 -3380 7493 41 
H(20) 674 8461 8536 33 
H(42) 3460 1506 6438 58 
H(11) 3998 2505 7275 36 
H(4A) 3930 5691 10128 34 
H(27) 6010 12383 5308 39 
H(24A) 1269 3738 7606 41 
H(24B) 1167 3151 8335 41 
H(19) 962 7181 7627 28 
H(15) 4115 3265 6169 36 
H(8A) 4019 4125 8396 39 
H(8B) 4056 1495 8542 39 
H(22) 564 2436 8566 35 
H(14) 4609 984 6076 40 
H(21) 232 5696 8567 38 
H(23A) 699 3432 7239 40 
H(23B) 804 1125 7588 40 
H(30A) 5531 17025 6201 32 
H(514) 4971 15971 5750 48 
H(31) 5660 17976 5064 25 
H(15A) 5355 15123 4595 33 
H(32) 6159 15659 4975 25 
H(516) 6349 17663 5730 48 
H(29A) 5332 12757 5783 15 
H(29B) 5343 13680 6510 15 
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H(30B) 5474 16389 6320 32 
H(31A) 5705 18700 5579 40 
H(15B) 5761 17543 4582 49 
H(32A) 6237 16824 5385 29 
H(16A) 6240 16189 6565 51 
H(29C) 5456 12772 5326 45 
H(29D) 5261 12551 6000 45 
H(50) 4879 -2929 6491 29 
H(50A) 4964 -1627 6501 51 
H(12A) 3807 -2015 6886 49 
H(12B) 3785 -1055 7609 49 
H(7A) 4582 2092 9062 40 
H(7B) 4590 3190 8352 40 
H(8) 4728 1649 7252 59 
H(51A) 5896 13326 6611 90 
H(51B) 5795 11150 6202 90 
H(16) 4351 -2377 6400 48 
_________________________________________________________________________ 
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Crystal data and structure refinement for 255 
Identification code  255 
Empirical formula  C14 H15 N O6 
Formula weight  293.27 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 6.5782(4) Å = 90°. 
 b = 8.7302(5) Å = 90°. 
 c = 21.2398(12) Å  = 90°. 
Volume 1219.78(12) Å3 
Z 4 
Density (calculated) 1.597 Mg/m3 
Absorption coefficient 0.126 mm-1 
F(000) 616 
Crystal size 0.50 x 0.20 x 0.10 mm3 
Theta range for data collection 1.92 to 27.21°. 
Index ranges -8<=h<=8, -10<=k<=11, -26<=l<=27 
Reflections collected 16471 
Independent reflections 1603 [R(int) = 0.0604] 
Completeness to theta = 27.21° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9875 and 0.9396 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1603 / 0 / 211 
Goodness-of-fit on F2 1.083 
Final R indices [I>2sigma(I)] R1 = 0.0334, wR2 = 0.0839 
R indices (all data) R1 = 0.0372, wR2 = 0.0857 
Absolute structure parameter 0.7(12) 
Largest diff. peak and hole 0.319 and -0.171 e.Å-3 
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Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) for 
255. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
 x y z U(eq) 
O(3) 12915(2) 3030(2) 8313(1) 15(1) 
O(4) 11547(3) 1263(2) 9381(1) 17(1) 
O(6) 5427(2) 325(2) 8932(1) 16(1) 
O(7) 6028(2) 3258(2) 6949(1) 16(1) 
O(10) 11951(3) 1587(2) 5447(1) 20(1) 
O(11) 14478(3) 594(2) 6093(1) 16(1) 
N(1) 6811(3) 1888(2) 7822(1) 14(1) 
C(1) 8088(3) 740(2) 8140(1) 12(1) 
C(2) 10330(3) 1176(2) 8045(1) 11(1) 
C(3) 10808(3) 2668(2) 8411(1) 13(1) 
C(4) 10350(3) 2461(2) 9113(1) 14(1) 
C(5) 8112(4) 2056(3) 9207(1) 15(1) 
C(6) 7552(3) 615(2) 8840(1) 13(1) 
C(7) 7211(3) 2402(2) 7236(1) 13(1) 
C(8) 9185(3) 1900(2) 6958(1) 13(1) 
C(9) 9462(4) 2055(2) 6302(1) 15(1) 
C(10) 11309(3) 1596(2) 6065(1) 15(1) 
C(11) 12824(3) 1017(2) 6451(1) 14(1) 
C(12) 12589(3) 852(2) 7090(1) 13(1) 
C(13) 10724(3) 1312(2) 7346(1) 12(1) 
C(14) 14097(4) 1267(3) 5480(1) 19(1) 
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Bond lengths [Å] for 255 
O(3)-C(3)  1.437(3) 
O(3)-H(3)  0.8400 
O(4)-C(4)  1.427(3) 
O(4)-H(4)  0.8400 
O(6)-C(6)  1.434(3) 
O(6)-H(6)  0.8400 
O(7)-C(7)  1.240(3) 
O(10)-C(10)  1.380(3) 
O(10)-C(14)  1.440(3) 
O(11)-C(11)  1.378(3) 
O(11)-C(14)  1.449(3) 
N(1)-C(7)  1.348(3) 
N(1)-C(1)  1.472(3) 
N(1)-H(1N)  0.92(3) 
C(1)-C(6)  1.531(3) 
C(1)-C(2)  1.537(3) 
C(1)-H(1)  1.0000 
C(2)-C(13)  1.510(3) 
C(2)-C(3)  1.550(3) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.530(3) 
C(3)-H(3A)  1.0000 
C(4)-C(5)  1.527(3) 
C(4)-H(4A)  1.0000 
C(5)-C(6)  1.526(3) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-H(6A)  1.0000 
C(7)-C(8)  1.492(3) 
C(8)-C(13)  1.403(3) 
C(8)-C(9)  1.412(3) 
C(9)-C(10)  1.374(3) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.386(3) 
C(11)-C(12)  1.373(3) 
C(12)-C(13)  1.401(3) 
C(12)-H(12)  0.9500 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
Bond angles [°] for 255 
C(3)-O(3)-H(3) 109.5 
C(4)-O(4)-H(4) 109.5 
C(6)-O(6)-H(6) 109.5 
C(10)-O(10)-C(14) 104.74(17) 
C(11)-O(11)-C(14) 104.53(17) 
C(7)-N(1)-C(1) 122.59(18) 
C(7)-N(1)-H(1N) 118.1(19) 
C(1)-N(1)-H(1N) 117.6(19) 
N(1)-C(1)-C(6) 111.25(17) 
N(1)-C(1)-C(2) 108.59(16) 
C(6)-C(1)-C(2) 111.52(17) 
N(1)-C(1)-H(1) 108.5 
C(6)-C(1)-H(1) 108.5 
C(2)-C(1)-H(1) 108.5 
C(13)-C(2)-C(1) 108.28(17) 
C(13)-C(2)-C(3) 113.10(16) 
C(1)-C(2)-C(3) 109.67(17) 
C(13)-C(2)-H(2) 108.6 
C(1)-C(2)-H(2) 108.6 
C(3)-C(2)-H(2) 108.6 
O(3)-C(3)-C(4) 110.96(18) 
O(3)-C(3)-C(2) 107.87(17) 
C(4)-C(3)-C(2) 110.47(16) 
O(3)-C(3)-H(3A) 109.2 
C(4)-C(3)-H(3A) 109.2 
C(2)-C(3)-H(3A) 109.2 
O(4)-C(4)-C(5) 108.05(17) 
O(4)-C(4)-C(3) 111.54(17) 
C(5)-C(4)-C(3) 110.15(17) 
O(4)-C(4)-H(4A) 109.0 
C(5)-C(4)-H(4A) 109.0 
C(3)-C(4)-H(4A) 109.0 
C(6)-C(5)-C(4) 110.89(18) 
C(6)-C(5)-H(5A) 109.5 
C(4)-C(5)-H(5A) 109.5 
C(6)-C(5)-H(5B) 109.5 
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C(4)-C(5)-H(5B) 109.5 
H(5A)-C(5)-H(5B) 108.1 
O(6)-C(6)-C(5) 108.13(18) 
O(6)-C(6)-C(1) 111.69(17) 
C(5)-C(6)-C(1) 112.44(17) 
O(6)-C(6)-H(6A) 108.1 
C(5)-C(6)-H(6A) 108.1 
C(1)-C(6)-H(6A) 108.1 
O(7)-C(7)-N(1) 122.2(2) 
O(7)-C(7)-C(8) 121.9(2) 
N(1)-C(7)-C(8) 115.97(19) 
C(13)-C(8)-C(9) 121.4(2) 
C(13)-C(8)-C(7) 120.15(19) 
C(9)-C(8)-C(7) 118.4(2) 
C(10)-C(9)-C(8) 116.6(2) 
C(10)-C(9)-H(9) 121.7 
C(8)-C(9)-H(9) 121.7 
C(9)-C(10)-O(10) 128.3(2) 
C(9)-C(10)-C(11) 121.7(2) 
O(10)-C(10)-C(11) 109.9(2) 
C(12)-C(11)-O(11) 127.3(2) 
C(12)-C(11)-C(10) 122.8(2) 
O(11)-C(11)-C(10) 109.80(18) 
C(11)-C(12)-C(13) 116.9(2) 
C(11)-C(12)-H(12) 121.5 
C(13)-C(12)-H(12) 121.5 
C(12)-C(13)-C(8) 120.55(19) 
C(12)-C(13)-C(2) 120.62(19) 
C(8)-C(13)-C(2) 118.8(2) 
O(10)-C(14)-O(11) 106.99(17) 
O(10)-C(14)-H(14A) 110.3 
O(11)-C(14)-H(14A) 110.3 
O(10)-C(14)-H(14B) 110.3 
O(11)-C(14)-H(14B) 110.3 
H(14A)-C(14)-H(14B) 108.6
Anisotropic displacement parameters (Å2x 103) for 255. The anisotropic displacement factor 
exponent takes the form: -22[ h2a*2U11 + ... + 2 h k a* b* U12] 
 U11 U22 U33 U23 U13 U12 
O(3) 13(1)  16(1) 18(1)  -3(1) 1(1)  -2(1) 
O(4) 14(1)  22(1) 16(1)  3(1) 1(1)  3(1) 
O(6) 15(1)  18(1) 16(1)  -2(1) 3(1)  -3(1) 
O(7) 15(1)  15(1) 17(1)  1(1) -2(1)  1(1) 
O(10) 20(1)  28(1) 11(1)  1(1) 2(1)  3(1) 
O(11) 16(1)  19(1) 14(1)  0(1) 3(1)  0(1) 
N(1) 11(1)  15(1) 15(1)  0(1) 1(1)  1(1) 
C(1) 12(1)  11(1) 13(1)  1(1) 0(1)  -1(1) 
C(2) 12(1)  12(1) 9(1)  -1(1) -1(1)  1(1) 
C(3) 12(1)  12(1) 13(1)  -1(1) -1(1)  0(1) 
C(4) 15(1)  15(1) 10(1)  -1(1) -1(1)  0(1) 
C(5) 16(1)  16(1) 14(1)  -2(1) 2(1)  2(1) 
C(6) 13(1)  14(1) 12(1)  1(1) 1(1)  0(1) 
C(7) 13(1)  11(1) 15(1)  -3(1) -2(1)  -4(1) 
C(8) 14(1)  10(1) 15(1)  0(1) -1(1)  -2(1) 
C(9) 16(1)  14(1) 16(1)  1(1) -2(1)  0(1) 
C(10) 20(1)  14(1) 11(1)  1(1) -1(1)  -4(1) 
C(11) 13(1)  11(1) 17(1)  -2(1) 2(1)  -2(1) 
C(12) 14(1)  9(1) 15(1)  0(1) -1(1)  -2(1) 
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C(13) 16(1)  9(1) 11(1)  -1(1) -2(1)  -2(1) 
C(14) 21(1)  22(1) 15(1)  1(1) 3(1)  0(1) 
Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 255 
 x  y  z  U(eq) 
H(3) 13206 3839 8506 43(10) 
H(4) 12733 1307 9236 33(9) 
H(6) 5074 -431 8713 37(9) 
H(1) 7846 -278 7938 12(6) 
H(2) 11199 334 8217 17(7) 
H(3A) 9950 3519 8241 10(6) 
H(4A) 10651 3441 9338 14(6) 
H(5A) 7844 1890 9660 14(6) 
H(5B) 7254 2920 9063 23(7) 
H(6A) 8330 -264 9021 14(6) 
H(9) 8426 2457 6038 30(8) 
H(12) 13642 445 7346 10(6) 
H(14A) 14889 2224 5430 40(9) 
H(14B) 14496 547 5142 28(8) 
H(1N) 5540(50) 2080(30) 7988(14) 30(8) 
___________________________________________________________________________ 
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